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ýý-  ý  ýý, Summary 
Recurrent  aphthous  stomatitis  is  the  most  common  condition  affecting  the  oral 
mucosa.  It  is  characterised  by  painful,  recurrent  oral  ulcers  which  appear  singly  or  in 
crops  and  heal  spontaneously.  Recurrent  aphthae  have  a  multifactorial  aetiology, 
although  the  basic  defect  suggested  in  many  published  investigations  an 
immunological  imbalance  caused  by  a  micro-organism.  The  aim  of  these  studies  was 
to  research  different  aspects  of  the  pathogenesis  and  therapeutic  features  of  recurrent 
aphthous  stomatitis. 
The  investigations  in  this  thesis  were  carried  out  in  two  groups  of  aphthous  patients, 
who  attended  the  Oral  Medicine  Clinic  in  different  periods  of  time  and  the  data  were 
analysed  in  a  different  way  in  each  group.  The  first  group  of  252  patients,  were 
studied  prospectively  and  a  second  group  of  213  patients  were  initially  studied 
retrospectively.  Haematological  investigations  and  therapeutic  effects  of  vitamins  and 
minerals  were  studied  and  were  compared  with  a  control  group.  For  the  first  time  in 
Glasgow  Dental  Hospital  and  School,  a  special  computer  program  for  oral  ulceration 
was  applied  for  the  collection  and  analysing  of  the  data  in  one  of  the  groups  of 
aphthous  patients. 
Food  allergens  as  environmental  factors  were  tested  in  295  patients  with  aphthae  as 
well  as  100  control  subjects.  Although  the  results  were  unable  to  prove  the 
involvement  of  food  additives  in  recurrent  aphthous  stomatitis,  reviewing  those 
patients  with  a  positive  allergic  reaction  showed  that  in  many  of  these  patients 
avoiding  the  allergens  may  potentially  improve  their  condition. 
2 Investigation  of  haematological  deficiencies  also  did  not  support  a  correlation  of  these 
deficiencies  with  recurrent  aphthous  stomatitis.  But  after  replacement  therapy,  during 
the  follow-up  time  available,  41  per  cent  of  patients  showed  some  improvement  in  the 
severity  of  their  ulceration. 
In  reviewing  the  literature,  symptomatic  therapy  was  found  to  be  ineffective  at 
inducing  remission  of  the  disease.  However,  it  is  the  only  treatment  for  many  patients 
for  decreasing  the  severity  of  the  disease.  A  topical  cream  of  5  amino-salicylate  was 
examined  in  a  double-blind  trial  with  cross-over.  However,  the  effect  of  this  cream 
could  not  be  distinguished  by  this  trial,  but  in  a  double-blind  study  without  a  cross- 
over,  a  minor  effect  of  the  drug  was  found. 
In  support  of  the  involvement  of  viruses  in  the  aetiology  of  recurrent  aphthous 
stomatitis,  the  nested  PCR  and  assays  of  ELISA  and  IFA  were  employed.  Results  of 
PCR  investigations  showed  that  HHV-6  DNA  was  present  in  29  per  cent  of  aphthous 
lesions.  Using  ELISA,  specific  IgG  antibodies  against  HHV-6  were  detected  in  96.7 
per  cent  of  all  serum  samples  with  no  significant  difference  between  aphthous  patients, 
oral  lichen  planus  or  control  subjects.  Specific  IgM  antibodies  against  HHV-6  was 
found  in  a  higher  prevalence  rate  in  aphthous  samples  compared  with  the  two  other 
groups:  a  significant  difference  of  p=0.01  was  found  between  sera  of  aphthous 
patients  compared  with  healthy  controls. 
HCMV  and  VZV  DNA  were  not  detected  in  aphthous  samples.  Also  serological 
findings  did  not  show  any  significant  increase  in  the  prevalence  of  specific  IgG 
antibodies  against  these  two  viruses.  Serum  IgM  antibodies  against  HCMV  were 
3 positive  in  a  small  number  of  samples  with  no  difference  between  groups  and  IgM 
antibody  against  VZV  was  not  positive  in  any  serum  samples.  These  data  fail  to  show 
that  recurrent  aphthous  stomatitis  can  be  a  manifestation  of  VZV  or  HCMV  infection 
or  reactivation.  However,  the  possibility  of  involvement  of  HHV-6  is  raised  by  the 
present  studies. 
The  possible  involvement  of  Mycobacterium  paratuberculosis  was  examined  by  the 
nested  PCR  investigations.  Although  mycobacterial  DNA  was  detected  only  in  four 
biopsy  samples  of  aphthous  patients  and  in  none  of  the  oral  lichen  planus  patients  or 
controls,  this  difference  was  not  significant  and  more  research  is  necessary  to  confirm 
such  involvement. 
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8 Glossary  of  Abbreviations 
5  ASA.  5  Amino-Salicylate 
ADCC.  Antibody  Dependent  Cellular  Cytotoxicity 
ATCC.  American  Type  Culture  Collection 
B-cell.  Bursa  Equivalent  Cell 
BPC  British  Pharmaceutical  Codex 
C.  Complement 
CD.  Cluster  of  Differentiation 
ELISA.  Enzyme-Linked  Immunosorbent  Assay 
Hb.  Haemoglobin 
HCMV.  Human  Cytomegalovirus 
HHV-6.  Human  Herpes  Virus  type  6 
HIV.  Human  Immunodeficiency  Virus 
HLA.  Human  Leukocyte  Antigen 
IFA.  Immunofluorescent  Assay 
Ig.  Immunoglobulin 
KD.  Kilo  Dalton 
MCV.  Mean  Cell  Volume 
OD.  Optical  Density 
PCR.  Polymerase  Chain  Reaction 
POD.  Peroxidase 
RAS.  Recurrent  Aphthous  Stomatitis 
Reference  P/N  Human  Ig  specific  for  virus  in  Tris  buffer  solution 
RPM.  Round  Per-Minute 
T-cell.  Thymus-Dependent  Cell 
TCR.  T  Cell  Receptor 
VZV.  Varicella  Zoster  Virus 
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17 Chapter  one.  General  Introduction  and  Literature 
Review 
18 Although  recurrent  aphthous  stomatitis  (RAS)  is  the  most  common  disease  of  the  oral 
mucosa,  it  is  one  of  the  least  understood  diseases  of  the  oral  cavity  (Vincent  and  Lilly, 
1992).  Recurrent  aphthous  stomatitis  is  a  disorder  characterised  by  recurring,  self- 
healing  ulcers  confined  to  the  oral  mucosa  (Wray,  1982a;  Greenberg,  1984). 
There  is  an  increasing  body  of  evidence  on  different  aspects  of  recurrent  aphthous 
stomatitis.  Since  the  aetiologic  factors  are  unknown,  laboratory  procedures  to  confirm 
the  diagnosis  of  recurrent  aphthous  stomatitis  have  not  been  established.  However,  an 
autoimmune  or  viral  aetiology  are  possible  factors  (Pedersen  and  Hornsleth,  1993). 
Occasionally  recurrent  aphthous  stomatitis  is  a  manifestation  of  other  syndromes,  such 
as  Behcet's  syndrome,  inflammatory  bowel  diseases  such  as  Crohn's  disease  and 
ulcerative  colitis  (Landesberg  et  al.  1990;  Endre,  1991),  and  some  immunodeficiency 
syndromes,  including  infection  with  human  immunodeficiency  virus  (Scully  and 
Porter,  1989;  Porter  and  Scully,  1993). 
1.1.  Historical  Review 
Hippocrates  (460-370  B.  C.  )  is  credited  with  the  first  use  of  the  word  "aphthai" 
accorded  to  the  prodromal  burning  sensation,  to  describe  an  oral  condition,  although 
the  lesions  described  were  probably  those  of  thrush  infection.  (Sircus  et  al.  1957) 
Similarly  Jourdain-Berchillet  (1849)  discussed  "aphthae"  in  great  detail  but  was  again 
clearly  describing  cases  of  thrush.  Indeed,  the  Oxford  English  Dictionary  defines  the 
word  aphtha  as  "the  infantile  disease  thrush".  (Farmer,  1958) 
19 The  first  clinical  description  of  the  recurrent  oral  ulcerations  which  are  now 
recognised  as  recurrent  aphthous  stomatitis  was  by  Von  Mikulicz  and  Kummel  in 
1888  (Mikulicz  and  Kummel,  1912;  Farmer,  1958)  and  the  first  description  in  the 
English  language  was  by  Sibley  in  1899  (Farmer,  1958). 
Early  publications  on  recurrent  aphthous  stomatitis  were  mainly  descriptive  and 
because  of  the  diversity  seen  in  the  clinical  presentations  and  apparent  aetiologies,  a 
large  number  of  synonyms  arose  to  describe  the  condition  (Table  1.1).  Sutton,  in  1911 
was  the  first  to  distinguish  the  major  formm  of  recurrent  aphthous  stomatitis  and 
termed  it  "peradenitis  mucosa  necrotica  recurrens"  although  this  has  now  been 
supplanted  by  the  term  "major  aphthous  stomatitis"  (Cooke,  1961;  Lehner,  1968).  In 
1960,  Cooke  described  another  type,  "herpetiform  stomatitis",  which  was  named  not 
on  the  basis  of  aetiology  but  on  clinical  appearance. 
1.2.  Clinical  Features 
Patients  with  recurrent  aphthous  stomatitis  are  classified  in  to  three  categories, 
depending  on  the  clinical  features  of  the  lesions:  minor  ulcers  (Mikulicz's  aphthae), 
major  ulcers  (periadenitis  mucosa  necrotica  recurrens,  Sutton's  aphthae,  stomatitis 
aphthous  recurrens  cicatricicans)  and  herpetiform  ulcers  (Lehner,  1968;  Lehner, 
1969c  ;  Wray,  1982a;  Greenberg,  1984;  Axell  and  Henricsson,  1985;  Scully  and 
Porter,  1989;  Pedersen,  1993). 
20 Table  1.1.  Synonyms  which  have  been  used  to  describe  the  Clinical 
entity  of  RAS  (Sircus  et  al.  1957) 
Acute  aphthous  stomatitis 
Canker  sores 
Dyspeptic  ulcers 
Fragmentary  Behcet's  syndrome 
Habitual  solitary  aphthous  ulcer 
Maculofibrinous  stomatitis 
Mikulic's  aphthae 
Periadenitis  mucosa  necrotica  recurrens 
Recurrent  aphthous  stomatitis 
Ulcus  necroticum  mucosae  oris 
Ulcus  neuroticum  mucosae  oris 
Vesicular  stomatitis 
21 Minor  ulcers  are  rounded  and  usually  less  than  10  mm  in  diameter  and  heal  within  4- 
14  days  without  any  scars.  Major  ulcers  are  usually  over  10  mm  in  diameter,  often 
with  irregular  borders  and  scar  on  healing.  The  herpetiform  ulcers  are  rounded,  well- 
demarcated  small  ulcers  of  one  to  two  mm  which  usually  appear  in  crops  of  10-100. 
The  herpetiform  ulcers  may  occasionally  occur  in  a  keratinized  area.  These  ulcers  heal 
without  scars  within  4-14  days  (Wray,  1982a;  Greenberg,  1984;  ]Pedersen,  1993). 
Approximately  80-85  per  cent  of  patients  with  a  diagnosis  of  recurrent  aphthous 
stomatitis  show  minor  ulcers,  7-10  per  cent  major  ulcers  and  7-10  per  cent 
herpetiform  ulcers.  (Wray,  1982c;  Wray,  1984;  Lamey  and  Lewis  1991) 
The  incidence  of  recurrent  aphthous  stomatitis  varies  from  15  per  cent  to  more  than 
50  per  cent  (Brody  and  Silverman,  1969;  Donatsky,  1973),  and  the  prevalence  from 
five  to  sixty-six  per  cent  (Donatsky,  1973;  Scully  and  Porter,  1989;  Porter  and  Scully, 
1991)  in  selected  population  samples.  However,  many  authors  have  reported  an 
incidence  of  20  per  cent  with  a  prevalence  of  two  per  cent  (Sircus  et  al.  1957;  Farmer, 
1958;  Axell  and  Henricsson,  1985;  Porter  and  Scully,  1991;  Pedersen  et  al.  1992; 
Taylor  et  at.  1992;  Hunter  et  al.  1993;  Pedersen  and  Ryder,  1994).  The  disease 
appears  to  have  higher  prevalence  in  females  than  in  males  (Sircus  et  al.  1957;  Farmer, 
1958;  Brody  and  Silverman,  1969;  Donatsky,  1973). 
The  first  appearance  of  ulcers  is  usually  in  childhood  or  the  teenage  years.  The  lesions 
rarely  occur,  for  the  first  time,  after  the  age  of  50  (Farmer,  1958;  Lehner,  1968; 
Brody  and  Silverman,  1969;  Donatsky,  1973;  Scully  and  Porter,  1989).  However,  10 
per  cent  of  females  have  their  first  attack  over  the  age  of  50  (Sircus  et  al.  1957; 
22 Farmer,  1958),  whereas  this  trend  is  not  seen  in  the  male  population  (Farmer,  1958). 
In  males,  ulcers  become  severe  in  the  first  and  third  decades,  in  contrast  to  females, 
where  they  are  more  severe  in  the  second  and  third  decades  (Farmer,  1958). 
Recurrent  aphthous  stomatitis  patients  may  suffer  from  ulcers  for  different  periods 
(weeks,  months  or  years)  and  in  some  severe  cases  ulcers  remain  indefinitely  (Brody 
and  Silverman,  1969;  Donatsky,  1973;  Pedersen,  1993). 
The  lesions  may  appear  asymptomatically  or  begin  with  either  premonitory  tingling,  a 
tenseness,  hyperaesthesia,  a  burning  sensation  or  pain,  a  roughening  or  a  raw 
sensation  of  the  mucosa,  for  a  period  of  up  to  24  hours  at  a  site  where  the  lesion  will 
develop  (Farmer,  1958;  Stanley,  1972) 
In  the  pre-ulcerative  stage,  a  macule  or  slightly  raised  papule  appears,  which  may 
become  slightly  indurated.  A  single  lesion  (or  several  pinhead  nodules)  gradually 
develops  a  superficial  membrane  or  coating,  which  is  surrounded  by  a  dusky  red 
inflammatory  halo.  (Farmer,  1958;  Brody  and  Silverman,  1969;  Stanley,  1972; 
Lennette  and  Magoffin,  1973;  Sciubba,  1984)  The  eventual  shape  of  the  lesion  is 
determined  by  its  site.  Those  on  the  lip  or  cheek  mucosa  are  rounded  or  slightly 
elongated,  while  those  in  the  vestibule  or  sulcus  or  on  the  floor  of  mouth  may  be 
markedly  elongated  or  linear  (Farmer,  1958;  Brody  and  Silverman,  1969;  Stanley, 
1972). 
Recurrent  aphthous  stomatitis  is  characterised  by  recurrent,  self-limiting,  painful, 
single  or  multiple  ulcers  of  the  non-keratinized  oral  and  pharyngeal  mucosa,  and  the 
23 tongue  (Farmer,  1958;  Lennette  and  Magoffin,  1973;  Pedersen,  1993).  Pain  varies  in 
severity  between  individuals  (Stanley,  1972).  Aphthae  occur  on  non-keratinized  oral 
mucosa  such  as  buccal  and  labial  mucosa,  lateral  and  ventral  aspect  of  the  tongue, 
floor  of  mouth  and  soft  palate,  but  occasionally  ulcers  enlarge  to  keratinized  mucosa 
(Vincent  and  Lilly,  1992).  Affected  sites  may  be  different  in  different  recurrent 
aphthous  stomatitis  patients.  Lips  and  buccal  mucosa  are  the  most  common  sites  for 
major,  minor  and  herpetiform  aphthous  ulcers,  but  pharyngeal  involvement  showed  a 
highly  significant  association  with  major  aphthae  (Lehner,  1968).  Although  the  hard 
palate  and  gingivae  are  very  rare  sites,  these  in  addition  to  the  floor  of  the  mouth,  are 
more  common  in  herpetiform  ulcers  (Lehner,  1968). 
In  the  ulcerative  stage,  the  central  superficial  membrane  changes  to  blanching 
necrosis.  During  the  first  to  second  days,  this  blanched  area  or  membrane  sloughs,  and 
a  shallow  well-defined  ulcer  is left  behind  (Stanley,  1972).  A  grey-white  or  yellowish 
fibrinous  exudate  or  clot  then  forms  over  the  floor  of  the  ulcer  (Farmer,  1958; 
Graykowski  et  al.  1966;  Stanley,  1972;  Pedersen,  1993).  The  small  and  painful  ulcer 
may  continue  to  enlarge  for  4  to  6  days,  until  it  reaches  its  maximum  size.  Small 
ulcers  may  coalesce  to  form  major  lesions.  Pain  decreases  when  the  covering  fibrinous 
clot  in  the  ulcer  develops.  After  a  period  of  time,  between  4  to  35  days,  the  ulcer 
heals,  without  a  clinically  observable  scar.  However,  in  a  very  small  percentage,  in 
major  lesions  with  a  long  healing  period,  a  scar  remains  for  many  years  (Stanley, 
1972). 
24 Bagan  et  al.  (1991)  have  reported  that  patients  with  minor  recurrent  aphthous 
stomatitis  have  the  lowest  rate  of  recurrence,  number  and  duration  of  the  lesions. 
Healing  time  for  major  recurrent  aphthous  stomatitis  was  higher  than  minor  recurrent 
aphthous  stomatitis  and  herpetiform  ulcers. 
1.3.  Histopathologic  Features 
1.3.1.  Light  Microscopy 
Histologically,  an  aphthous  ulcer  is  covered  by  fibrinous  slough,  and  inflammatory 
cell  migration  has  filled  the  underlying  tissues  (Lehner,  1969c;  Marsland  and  Brown, 
1975;  Sciubba,  1984). 
In  the  premonitory  stages  of  recurrent  aphthous  stomatitis,  the  underlying  connective 
tissue  shows  no  marked  inflammatory  reaction  (Stenman  and  Heyden,  1980).  As  the 
reaction  become  more  severe,  the  vacuolation  of  individual  supra-basal  cells  in  the 
oral  epithelium  can  be  distinguished  (Stenman  and  Heyden,  1980).  In  later  stages  of 
premonitory  lesions,  in  addition  to  extensive  distribution  of  vacuolated  cells 
throughout  the  spinous  cells,  the  oral  mucosa  becomes  thicker,  due  to  a  slight 
hypertrophy  (Stenman  and  Heyden,  1980).  These  vacoulated  cells  may  subsequently 
coalesce  to  form  intraepithelial  vesicles  (Stanley,  1972;  Stenman  and  Heyden,  1980). 
Such  early  disruption  of  epithelium  and  vesicle  formation  has  also  been  reported  by 
others  (Farmer,  1958;  Brody  and  Silverman,  1969). 
The  earliest  cellular  infiltration  into  the  submucosa  in  the  pre-ulcer  stage  of  a  lesion 
appears  to  consist  mainly  of  lymphocytes  with  some  plasma  cells,  mast  cells  and 
25 eosinophils  (Dolby  and  Allison,  1969).  Although  there  is  a  difference  in  the  amount  of 
eosinophilic  cells  in  different  specimens  (Stanley,  1972),  the  lymphocytes  predominate 
until  frank  ulceration  is  established  when  polymorphonuclear  leukocytes  become  more 
predominant  in  the  areas  subjacent  to  the  ulcer.  However,  the  lymphocytes  remain 
quantitatively  the  most  common  cell  type  in  the  periphery  of  the  lesion  and  in  the 
deeper  aspects  (Graykowski  et  al.  1966;  Brody  and  Silverman,  1969;  Stanley,  1972). 
After  about  48  hours  of  ulceration  the  mast  cell  population  in  the  subepithelial  region, 
reduces  (Dolby  and  Allison,  1969).  Polymorphonuclear  leukocyte  migration, 
prevascular  infiltration,  oedema  and  hyperaemia  are  also  seen  (Stanley,  1972;  Sciubba, 
1984). 
In  an  other  report  from  sections  through  one  and  three  day  old  lesions,  variable 
numbers  of  haemorrhagic  foci  of  extravasated  erythrocytes  have  been  demonstrated. 
These  foci  coalesced  and  occurred  in  the  centre  and  lateral  to  the  ulcer,  that  is  in 
region  of  connective  tissue  papillae.  The  bottom  of  the  ulcers  consisted  of  a 
superficial  exudate  with  clotted  fibrin,  numerous  red  blood  cells,  neutrophilic 
granulocytes  and  cellular  debris,  while  beneath  this  layer,  the  infiltrate  consisted  of 
lymphocytes,  macrophages,  and  neutrophilic  granulocytes.  As  the  infiltrates  spreads 
laterally,  lymphocytes  become  more  numerous.  Foci  of  perivascular  round-cell 
infiltration  were  also  seen  in  the  underlying  lamina  propria  and  submucosa.  (Sciubba, 
1984)  Similar  observations  were  made  on  7-day  old  aphthae  (Sciubba,  1984). 
In  the  healing  stage,  granulation  tissue,  which  contains  numerous  immature  capillaries 
lined  by  endothelial  cells  and  surrounded  by  delicate  fibrous  tissue,  underlies  the 
26 fibropurulent  plaque  of  the  ulcer  (Stanley,  1972).  In  advance  of  the  period  of  healing, 
the  granulation  tissue  undergoes  collagenisation  and  some  chronic  inflammatory  cells, 
particularly  plasma  cells,  may  persist  in  the  deeper  layer  of  the  lamina  propria 
(Stanley,  1972).  These  findings  might  support  a  viral  or\and  an  immunological 
aetiology  of  recurrent  aphthous  stomatitis  (Stenman  and  Heyden,  1980). 
The  inflammatory  cell  expression  in  the  connective  tissue,  underlying  the  ulcer,  is  a 
later  occurrence  in  the  RAS-lesion  (Stenman  and  Heyden,  1980).  In  a  study  on  43 
patients  with  minor  recurrent  aphthous  stomatitis  and  15  healthy  individuals  as 
controls,  there  was  no  significant  difference  between  mononuclear  cells  in  ulcer 
specimens  and  healthy  mucosa  of  non-RAS  individuals.  However,  mononuclear  cell 
counts  in  the  lamina  propria  of  clinically  unaffected  mucosa  of  both  active  and 
remission  stages  of  recurrent  aphthous  stomatitis  were  significantly  lower  than 
mucosal  biopsies  from  controls  and  ulcerative  areas  of  recurrent  aphthous  stomatitis 
patients  (Pedersen  et  al.  1992). 
In  the  subepithelial  region  of  aphthous  lesions  which  are  more  than  48  hours  old,  the 
mast  cell  population  is  significantly  reduced,  and  does  not  support  an  immediate 
hypersensitivity  reaction  as  an  aetiological  factor  (Dolby  and  Allison,  1969;  Brody  and 
Silverman,  1969).  More  often,  plasma  cells  and  eosinophils  are  found  in  the  older 
lesions  (Lehner,  1969c). 
However  there  are  no  pathological  indices  to  diagnose  recurrent  aphthous  stomatitis 
by  light  microscopy,  but  most  findings  show  inflammatory  cell  expression  in  the 
27 connective  tissue  in  the  ulcerative  stage.  This  may  be  found  in  any  non-specific 
ulcerative  disease,  but  reduced  numbers  of  mononuclear  cells  in  the  oral  mucosa  of 
recurrent  aphthous  stomatitis  patients  indicate  a  cell  immune  deficiency  in  these 
patients  which  may  be  due  to  an  autoimmune  or  viral  aetiology. 
1.3.2.  Electron  Microscopy 
Electron  microscopy  confirms  the  light  microscopic  findings  (Lehner  and  Sagebiel, 
1966;  Lehner,  1969c).  Degeneration  of  the  prickle  cells  can  be  seen  on  electron 
microscopy  as  a  prominent  feature  in  aphthous  lesions  and  macrophage-like  cells  and 
T-lymphocytes  have  been  reported  to  be  attached  to  these  degenerating  cells  (Lehner, 
1969c;  Honma,  1976).  In  addition,  intra-nuclear  inclusion  bodies  and  intra- 
cytoplasmic  phagosome-like  bodies  were  observed  (Lehner  and  Sagebiel,  1966).  The 
intra-nuclear  inclusion  bodies  were  also  found  in  the  epithelial  cells  of  herpetiform 
ulcer  biopsies.  The  size  of  these  spherical  shaped  bodies  has  been  reported  to  be  from 
500  to  650  millimicrons  in  diameter  (Lehner  and  Sagebiel,  1966;  Lehner,  1969c).  The 
type  and  shape  of  these  inclusion  bodies  may  vary  in  different  cells  and  they  have  been 
observed  in  many  diseases,  particularly  those  of  viral,  neoplastic  or  autoimmune 
aetiology  (Sapp  and  Brooke,  1977).  Intra-cytoplasmic  phagosome-like  bodies  were 
found  in  all  ulcers,  at  sites  with  severe  intra-cellular  separation,  mononuclear 
infiltration  and  at  the  epidermal  portion  of  the  basement  membrane.  Their  size  differs 
from  350  to  650  millimicrons  in  diameter.  (Lehner  and  Sagebiel,  1966;  Lehner,  1969c; 
Luzardo  Baptista,  1975)  Also  mitochondria  were  frequently  swollen  with  loss  of 
internal  cristae,  in  the  cells  containing  the  inclusion  bodies  and  in  epithelial  cells 
28 adjacent  to  the  inflammatory  cells  (Lehner  and  Sagebiel,  1966;  Lehner,  1969c; 
Luzardo  Baptista,  1975).  The  phagosome-like  bodies  seen  in  aphthous  ulcers 
including  the  herpetiform  type,  are  like  the  early  invasive  destructive  process  of 
mononuclear  cells  upon  antigen-containing  epithelial  cells  in  the  delayed  type  of 
hypersensitivity  reactions  (Lehner  and  Sagebiel,  1966). 
Sterologic  study  of  biopsy  specimens  of  one  to  seven  day  old  oral  ulcers  from  minor, 
herpetiform,  Behcet's  syndrome  and  non-ulcerated  oral  mucosa  of  aphthous  patients 
confirmed  that  the  infiltration  of  inflammatory  cells  at  the  ulcer's  centre  is  different  in 
composition  from  that  in  the  lateral  border  region  (Schroeder  et  al.  1983). 
Monocytes/macrophages  are  a  constant  and  large  infiltrate  component  in  this  infiltrate 
composition.  Also  blast-forming  T-lymphocytes  are  present  and  small,  non-active 
lymphocytes  are  a  rare  component  (Schroeder  et  al.  1983).  Neutrophilic  granulocytes, 
monocytes/macrophages,  and  medium-sized  lymphocytes  each  provided  almost  one 
third  of  the  infiltrate  population  in  central  region  of  the  ulcer,  while  in  the  region 
lateral  to  the  ulcer  medium-sized  lymphocytes  provided  two  thirds  and  neutrophilic 
granulocytes  and  monocytes/macrophages  together  the  rest  of  the  infiltrate  population 
(Schroeder  et  al.  1983). 
Merckel  cells  have  been  demonstrated  in  the  oral  cavity  by  electron  microscopy.  This 
finding  may  suggest  that  catecholamines  released  from  these  cells  by  psychogenic 
stimuli  would,  through  local  vasoconstriction,  trigger  epithelial  necrosis  and  hence 
lead  to  ulceration  of  the  oral  mucosa  (Wilgram,  1972). 
29 Electron  microscopic  investigation  of  recurrent  aphthous  stomatitis  failed  to  show 
recognisable  micro-organisms  such  as  mycoplasma  or  L-form  organisms.  However  a 
viral  aetiology  could  not  be  excluded  on  the  basis  of  finding  intra-nuclear  inclusion 
bodies. 
1.3.3.  Immunofluorescence  and  Immunohistochemistry 
Direct  and  indirect  immunofluorescent  staining  of  sections  from  recurrent  aphthous 
stomatitis  both  in  vivo  and  in  vitro,  indicated  binding  of  IgG  and  IgM  in  the 
cytoplasm  of  autologous  prickle  cells  in  biopsies  obtained  from  four  patients  with 
minor  aphthae  and  two  patients  with  major  aphthae.  Indirect  staining  of  normal  oral 
mucosa  with  sera  from  these  patients  failed  to  show  any  immunoglobulin  binding 
(Lehner,  1969c).  Immunofluorescent  staining  appears  in  biopsies  from  patients  with 
minor  aphthae  and  major  aphthae,  but  negative  results  were  obtained  with  herpetiform 
ulcers  (Lehner,  1969c).  However  immunohistochemical  studies  (for  IgG,  IgM,  IgA, 
and  C3)  of  biopsies  obtained  from  aphthous  lesions  and  normal  mucosa  of  patients 
with  and  without  a  history  of  recurrent  aphthous  stomatitis  were  positive  for  all 
samples  (Sciubba,  1984).  The  labelled  cells  occurred  singly  or  in  clusters  in  the  lower, 
and  upper  stratum  spinosum  but  rarely  in  the  basal  and  superficial  layer  (Sciubba, 
1984).  This  appearance  might  be  due  to  non-selective  and  non-specific  binding  of  a 
whole  battery  of  immune  components  including  IgA,  IgG,  IgM,  Clq  and  C3  by 
stratum  spinosum  (Malmstrom  et  al.  1983;  Sciubba,  1984). 
30 On  the  other  hand,  Malmstrom  et  al  (1983)  observed  no  IgG,  IgM,  IgA  or  fibrinogen 
fluorescence  in  the  mucosa  of  recurrent  aphthous  stomatitis  patients,  using  direct 
immunofluorescence.  However  15  of  16  biopsies  showed  deposits  of  C3  along 
capillary  walls  (Malmstrom  et  al.  1983). 
A  strong  fluorescent  reticular  network  was  observed  at  the  site  of  the  ulcer  and 
connective  tissue  beneath  the  ulcer.  This  binding  was  positive  only  with 
immunoglobulin  A,  while  other  ulcerative  lesions  from  other  patients  selected  as 
controls  were  negative  (Brody  and  Silverman,  1969). 
By  using  highly  specific  IgG,  IgM,  and  IgA  conjugates,  direct  staining  of  the 
basement  membrane  zone  in  14  aphthous  lesions  with  IgG  and  in  16  lesions  with  C3 
was  reported  (Donatsky  and  Dabelsteen,  1977).  C3  was  also  demonstrated  in  11  of 
12  experimental  oral  wounds  but  not  in  normal  mucosa.  When  the  sections  were 
stained  indirectly,  it  was  difficult  to  determine  the  degree  of  staining  due  to  non- 
specific  staining  of  the  connective  tissue.  Direct  staining  of  the  prickle  cells  was  not 
seen  with  any  isotype  of  immunoglobulin  in  patients  or  controls  (Donatsky  and 
Dabelsteen,  1977).  Indirect  staining  , 
however,  revealed  cytoplasmic  immunoglobulin 
deposition  in  the  prickle  cells  with  IgG,  IgA  and  IgM  in  aphthous  lesions, 
experimental  oral  wounds  and  normal  oral  mucosa.  The  distribution  of  end  point  titres 
in  the  sera  of  these  three  groups  showed  that  most  immunoglobulin  was  directed 
against  oral  mucosa  in  the  group  with  recurrent  aphthous  stomatitis.  These 
investigations  (Donatsky  and  Dabelsteen,  1977),  therefore,  could  not  confirm  the 
finding  of  Lehner  (1969c)  with  respect  to  the  direct  immunofluorescent  staining  of 
31 prickle  cells,  but  showed  staining  of  the  basement  membrane  zone.  Furthermore,  they 
demonstrated  only  quantitative  immunofluorescence.  In  addition,  they  felt  the  IgA 
staining  of  connective  tissue  demonstrated  by  Brody  and  Silverman  (1969)  was  non- 
specific.  (Donatsky  and  Dabelsteen,  1977) 
In  another  study  direct  immunofluorescence  of  biopsies  and  peripheral  blood  of 
patients  with  recurrent  aphthous  stomatitis  showed  a  high  incidence  of  IgM  and  IgE 
bearing  lymphocytes  and  polymorphonuclear  leukocytes  in  aphthous  lesions  and  an 
increase  in  the  number  of  IgE-coated  lymphocytes  in  the  peripheral  blood  of  these 
patients  (Bays  et  al.  1977).  Direct  fluorescence  also  showed  that  vascular 
fluorescence  with  C3  was  positive  in  approximately  one  third  of  the  biopsies  from 
recurrent  aphthous  stomatitis  patients  (Van  Hale  et  al.  1981).  Forty-five  per  cent  (10 
of  22  patients)  of  specimens  demonstrated  fluorescence  along  the  basement  membrane 
zone  (Van  Hale  et  at.  1981).  In  this  group  of  patients  only  two  cases  showed  positive 
basement  membrane  zone  deposition  of  conjugated  anti-sera  to  immunoglobulin  (one 
each  of  IgG  and  IgM)  (Van  Hale  et  al.  1981).  In  this  study,  the  pattern  of 
immunofluorescence  findings  was  similar  to  those  in  certain  other  oral  diseases  such 
as  lupus  erythematosus,  bullus  and  cicatrical  pemphigoid,  desquamative  gingivitis  and 
lichen  planus  (Van  Hale  et  al.  1981). 
In  a  study  of  peripheral  T  lymphocytes  sub-populations  in  30  patients  with  recurrent 
aphthous  stomatitis  and  29  sex  and  age  matched  recurrent  aphthous  stomatitis  free 
controls,  the  CD4+  percentage  was  significantly  lower  in  the  patients  than  in  the 
control  group,  whereas  CD8+  cells  and  the  CD4+/CD8+  ratio  did  not  differ 
32 significantly  between  patients  and  controls  (Pedersen  et  al.  1991)  Also,  these  findings 
were  observed  by  other  investigators  (Kayavis  et  al.  1987;  Savage  et  al.  1988; 
Landesberg  et  al.  1990).  Although  in  similar  studies,  it  has  been  reported  that  the 
number  CD4+  (T-helper)  cells  in  recurrent  aphthous  stomatitis  patients  did  not  differ 
in  either  active  or  non-active  stages  of  the  disease  compared  with  controls  (Pedersen 
et  al.  1992).  In  this  study,  the  CD8+  cell  percentage  was  significantly  higher  in  both 
unaffected  and  ulcer  areas  of  the  recurrent  aphthous  stomatitis  patients  in  the  active 
stage  of  the  disease  as  compared  with  controls  (Pedersen  et  al.  1992).  The  CD4:  CD8 
ratio  also  was  reported  to  be  lower  than  previous  reported  in  both  unaffected  and 
ulceration  areas  of  recurrent  aphthous  stomatitis  patients  in  the  active  stage  of 
ulceration.  In  peripheral  blood  the  ratio  of  CD4+/CDS+  lymphocytes  was  decreased 
due  to  a  significant  increase  of  CD8+  cells  (Kayavis  et  al.  1987;  Savage  et  al.  1988; 
Pedersen  et  al.  1989).  In  addition,  it  has  been  reported  that  in  the  peripheral  blood  of 
all  patients  with  severe  aphthous  ulceration,  the  number  of  T-helper/inducer  cells 
(Cdw29)  was  increased  and  the  number  of  T-suppresser/inducer  cells  (CD45R) 
decreased  during  both  remission  and  early  periods  of  ulceration  (Savage  et  al.  1988; 
Landesberg  et  al.  1990).  Helper/inducer  T-lymphocytes  of  peripheral  blood  help  B 
cells  in  the  antibody  producing  process.  The  CD45R  subset  appears  to  represent  a 
"naive"  cell  whereas  the  Cdw29  subset  is  a  memory  cell.  (Savage  et  al.  1988) 
The  natural  killer  cells  (CD45RA+)  were  significantly  higher  in  peripheral  blood  of 
patients  with  recurrent  aphthous  stomatitis  (Pedersen  et  al.  1991)  while  natural  killer 
cell  activity  was  not  significantly  different  between  patients  with  recurrent  aphthous 
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ulcers  (Pedersen  and  Pedersen,  1993). 
By  applying  three-colour  immunofluorescence,  Pedersen  and  Ryder  (1994)  observed 
an  increase  in  the  fraction  of  the  T  cell  receptor  yS+  cells  in  patients  with  active 
recurrent  aphthous  stomatitis.  They  also  reported  changes  in  natural  killer  cell  subsets: 
an  increase  in  the  percentage  of  CD16+/CD56-  and  CD16-/CD56+  in  patients  with 
active  recurrent  aphthous  stomatitis  compared  with  those  in  controls  and  also  an 
increase  in  the  percentage  of  CD56+/CD8-  cells  in  active  compared  with  inactive 
patients.  There  were,  however,  no  significant  differences  in  the  CD57+  figures 
(Pedersen  and  Ryder,  1994). 
T-lymphocyte  subsets  in  the  oral  mucosa,  in  general,  were  significantly  lower  in 
patients  with  recurrent  aphthous  stomatitis  in  active  and  inactive  stages,  compared 
with  the  control  group.  However  CD4+  percentages  were  not  significantly  different 
between  the  two  groups  of  controls  and  patients  with  recurrent  aphthous  stomatitis 
(Pedersen  et  al.  1992).  CD8+  percentage  cells  in  lesions  from  recurrent  aphthous 
stomatitis  patients  were  significantly  increased  during  the  active  process  as  compared 
with  controls  (Pedersen  et  al.  1992;  Pedersen,  1993). 
There  are  therefore,  no  exact  pathogonomic  features  which  can  be  demonstrated  in 
recurrent  aphthous  stomatitis  by  histological  methods.  Immune  complex  and 
immunoglobulin  deposition  may  be  an  epiphenomenon  secondary  to  inflammation. 
Histological  features  mainly  strengthen  the  hypothesis  that  immunological  factors  are 
34 involved  in  the  pathogenesis  of  recurrent  aphthous  stomatitis.  However,  studies  on  T- 
lymphocytes  in  peripheral  blood  and  oral  mucosa  raise  the  possibility  of  an 
autoimmune  and  /  or  micro-organism  aetiology. 
1.4.  Differential  Diagnosis 
Superficial  ulceration  of  the  oral  mucosa  is  common  in  diseases  of  the  oral  cavity.  A 
diagnosis  is  made  by  the  analysis  of  multiple  factors,  including  the  lesion's  location, 
size,  grouping,  onset,  patient's  age,  involvement  of  other  systems  of  the  body  and 
course  of  the  disease  (Chole  and  Domb,  1979). 
The  diagnosis  of  recurrent  aphthous  stomatitis  depends  on  clinical  features.  It  is 
necessary  to  differentiate  recurrent  aphthous  stomatitis  from  other  conditions  which 
may  have  a  similar  presentation.  Disorders,  such  as  erosive  lichen  planus,  bullous 
lesions,  erythma  multiforme  and  oral  Crohn's  disease  can  be  distinguished  from 
recurrent  aphthous  stomatitis  clinically  and  in  some  complex  cases  histologically  or  by 
immunofluorescence.  (Wray,  1982a) 
Recurrent  aphthous  stomatitis  is  often  misdiagnosed  as  a  recurrent  herpes  simplex 
virus  infection.  An  acute  viral  stomatitis  can  be  distinguished  by  virus  culture  or  other 
virology  methods.  Besides,  recurrent  herpes  simplex  infections,  generally  affect  the 
vermilion  border  only,  although  recurrent  intra-oral  herpes  infection  is  often  difficult 
to  distinguish  from  herpetiform  type  of  recurrent  aphthous  stomatitis.  However  there 
are  some  clinical  differences  between  these  two  groups.  In  herpetiform  recurrent 
aphthous  stomatitis,  crops  of  ulcers  (up  to  100)  involve  the  non-keratinized  mucosa 
35 buccally  and  sublingually.  In  contrast,  recurrent  intra-oral  herpes  tends  to  be  more 
localised  on  keratinized  areas  such  as  attached  gingivae  and  hard  palate.  In  case  of 
any  doubt,  viral  culture,  cytology,  or  histology  can  be  applied  in  the  differential 
diagnosis.  (Wray,  1982a) 
Recurrent  aphthous  stomatitis  can  be  a  feature  of  Behcet's  syndrome,  although 
Behcet's  syndrome  is  a  rare  condition,  in  contrast  with  recurrent  aphthous  stomatitis 
which  is  extremely  common.  Behcet's  syndrome  has  many  features:  oral  ulceration, 
erythma  nodosum,  phlebitis,  peripheral  arthritis  and  sacroileitis.  The  diagnosis  of 
Behcet's  syndrome  can  be  confirmed  when  two  or  more  major  criteria  (oral,  genital, 
ocular  or  cutaneous  involvement)  or  a  combination  of  major  and  minor  (vascular, 
neurological,  skeletal  or  intestinal)  manifestations  are  present  (Wray,  1982a).  The 
distribution  of  symptoms  can  be  associated  with  a  genetic  component  such  as,  an 
increased  frequency  of  HLA-Bs  and  B27.  However  complete  evidence  for  an 
immunogenetic  basis  for  recurrent  aphthous  stomatitis  has  not  been  established 
(Wray,  1982a). 
1.5.  Actiologic  Factors 
It  has  been  postulated  that  the  aetiology  of  recurrent  aphthous  stomatitis  is  unknown 
and  controversy  has  existed  in  the  literature  about  the  importance  of  various  factors  in 
the  pathogenesis  of  recurrent  aphthous  stomatitis. 
36 In  this  thesis  they  will  be  divided  into:  genetic  factors,  exogenous  environmental 
factors,  host  or  endogenous  environmental  factors,  immunological  factors  and  micro- 
organisms  associated  with  recurrent  aphthous  stomatitis. 
1.5.1.  Genetic  Factors 
a)  Inheritance  patterns 
Ship  (1965)  in  a  study  on  a  large  population  of  students,  could  not  show  a  definitive 
genetic  background  on  susceptibility  to  recurrent  aphthous  stomatitis.  However.  it 
was  not  possible  to  rule  out  a  genetic  relationship  in  those  subjects  with  a  positive 
parental  background  and  those  with  a  negative  parental  background. 
In  one  study,  12  sets  of  monozygotic  twins  and  seven  sets  of  dizygotic  twins  with  a 
positive  family  history  of  recurrent  aphthous  stomatitis  were  investigated  to  identify 
any  inheritance  patterns  involved  in  the  aetiology  of  the  disease  (Miller  et  al.  1977). 
Results  have  shown  that,  identical  twins,  with  a  positive  family  history,  develop 
aphthous  lesions  more  than  non-identical  twins  (91.5  per  cent  versus  57  per  cent) 
(Miller  et  al.  1977).  This  difference,  like  conditions  in  other  diseases  may  suggest 
polygenetic  inheritance  with  environmental  or  infectious  components  modifying  the 
expression  of  the  disease  (Miller  et  al.  1977). 
The  proportion  of  recurrent  aphthous  stomatitis  positive  individuals  is  higher  when 
either  the  father  (33.8  per  cent)  or  mother  (52.5  per  cent)  are  positive  than  when 
neither  parent  is  positive  (8.9  per  cent).  The  incidence  of  the  disease  was  thus 
increased  in  individuals  with  a  positive  family  history  (Miller  et  al.  1980).  On  the  basis 
37 of  these  findings,  also,  it  was  not  possible  to  define  the  precise  pattern  of  genetic 
transmission.  (Miller  et  al.  1980) 
Given  these,  inheritance  patterns  in  recurrent  aphthous  stomatitis  show  that  factors 
other  than  inheritance  may  have  accounted  for  some  components  of  the  disease 
expression. 
b)  HLA  tissue  typing 
In  recent  years,  there  has  been  an  extensive  search  for  association  between  specific 
diseases  and  antigens  of  the  major  HLA  histocompatibility  locus  (Katz,  1977).  HLA 
associated  diseases  can  be  categorised  in  to  different  groups.  The  major  groups  are: 
autoimmune  diseases,  malignancies,  disease  with  a  metabolic  component  or  diseases 
with  unknown  aetiology.  Until  now,  no  certain  role  of  LILA  has  been  identified  in  the 
development  of  autoimmunity  in  related  diseases.  One  of  the  early  hypothesis  for 
HLA  disease  associations  is  that,  the  cell  surface  HLA  molecule  could  act  as  a 
receptor  for  a  specific  virus  and  provide  a  way  for  it  to  infect  the  cell,  thus  making 
individuals  carrying  a  particular  gene  susceptible.  Several  instances  have  been 
described  in  the  mouse  where  H-2  molecules  can  bind  specifically  to  viruses  (e.  g. 
semliki  forest  virus  and  adenovirus  type  II).  No  specific  examples  are  known  in  man 
for  HLA  being  a  viral  receptor.  However,  it  is  clear  that  cell  surface  markers  in  man, 
such  as  CD4,  can  act  in  this  capacity  (e.  g.  as  receptor  for  the  human 
immunodeficiency  virus,  HIV).  This  hypothesis  would  explain  the  genetic  and 
environmental  component  in  the  aetiology  of  many  diseases  (Oilier  and  Symmons, 
1992).  For  instance,  individuals  who  have  the  genetic  background  of  HLA-B15  and 
38 HLA-DQw3  appear  to  be  predisposed  to  HSV-induced  erythma  multiforme  (Scully, 
1993). 
Susceptibility  to  many  oral  diseases  was  reported  to  be  associated  with  HLA  antigens. 
HLA-A3.  HLA-B5  and  HLA-B8  were  more  frequent  in  patients  with  lichen  planus  than 
in  controls  (Saurat  et  al.  1977),  HLA-B5  was  increased  in  Behcet's  syndrome  (Erosy 
et  al.  1977),  recurrent  herpes  labialis  appeared  to  have  an  increased  frequency  of 
HLA-Al  (Russell  and  Schlaut,  1977),  and  the  prevalence  of  HLA-B12  was  found  to 
increase  in  recurrent  aphthous  stomatitis  (Challacombe  et  al.  1977b).  The  HLA-B12 
type  was  present  in  43  of  100  patients  with  the  disease  compared  to  22  of  100 
controls  (Challacombe  et  al.  1977b).  However  in  a  similar  study  of  66  patients  and 
100  controls,  no  differences  in  incidence  were  found  (Dolby  et  al.  1977).  Also  HLA- 
B12  was  related  to  the  muco-cutaneous  type  of  Behcet's  syndrome,  which  has  the 
same  clinical  features  as  recurrent  aphthous  stomatitis  (Lehner  et  al.  1979a). 
Recurrent  aphthous  stomatitis  also  showed  an  increased  frequency  of  the  HLA  type 
A2  (Lehner  et  al.  1979a).  Disease  susceptibility  may  segregate  with  the  HLA 
haplotype  (Dolby  et  at.  1977).  In  a  study  in  different  populations,  the  increased  HLA- 
DR7  and  a  decreased  HLA-Bs  was  indicated  to  be  related  to  recurrent  aphthous 
stomatitis  (Galling  et  at.  1985).  However,  Dolby  et  al.  (1977)  were  unable  to  find  such 
a  relation  between  recurrent  aphthous  stomatitis  and  HLA  antigens.  In  this  study,  only 
HLA-A  phenotypes  were  investigated  whereas,  the  possible  involvement  of  other 
phenotypes  such  as  HLA-B12  could  not  be  excluded. 
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a)  Mucosal  injury 
Clinicians  have  long  suspected  that  trauma  can  initiate  lesions  in  patients  with  a 
history  of  recurrent  aphthous  stomatitis  (Sircus  et  al.  1957;  Farmer,  1958; 
Graykowski  et  al.  1966).  In  a  study  by  Wray,  et  al  (1981)  there  was  no  clinical  and 
histological  difference  between  mechanical  ulcerated  lesions  and  spontaneous  ulcers. 
This  phenomenon  also  has  been  observed  in  Behcet's  syndrome,  where  intradermal 
injection  causes  formation  of  pustules  and  mucosal  injury  initiates  mouth  ulcers  (Wray 
et  al.  1981).  Patients  with  Behcet's  syndrome  also  show  an  increased  sensitivity  to 
inflammatory  mediators  such  as  histamine,  which  will  induce  pustules  when  inoculated 
intradermally.  In  Ehlers-Danlos  syndrome  the  oral  tissues  are  also  more  sensitive  to 
injury  presumably  due  to  defective  synthesis  of  collagen  (Wray  et  al.  1981). 
b)  Allergy  and  food  sensitivity 
Allergy  affects  10  per  cent  of  the  population  and  is  usually  genetically  determined 
(Porter  and  Scully,  1990;  Scully  and  Cawson,  1993)).  Atopic  allergy  depends  on 
production  of  specific  IgE  antibodies  which  bind  to  mast  cells  and  basophils.  Antigen 
binding  to  the  surface  IgE  causes  degranulation  of  mast  cells  with  release  of  mediators 
such  as  histamine  and  leukotrienes.  Patients  with  atopic  allergies  are  also  possibly 
more  prone  to  develop  allergy  or  anaphylaxis  in  response  to  drugs,  however,  some 
normal  individuals  can  produce  IgE  antibodies  but  without  ill-effect  (Porter  and 
Scully,  1990).  There  is  no  reliable  evidence  that  immediate-type  hypersensitivity 
reactions  produce  oral  mucosal  disease  and  there  is  no  oral  counterpart  of  eczema. 
40 Furthermore,  no  oral  diseases  have  been  proved  to  have  any  significant  direct 
association  with  atopic  allergy,  although  patients  with  allergic  orofacial 
granulomatosis  and  erythma  migrans  may  have  a  higher  prevalence  of  atopy  than  the 
normal  population  (Porter  and  Scully,  1990).  Ship  in  1960  claimed  a  complete 
remission  in  seven  patients  with  recurrent  aphthous  stomatitis  when  placed  on  an 
elemental  diet,  but  failed  to  confirm  this  later  in  a  series  of  six  patients  (Ship  et  at. 
1962).  Moreover,  patients  with  recurrent  aphthous  stomatitis  have  been  shown  to 
display  increased  serum  antibodies  to  cow's  milk  proteins  (Taylor  et  al.  1964)  and 
other  food  antigens  (Thomas  et  al.  1973)  compared  to  normal,  but  not  when 
compared  to  patients  with  other  oral  ulcerative  conditions.  (Thomas  et  al.  1973). 
However,  it  is  possible  that  local  mucosal  breakdown  leading  to  absorption  of 
increased  amounts  of  food  antigens  was  the  cause  of  the  increased  incidence  of  food 
antibodies  (Thomas  et  al.  1973). 
Certain  foods,  especially  walnuts,  chocolate  or  citrus  fruits,  appear  to  precipitate 
ulcers  in  a  few  patients  with  aphthous  stomatitis,  but  although  there  may  be  a  slightly 
increased  prevalence  of  allergic  disease  associated  with  recurrent  aphthous  stomatitis, 
there  is  little  evidence  for  an  allergic  mechanism  (Eversole  et  al.  1982;  Porter  and 
Scully,  1990). 
In  a  in  vitro  study  on  recurrent  aphthous  stomatitis  patients  (Wray  et  al.  1982)  the 
leukocytes  from  60  patients  with  recurrent  aphthous  stomatitis  were  tested  for 
histamine  release  in  response  to  environmental  and  food  allergens.  Of  the  sixty 
patients  tested,  nine  patients  showed  a  significant  release  to  only  food-stuffs.  Fourteen 
41 patients  had  a  positive  reaction  in  vitro  to  both  foods  and  environmental  allergens, 
and  four  showed  a  significant  release  of  histamine  in  response  to  respiratory  allergens 
alone.  The  remaining,  thirty-three  patients  showed  a  negative  or  insignificant  release 
of  histamine  to  all  antigens  tested.  In  this  study  eight  patients  gave  a  history  of  food 
allergy  but  only  two  of  these  patients  showed  a  positive  histamine  release  reaction  to 
food  allergens.  However  in  twenty-one  of  the  patients  who  had  a  positive  histamine 
release  to  certain  foods,  there  was  no  correlation  between  the  clinical  history  and  the 
results  of  the  in  vitro  assay  (Wray  et  al.  1982).  Therefore  there  was  no  evidence  for  a 
correlation  between  atopic  allergies  and  recurrent  aphthous  stomatitis. 
Recently,  in  a  study  on  patients  with  recurrent  aphthous  stomatitis,  22  patients  had 
undergone  dermatological  patch  testing  to  investigate  a  possible  allergic  component 
(Nolan  et  al.  1991a).  In  20  patients  at  least  one  allergen  was  identified.  Benzoic  acid 
and  cinamonaldehyde  were  positive  in  most  of  the  patients  (Nolan  et  al.  1991  a).  After 
dietary  advice  on  avoidance  of  allergens,  patients  were  followed  up  for  a  period  of  six 
months  to  six  years.  Eight  of  20  patients  with  identified  allergens  had  no  further 
ulceration  despite  being  followed  up  for  average  of  three  years.  Of  the  12  other 
patients  an  80  per  cent  improvement  on  average  was  reported  (Nolan  et  al.  1991a). 
Recurrent  aphthous  stomatitis  is  one  of  the  oral  manifestations  of  gluten  sensitivity 
(coeliac  disease)  (Ferguson  et  al.  1980;  Hunter  et  al.  1993).  However  a  gluten-free 
diet  has  been  effective  in  causing  remission  of  ulcers  in  some  patients  with  recurrent 
aphthous  stomatitis  in  whom  coeliac  disease  had  been  specifically  excluded  (Walker  et 
42 al.  1980;  Wray,  1981).  Aphthous  ulcers  rarely  have  been  reported  as  an  allergic 
reaction  to  foreign  bodies  (Gordon  and  Gordon,  1974). 
c)  Psychological  factors 
Sircus  et  al  (1957)  stated  that  mental  stress  precipitated  attacks  of  ulceration  in  21  per 
cent  of  patients;  they  described  psychological  factors  as  aggravating  mechanisms 
rather  than  the  cause  of  the  disease.  Other  authors  have  also  drawn  these  associations 
(Farmer,  1958;  Ship  et  al.  1961;  Ship  et  al.  1962;  Graykowski  et  al.  1966).  Whether 
such  factors  are  of  primary  aetiological  significance  or  a  result  of  the  ulceration  has 
not  been  established.  Ship  et  al,  (1967)  however  reported  finding  significant 
differences  between  aphthous  stomatitis  patients  and  controls  when  both  groups  were 
evaluated  by  the  Cornell  medical  index  as  to  depression,  tension  inadequacy,  anxiety 
and  anger. 
In  the  study  of  Pedersen  (1989a),  psychological  stress  was  evaluated  by  means  of  the 
social  readjustment  rating  scale  (SRRS)  and  a  visual  analog  scale  (VAS).  In  this 
study,  the  evaluation  was  carried  out  on  22  patients  with  minor  recurrent  aphthous 
ulceration  after  the  onset  of  new  ulcers  (0-8  days),  as  well  as  in  an  ulcer-free  stage. 
However,  it  was  not  possible  to  find  any  positive  association  between  psychological 
stress  as  a  wide  entity  and  recurrence  of  recurrent  aphthous  stomatitis. 
Although  the  basis  of  the  immunological  changes  associated  with  psychological  stress, 
is  unknown,  the  nervous  system  might  inhibit  lymphoid  function  or  induce 
immunosuppression  by  causing  the  increased  release  of  immunosuppressive 
43 corticosteroids,  catecholamines,  prostaglandins  or  opioids  (Wilgram,  1972;  Porter  et 
al.  1990). 
d)  Smoking  habits 
Some  reports  have  indicated  a  potential  inhibitory  effect  of  smoking  on  the 
occurrence  of  recurrent  aphthous  stomatitis,  (Chellemi  et  al.  1970;  Shapiro  et  al. 
1970)  and  others  (Sallay  and  Banoczy,  1968)  have  shown  a  significantly  reduced  level 
of  keratinization  of  the  oral  mucosa  in  patients  with  recurrent  aphthae,  94  per  cent  of 
whom  were  non-smokers. 
There  seemed  to  be  different  qualities  between  different  tobacco  habits  regarding 
reduction  in  the  frequency  of  episodes.  Pipe  smoking  caused  the  most  reduction  in  the 
frequency  of  recurrent  aphthous  ulceration  (Axell  and  Henricsson,  1995).  Gardy  et  al 
(1992)  documented  the  positive  therapeutic  effect  of  smokeless  tobacco  used  in  the 
symptomatic  alleviation  of  aphthous  lesions.  The  biologic  mechanism  behind  the 
negative  association  between  tobacco  habits  and  the  frequency  of  recurrent  aphthous 
stomatitis  is  not  clear,  and  multidisciplinary  longitudinal  studies  are  needed  if 
meaningful  data  are  to  be  obtained  (Axell  and  Henricsson,  1995).  However  increased 
keratinization  of  the  mucous  membrane  to  resist  the  formation  of  recurrent  aphthous 
stomatitis  in  the  mouth  is  most  likely  to  be  the  main  mechanism  (Axell  and 
Henricsson,  1995).  For  instance  a  negative  correlation  between  keratinization  of  oral 
mucosa  and  aphthae  in  patients  with  leukoplakia  has  been  pointed  out  (Axell  and 
Henricsson,  1995).  In  a  preliminary  trial,  nicorette  tablets  have  had  a  beneficial  effect 
on  aphthous  ulcers  (Bittoun,  1991).  Like  cigarette  smoking,  smokeless  tobacco  use  is 
44 also  associated  with  hyperkeratosis  of  the  oral  mucosa,  but  hyperkeratosis  is  topicaly 
localised  to  the  mucosal  area  where  the  tobacco  is  held  (Ernster  et  al.  1990;  Grady  et 
al.  1990;  Grady  et  al.  1992).  Because  in  the  smokeless  tobacco  user,  few  components 
other  than  nicotine  are  systemically  absorbed,  nicotine  may  be  one  of  the  protective 
factor  against  aphthous  ulcers  (Grady  et  al.  1992). 
In  the  study  of  salivary  IgA  levels  in  tobacco  smokers,  patients  with  minor  aphthous 
ulceration  and  normal  subjects,  the  level  of  salivary  IgA  remained  within  normal  limits 
in  both  the  ulcerative  and  non-ulcerative  phases  of  aphthous  ulcers,  however  in 
tobacco  smokers  there  was  a  significant  depression  of  salivary  IgA  concentration.  It 
seems  probable  that  salivary  IgA  has  no  definitive  role  in  the  pathogenesis  of  minor 
aphthae  (Bennet  and  Reade,  1982).  A  similar  study  has  been  reported  on  the  effect  of 
smoking  in  ulcerative  colitis,  and  the  results  shows  that  the  IgA  concentration  in  the 
intestinal  fluid  of  smokers  with  ulcerative  colitis  was  reduced  compared  with  non- 
smokers  (Srivastava  et  al.  1991).  However  most  of  the  smoker  patients  with 
ulcerative  colitis  are  only  light  smokers  (Srivastava  et  al.  1991). 
Given  this,  it  may  be  deduced  that  decreased  keratinization  may  play  an  important  role 
in  the  pathogenesis  of  this  disease.  However  the  effect  of  smoking  in  prevention  of 
ulcerative  colitis  does  not  support  this  hypothesis. 
e)  Micro-organisms 
Several  investigations  into  the  occurrence  of  viruses,  bacteria,  fungi,  mycoplasmas 
and  protozoa  in  recurrent  aphthous  stomatitis  have  been  carried  out  in  an  attempt  to 
45 implicate  one  of  these  micro-organisms  in  the  pathogenesis  (Farmer,  1958;  Fraser- 
Moodie,  1960;  Griffin,  1963;  Barile  et  al.  1968;  Ferguson,  1975;  Donatsky  et  al. 
1977;  Studd  et  al.  1991). 
Parasites 
Toxoplasmosis  has  been  associated  with  oral  ulceration,  although  antibodies  against 
this  protozoa  have  not  been  shown  to  be  increased  in  patients  with  recurrent  aphthous 
stomatitis  (Sircus  et  al.  1957). 
Mycoplasmas 
Despite  attempts  to  isolate  mycoplasmas  from  aphthous  lesions,  there  is  no  evidence 
of  an  aetiological  relationship  between  these  organisms  and  recurrent  aphthous 
stomatitis  (  Gordon  et  al.  1967;  Lehner,  1972;  Donatsky  et  al.  1977). 
Fungi 
No  systematic  mycological  investigations  exist  on  the  occurrence  of  fungi  in  recurrent 
aphthous  stomatitis,  although  Candida  albicans  cannot  be  consistently  isolated  from 
aphthous  lesions  (Donatsky  et  al.  1977). 
Bacteria 
The  occurrence  of  fusiform  bacteria  and  spirochaetes  in  smears  from  recurrent 
aphthous  ulcers  reported  in  early,  preliminary  studies  and  the  observation  that 
specimens  from  recurrent  aphthous  lesions  produced  pox-like  formations  not  caused 
by  viruses  but  by  large  numbers  of  fusiform-like  organisms,  resulted  in  discussion  of  a 
possible  role  for  these  organisms  in  recurrent  aphthous  stomatitis  (Bartle  et  al.  1968). 
46 Recent  bacteriological  studies  have  not  confirmed  that  fusiform  bacteria  or 
spirochaetes  occur  in  specimens  from  recurrent  aphthous  lesions  (Barfile  et  al.  1968; 
Donatsky  et  al.  1977). 
Pure  cultures  of  a  transitional  L-form  of  Streptococcus  sanguis  were  isolated  from 
aphthous  lesions  of  one  patient  with  minor  and  two  with  major  recurrent  aphthae  of 
total  of  three  patients  with  the  disease  when  the  entire  pseudomembrane  was  removed 
and  material  for  examination  scraped  off  from  the  base  of  the  lesion  (Barile  et  al. 
1963).  The  pseudomembrane  and  saliva  were  reported  to  contain  a  mixed  microbial 
flora.  Blood  obtained  from  culture  during  two  exacerbation  was  found  to  be  positive 
for  the  organism,  whereas  blood  examined  during  remission  was  sterile.  Scarred  tissue 
from  previous  lesions  of  one  patient  was  biopsied  during  a  remission  period  and 
homogenised;  on  culture,  this  homogenised  tissue  showed  the  presence  of  L-form 
colonies  (Barile  et  al.  1963).  Later,  a  similar  L-form  organism  was  isolated  from  a 
biopsy  specimen  taken  from  a  lesion  of  one  patient  with  major  aphthae  (Graykowski 
et  al.  '  1964).  These  authors  (Graykowski  et  al.  1964)  further  reported  that  the 
bacterial  parent  of  the  transitional  L-form  was  probably  an  alpha-haemolytic 
streptococcus  and  that  the  isolated  L-form  was  able  to  produce  ulcer-like  lesions 
when  injected  into  the  flank  of  rabbits  (Graykowski  et  al.  1964).  An  association 
between  these  streptococcal  L-forms  and  recurrent  major  and  minor  aphthous 
stomatitis  was  suggested  in  the  light  of  these  preliminary  findings  (Barile  et  al.  1963; 
Graykowski  et  al.  1964). 
47 This  micro-organism  was  found  in  the  majority  of  aphthous  lesions  (93  per  cent),  and 
less  frequently  in  non-aphthous  lesions  (40  per  cent)  but  also  in  post  mortem  oral 
mucosa  (47  per  cent).  This  micro-organism  was  primarily  described  as  the  occurrence 
of  an  L-form  in  the  tissue  sections  (Stanley  et  al.  1964).  Further,  in  a  later  review  of 
the  micro-biological  aspects  of  Streptococcus  sanguis  in  the  pathogenesis  of  recurrent 
aphthous  stomatitis,  the  micro-organisms  in  the  sections  were  shown  to  be 
pleomorphic  streptococci  with  diplococcoid  or  short  chain  structures  (Bartle  et  al. 
1968).  Isolation  of  L-forms  from  recurrent  aphthous  stomatitis  has  been  repeated 
(Donatsky  et  al.  1977). 
However,  alpha-haemolytic  streptococci,  coagulase  negative  staphylococci  and 
Neisseria  species  were  together  shown  to  be  the  predominant  quantitative  bacterial 
flora  in  cultures  from  abraded  material  or  biopsies  from  recurrent  aphthous  lesions  if 
the  pseudomembrane  was  removed  before  the  specimens  were  obtained  (Donatsky  et 
al.  1977). 
A  thorough  microbiological  examination  of  the  morphology,  biochemical  properties, 
serological  characteristics  and  lesion  producing  capacity  of  streptococcal  isolates  from 
recurrent  aphthous  ulceration  concluded  that  the  prototype,  streptococcus,  strain  2A 
was  a  Streptococcus  sanguis,  Lancefield  group  H,  related  to  or  identical  with 
Streptococcus  sanguis,  American  Type  Culture  Collection  (ATCC)  10556.  The  skin 
lesion  producing  capacity  of  Streptococcus  sanguis,  strain  2A  appeared  to  be  related 
to  the  acid-soluble  cell  wall  substances  (Bartle  et  al.  1968).  However,  this  strain  of 
streptococci,  subsequently,  has  shown  to  be  actually  a  strain  of  Streptococcus  mills 
48 and  antigenically  is  more  like  ATCC  10557  than  ATCC  10556  (Hoover  and 
Greenspan,  1983). 
In  conclusion,  the  high  occurrence  of  oral  Streptococcus  sanguis,  Neisseria  and 
staphylococci  in  cultures  obtained  from  major  and  minor  recurrent  aphthous  stomatitis 
and  the  high  occurrence  of  pleomorphic  streptococci  in  the  tissue  sections  might 
indicate  an  aetiological  role  for  these  bacteria  and  perhaps  especially  for 
Streptococcus  sanguis.  Further  support  of  that  hypothesis  has  been  revealed  in  studies 
on  the  immunity  against  bacteria  in  recurrent  aphthous  stomatitis  as  discussed  later. 
Viruses 
Many  of  oral  mucosal  ulceration,  other  than  recurrent  aphthous  stomatitis,  results 
from  viral  infection.  Over  the  past  years,  many  investigators  have  searched  for  a  virus 
to  explain  the  aetiology  of  recurrent  aphthous  stomatitis.  The  hypothesis  of  a  viral 
aetiology  is  consistent  with  many  features  seen  in  this  condition.  The  recurrent  nature 
of  the  lesions  is  compatible  with  a  virus  infection  (Gajdusek,  1977).  However 
immunological  features  of  recurrent  aphthous  stomatitis  (section  1.6)  have  mainly 
referred  to  either  autoimmunity  or  a  viral  pathogenicity  (Pedersen,  1993).  Hence, 
viruses  are  the  strongest  infective  candidate  for  a  role  in  the  production  of 
autoimmune  disease  (MacPhail  et  al.  1993).  The  immunological  imbalances  in 
recurrent  aphthous  stomatitis  may  be  the  result  of  viral  involvement. 
Viruses  have  never  been  isolated  in  aphthae  of  the  major  and  minor  type.  However, 
viral  isolates  and  antigens  of  adenovirus  type  1  have  been  reported  in  a  high 
49 percentage  of  herpetiform  ulcers  (Nasz  et  al.  1971;  Sallay  et  al.  1971a).  In  addition, 
adenovirus  type  I  and  herpes  simplex  virus  caused  blast  transformation  in  a  significant 
number  of  patients  with  recurrent  aphthous  stomatitis  (Sallay  et  al.  1971b).  These 
findings  await  confirmation.  In  herpetiform  ulcers,  inclusion  bodies  have  been 
described  by  workers  using  electron  microscopy  (Lehner,  1969c)  and  some 
investigators  have  demonstrated  degenerative  changes  histologically  (Stenman  and 
Heyden,  1980).  These  changes  are  however  compatible  with  both  a  viral  and  an 
immunological  aetiology  (Sapp  and  Brooke,  1977;  Stenman  and  Heyden,  1980). 
Hooks  (1978)  reported  that  although  viruses  may  be  implicated  in  the  aetiology  of 
recurrent  aphthous  stomatitis  and  Behcet's  syndrome,  there  are  several  considerations 
which  make  it  hard  to  isolate  a  virus  in  these  diseases. 
Sallay  et  al.  (1973)  demonstrated  isolation  of  two  strains  of  Adenovirus  type  1  from 
scraping  samples  of  two  patients  suffering  from  herpetiform  aphthous  ulcers.  By  an 
immunoflurescent  method,  they  also  found  adenovirus  antigen  in  cell  nuclei  of  ten 
patients  with  recurrent  aphthous  stomatitis  including  two  patients  in  whom  virus  was 
isolated  from  the  ulcers  (Sallay  et  al.  1973). 
Herpes  simplex  has  not  been  cultured  from  aphthous  ulcers.  Also,  specific 
fluorescence  with  herpes  simplex  immun  sera  was  not  observed  in  recurrent 
aphthous  stomatitis  samples  (Sallay  et  al.  1973).  In  an  immunofluorescent  method, 
using  fluorescein-labeled  monoclonal  antibodies,  herpes  simplex  type  1  was  detected 
in  two  out  of  30  patients  with  recurrent  aphthous  stomatitis  (Ogawa  et  al.  1990). 
50 However  using  an  in  situ  hybridisation  method,  part  of  the  herpes  simplex  virus 
genome  was  present  in  peripheral  blood  mononuclear  cells  (probably  lymphocytes)  of 
patients  with  the  ocular  and  arthritic  type  of  Behcet's  syndrome  and  minor  aphthous 
ulcers  (Eglin  et  al.  1982).  This  was  also  confirmed  in  all  three  groups  of  recurrent 
aphthous  stomatitis  by  applying  the  polymerase  chain  reaction  (PCR),  although  there 
were  differences  in  the  proportions  of  those  with  the  herpes  simplex  type  1  genome  in 
the  major  and  minor  aphthous  ulcer  groups  (Studd  et  al.  1991). 
Varicella  zoster  virus  (VZV)  was  detected  in  four  out  of  30  aphthous  lesions  by  an 
immunofluorescent  method  (Ogawa  et  al.  1990).  However  Pedersen  (1993)  reported 
the  presence  of  varicella  zoster  virus  DNA  by  applying  PCR  in  all  20  biopsies  from 
aphthous  lesions. 
Human  cytomegalovirus  (HCMV)  was  not  detected  by  immunofluorescence  (Ogawa 
et  al.  1990)  and  in  situ  hybridisation  (Sun  et  al.  1996).  But  by  applying  PCR,  three 
out  of  nine  recurrent  aphthous  stomatitis  patients  were  HCMV  DNA  positive  in  their 
biopsy  samples  (Sun  et  al.  1992;  Sun  et  al.  1996). 
Siegnel  and  Granich  (1993)  reported  that  recurrent  aphthous  stomatitis  could  be  the 
oral  manifestation  of  human  herpes  virus  type  6  (HHV-6)  reactivation,  however  they 
did  not  present  enough  evidence  to  support  their  hypothesis.  Recently  HHV-6  DNA 
was  detected  in  saliva  samples  from  two  out  of  12  (17  per  cent  )  patients  with 
recurrent  aphthous  stomatitis  by  the  PCR  method,  although  three  per  cent  of  healthy 
51 subjects  were  also  HHV-6  DNA  positive.  There  was  no  significant  difference  between 
these  two  groups  (Di  Luca  et  al.  1995). 
No  virus  has  been  consistently  detected  from  recurrent  aphthous  stomatitis  lesions, 
but  combined  clinical,  immunopathological  and  virological  observations  on  recurrent 
aphthous  stomatitis  seem  to  support  a  viral  aetiology.  With  herpesviruses  in  particular 
having  a  propensity  for  latency  and  reactivation  after  primary  infection,  the  theory  of 
recurrent  aphthous  stomatitis  being  due  to  reactivation  of  one  or  more  members  of  the 
herpesvirus  family  cannot  be  excluded. 
1.5.3.  Host  or  Endogenous  Environmental  Factors 
a)  Haematological  deficiency 
Although  many  studies  suggest  the  relationship  between  haematological  deficiencies 
and  recurrent  aphthous  stomatitis  (Hutcheon  et  al.  1978;  Challacombe  et  al.  1983; 
Porter  et  al.  1988)  there  are  also  a  number  of  investigations  which  denied  such  an 
association  (Challacombe  et  al.  1977a;  Olson  et  al.  1982).  Because  of  full  remission  or 
improvement  of  ulceration  after  replacement  of  deficient  factors,  it  seems  that  a  full 
blood  count  including  assays  of  haematinics  is  necessary  to  diagnose  those 
haematological  deficiencies  which  appear  with  a  normal  blood  film  (Wray  et  al.  1975; 
Challacombe  et  al.  1977a;  Hutcheon  et  al.  1978;  Challacombe  et  al.  1983;  Tyldesley, 
1983;  Palopoli  and  Waxman,  1990). 
Recurrent  aphthous  stomatitis,  unlike  glossitis  and  angular  chielitis  has  been  reported 
to  occur  infrequently  with  deficiencies  of  iron,  folic  acid  and  vitamin  B12.  Thus, 
52 deficiency  of  vitamin  B12  is  not  generally  recognised  as  a  cause  of  recurrent  aphthae, 
though  isolated  cases  have  been  reported  (Hjorting-Hansen  and  Bertram,  1968; 
Walker,  1973;  Porter  et  al.  1988;  Palopoli  and  Waxman,  1990). 
Wray  et  al.  (1975)  reported  in  a  series  of  130  patients  with  recurrent  aphthous 
stomatitis,  that  deficiencies  of  iron,  folic  acid  and  vitamin  B12  were  found  in  17.7  per 
cent  and  that  most  patients  with  proven  deficiency  improved  rapidly  on  replacement 
therapy.  These  findings  have  been  supported  in  similar  studies.  (Hutcheon  et  al.  1978; 
Tyldesley,  1981) 
Challacombe  et  al  (1977a)  however,  reported  later  a  series  of  193  patients  with 
recurrent  aphthous  stomatitis  and  found  a  lower  incidence  of  deficiencies.  They 
reported  that  anaemia  did  not  play  a  primary  aetiological  role  in  most  cases  of 
recurrent  aphthae  on  the  basis  of  the  low  prevalence.  Twenty  per  cent  of  patients  in 
this  series,  however  were  sideropenic  and  the  authors  postulated  that  this  was 
secondary  to  the  oral  ulceration. 
In  addition,  those  workers  found  that  in  this  group  of  patients  they  were  able  to 
distinguish  the  ulcers  occurring  in  these  deficient  patients  on  a  clinical  and 
haematological  basis  from  major,  minor  and  herpetiform  ulcers  and  termed  them 
pseudo-major,  pseudo-minor  and  pseudo-herpetiform  ulcers  (Challacombe  et  al. 
1977a).  These  lesions  could  not  be  distinguished  clinically  by  Wray  et  al  in  their 
original  series  (1975)  or  in  a  subsequent  study  (Wray  et  al.  1978). 
53 Iron  deficiency  has  been  identified  to  be  increased  in  other  ulcerative  oral  mucosa 
lesions  compared  with  normal  individuals  (Challacombe  et  al.  1983). 
Recently,  perhaps  because  of  the  improvement  in  diet,  folic  acid  deficiency  has 
decreased  and  is  now  rarely  diagnosed  in  recurrent  aphthous  stomatitis  patients 
(Miller  et  al.  1994).  In  a  younger  population  (age  7-16  years)  of  patients, 
haematological  investigations  have  been  reported  to  have  the  same  pattern  as  in  adults 
patients  with  recurrent  aphthous  stomatitis  (Field  et  al.  1987). 
b)  Concurrent  systemic  disease 
The  oral  manifestations  of  Behcet's  syndrome  can  be  very  similar  to  those  in  recurrent 
aphthous  stomatitis,  especially  when  they  occur  as  the  earliest  manifestation  of  this 
syndrome  (Cooke,  1979). 
In  addition  to  the  evidence  associating  recurrent  aphthous  stomatitis  with 
haematological  deficiencies,  a  consistent  association  has  been  shown  with 
gastrointestinal  disease.  Recurrent  aphthae  are  associated  with  various  gastrointestinal 
disorders,  especially  Crohn's  disease,  ulcerative  colitis  and  coeliac  disease  (Wray  et  al. 
1975;  Ferguson  et  al.  1980;  Tyldesley,  1981;  Plauth  et  al.  1991;  Seo  et  al.  1992).  In 
addition,  an  association  with  orofacial  granulomatosis  has  been  reported  (Wiesenfeld 
et  al.  1985;  Field  and  Tyldesley,  1989;  Bozkurt  et  al.  1992).  Sircus  et  al  (1957) 
however,  believed  that  the  incidence  of  recurrent  aphthae  among  the  population  was 
so  great  that  associations  with  gastrointestinal  disease  were  probably  of  minor 
significance.  This  does  not  take  into  account,  however,  the  clinical  response  seen  in 
54 recurrent  aphthae  patients  when  the  underlying  disease  is  treated  (Wray  et  al.  1975; 
Lisciandrano  et  al.  1996). 
Wray  et  al  (1975)  showed  an  incidence  of  5.3  per  cent  of  malabsorption  and  gluten 
sensitivity  in  their  patients  and  later  Ferguson  et  al  (1975)  reported  that  8  of  33 
patients  with  recurrent  aphthous  stomatitis  had  gluten  sensitive  enteropathy.  Others 
subsequently  have,  however,  been  unable  to  confirm  the  high  prevalence  seen  in  the 
latter  study  (Ferguson  et  al.  1980;  Rose  et  al.  1996).  However,  Walker  et  al  (1980) 
showed  a  favourable  response  to  gluten  withdrawal  in  a  small  series  of  patients  with 
recurrent  aphthous  stomatitis  without  enteropathy.  This  was  strongly  confirmed  by 
other  investigators  (Wray,  1981;  Hay  and  Reade,  1984). 
Recently,  it  has  been  believed  that  there  was  no  significant  effect  with  gluten 
withdrawal  and  it  has  been  suggested  that  in  previous  studies  there  were  marked 
placebo  responses  in  the  condition  (Hunter  et  al.  1993). 
Aphthous  ulcers  can  be  one  of  the  oral  manifestations  of  immunodeficiency  diseases 
such  as  AIDS.  Aphthous-like  ulcers  may  first  be  seen  during  the  acute  illness 
associated  with  HIV  infection  (Phelan  et  al.  1991;  MacPhail  et  al.  1991;  Ficarra, 
1992;  Scully  and  McCarthy,  1992;  Porter  and  Scully,  1993;  Muzyka  and  Glick,  1994; 
Weidle,  1996;  Scott  and  Bender,  1996;  Youle  et  al.  1996). 
Recurrent  aphthous  stomatitis  has  also  been  reported  as  a  muco-cutaneous 
manifestation  of  chronic  fatigue  syndrome  (Krueger  et  al.  1987;  Wahren  and  Linde, 
1991;  Rebora  and  Drago,  1994). 
55 c)  Endocrine  influences 
A  clear  relationship  has  been  demonstrated  in  some  women  with  recurrent  aphthous 
stomatitis  and  their  menstrual  cycle,  with  ulceration  being  most  troublesome  in  the 
luteal  phase  between  ovulation  and  menstruation  (Dolby,  1968a;  McCartan  and 
Sullivan,  1994).  These  patients  usually  notice  clearing  of  their  ulcers  during 
pregnancy.  In  the  study  of  Silverman  and  Shouse  (1966)  50  per  cent  of  the  female 
patients  with  recurrent  aphthous  stomatitis  were  symptomatically  improved  during 
oestrogen  administration.  However  their  findings  did  not  indicate  the  effect  of 
endogenously  secreted  oestrogen  and  conjugated  oestrogen  substances  administered 
in  the  form  of  an  oral  contraceptive  on  cornification  of  human  oral  epithelium 
(Silverman  and  Shouse,  1966). 
Carruthers  (1967)  also  treated  patients  with  oral  contraceptives  and  subsequently  high 
dose  oestrogen  was  effectively  used  (Bishop  et  al.  1967).  Ferguson  et  al  (1978)  have 
used  progestogens  successfully  in  women  with  pre-menstrual  aphthae  but  found  them 
ineffective  when  no  menstrual  relationship  existed.  This  is  also  supported  by 
McCartan  and  Sullivan  (1996)  who  tried  oestrogen  replacement  therapy  on  114 
women  with  aphthous  ulcers.  In  this  trial,  women  with  menstrual  cycle  associated 
aphthae  were  more  likely  to  have  complete  or  partial  remission  when  receiving 
therapeutic  ovarian  hormones  than  those  with  unassociated  aphthae.  Also,  women  in 
whom  lesions  started  or  deteriorated  during  pregnancy,  hormone  therapy  did  not 
effect  an  improvement  in  the  ulceration  (McCartan  and  Sullivan,  1996). 
56 In  epithelium,  two  actions  of  oestrogen  are  to  increase  the  rate  of  cellular  proliferation 
and  to  promote  keratinization.  Such  changes  have  been  best  identified  in  the  vagina 
but  oral  mucosa  also  follows  a  similar  trend  (Ferguson,  1975).  Keratinization  of  oral 
and  vagina  mucosa  probably  undergoes  comparable  changes  during  the  menstrual 
cycle  and  pregnancy  (Ferguson,  1975)  although  Silverman  and  Shouse  (1966)  did  not 
detected  these  changes. 
It  is  not  yet  clear,  how  sex  hormones  can  effect  different  diseases.  In  in  vitro  studies 
of  the  differences  in  the  susceptibility  of  mice  to  coxsackievirus  B3  infection,  it  was 
reported  that  males  generated  an  earlier  and  more  powerful  cytotoxic  T  cell  response 
but  a  lower  antibody  response  than  females  (Mims  and  White,  1984). 
Sex  hormones  act  via  different  surface  receptors  directly  on  T  cells,  especially  CD8- 
positive  cells.  Oestrogen  can  increase  the  level  of  antibody  production  by  inhibiting  T 
suppresser  activity.  Progesterone,  on  the  other  hand,  increases  T  suppresser  function. 
Thus  it  is  clear  that  hormones  can  influence  the  immune  system  and  play  a  part  in  the 
higher  frequency  of  autoimmunity  in  females.  However,  understanding  of  this  role  is 
still  incomplete  (MacPhail  et  al.  1993).  It  should  be  noted  that,  the  administration  of 
excess  sex  and  cortocosteroid  hormones  enhanced  the  severity  of  viral  infection  and 
may  depress  immune  responses,  but  adequate  production  of  these  hormones  in  the 
body  is  vital  for  normal  resistance  to  infection.  In  case  of  imbalance  in  hormone 
production,  excessive  or  widespread  inflammatory  responses  could  cause  damage  to 
host  organs,  and  viral  infections  often  shows  much  greater  severity  (Mims  and  White, 
1984) 
57 1.6.  Immunological  Factors 
1.6.1  Humoral  Immunity  in  Recurrent  Aphthous  Stomatitis 
a)  Total  immunoglobulin  levels  in  serum 
The  levels  of  immunoglobulin  in  serum  from  patients  with  recurrent  aphthous 
stomatitis  has  had  conflicting  results  in  different  studies.  A  decreased  level  of  IgA  was 
reported  in  six  of  eight  sera  from  patients  with  recurrent  aphthae  (Brody  and 
Silverman,  1969).  Other  studies  have  shown  no  differences  between  patients  and 
controls  for  IgG,  IgM  or  IgA  (Thomas  et  al.  1973;  Ben-Areh  et  al.  1976;  Malmstrom 
et  al.  1983)  and  no  changes  in  relation  to  disease  activity  (Ben-Areh  et  al.  1976).  Sun, 
et  al  (1986)  measured  serum  IgG,  IgM  and  IgA  levels  in  oral  aphthous  patients  during 
the  various  stages  of  the  disease.  IgG,  IgM  and  IgA  were  significantly  higher  than  the 
normal  levels  for  healthy  subjects.  Serum  IgG  and  IgM  in  patients  were  elevated 
during  the  early  stage  as  compared  with  normal  (p<0.001)  (Sun  et  al.  1986).  In  the 
late  stages  IgA  was  also  significantly  increased  but  only  IgG  remained  elevated  in  the 
convalescent  stage,  when  IgA  and  IgM  returned  to  normal.  Significantly  raised  levels 
of  IgG  and  IgA  have  been  reported  in  sera  from  major  aphthous  stomatitis  (Lehner, 
1969a)  although  this  has  not  been  confirmed  (Scully  et  al.  1979). 
In  a  recent  study  of  IgG  subclasses,  the  majority  of  patients  with  minor  recurrent 
aphthous  stomatitis  had  no  significant  changes  in  serum  levels  of  IgGl,  IgG2,  IgG3  or 
IgG4.  However  8.4  per  cent  had  marginally  raised  IgGi  levels  and  1.4  per  cent  a 
significantly  low  level  of  IgG3  (Porter  et  al.  1992). 
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Salivary  IgA  levels  have  been  reported  as  normal  in  patients  with  recurrent  aphthous 
stomatitis  and  have  not  been  shown  to  vary  with  disease  activity  (Wolf  and 
Graykowski,  1979;  Bennet  and  Reade,  1982).  Raised  IgG  and  IgA  levels  in  stimulated 
mixed  saliva  have  been  reported,  however,  in  Behcet's  syndrome(Lehner,  1969a). 
A  significant  reduction  in  IgA  levels  in  stimulated  parotid  saliva  has  been  reported  in 
major  aphthae,  herpetiform  ulcers  and  Behcet's  syndrome  (Scully  et  al.  1979).  IgA 
secretion  rates  were  also  depressed  in  patients  in  arthritic,  ocular  and  muco-cutaneous 
types  of  Behcet's  syndrome.  Lacrimal  fluid  IgA  concentrations  were  increased  in 
arthritic  and  ocular  Behcet's  syndrome,  indicating  there  was  not  a  generalised 
secretory  abnormality  in  these  patients  (Scully  et  al.  1979).  These  data  may  indicate 
that  IgA  is  necessary  to  protect  the  oral  mucosa  against  disease. 
c)  Circulating  immune  complexes 
It  has  been  reported  that,  C9  and  C-reactive  protein  are  increased  in  Behcet's 
syndrome  and  recurrent  aphthous  stomatitis  (Al-Bayaty  et  al.  1989).  The  higher  levels 
of  C9  and  C-reactive  protein  in  Behcet's  syndrome  might  be  important  in  the 
transition  from  the  unifocal  aphthous  stomatitis  to  its  systemic  counterpart  (Al-Bayaty 
et  al.  1989).  However,  in  patients  with  recurrent  aphthous  stomatitis,  these  changes  in 
serum  levels  of  complement  throughout  the  course  of  the  disease  were  not  confirmed 
(Sun  et  al.  1986).  Also,  in  various  stages  of  recurrent  aphthous  stomatitis  the  levels  of 
circulating  immune  complexes  increased  (Sun  et  al.  1986).  The  increased  level  of 
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(Sun  et  al.  1986). 
IgG  circulating  immune  complexes  were  found  in  recurrent  aphthous  stomatitis  and 
Behcet's  syndrome  although  they  were  far  more  prominent  in  Behcet's  syndrome, 
especially  in  the  neuro-ocular  and  arthritic  types.  In  recurrent  aphthae  immune 
complexes  were  at  the  highest  level  in  herpetiform  ulcers  but  these  differences  were 
not  significant  (Adinolfi  and  Lehner,  1976).  Periods  of  remission  were  characterised 
by  a  switch  from  IgG  or  IgM  complexes  to  IgA  complexes  and  it  has  been 
hypothesised  that  immune  complexes  are  not  only  of  aetiological  significance  in 
Behcet's  syndrome  but  are  also  important  in  determining  the  transition  from  recurrent 
aphthous  stomatitis  to  Behcet's  syndrome  (Adinolfi  and  Lehner,  1976).  Recently 
investigations  have  been  carried  out  to  identify  the  specificity  of  the  complexed 
antibodies  (Burton  Kee  et  al.  1981).  Preliminary  results  indicate  that  complexes  cross 
react  only  within  patient  populations  and  not  controls,  implying  the  presence  of  an 
exogenous  antigen  (Burton  Kee  et  al.  1981). 
Furthermore,  antigens  from  different  damaged  tissues  may  differentiate  subsets  of 
patients.  It  is  hypothesised  that  this  approach  could  eventually  lead  to  the 
identification  of  antigens  important  in  the  aetiology  of  recurrent  aphthous  stomatitis 
and  Behcet's  syndrome  (Burton  Kee  et  al.  1981). 
Cryoglobulins  of  the  IgG,  IgM  or  IgA  class,  with  or  without  C3,  were  significantly 
found  in  recurrent  aphthous  stomatitis  and  Behcet's  syndrome  (Lehner  et  al.  1979b). 
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gamma  globulin.  They  are  characterised  by  precipitating,  gelling  or  crystallising  when 
serum  or  solutions  of  them  are  cooled.  Cryoglobulins  can  play  a  pathogenic  role  in 
disease  by  complement  activation,  platelet  aggregation  and  cytotoxic  activity  (Lehner 
et  al.  1979b). 
d)  Circulating  antibodies  against  micro-organisms 
Mycoplasmas  and  parasites 
Haemagglutinating  antibodies  to  Mycoplasma  orale  were  found  in  five  of  33  patients 
with  recurrent  aphthae.  No  antibodies  were  found  to  Mycoplasma  laminus.  Control 
sera  however  showed  a  similar  prevalence  of  antibodies  against  these  mycoplasmas 
(Gordon  et  al.  1967). 
Complement  fixing  antibodies  to  Toxoplasma  were  similar  in  patients  and  controls 
(Sircus  et  al.  1957). 
Bacteria 
Donatsky  and  Dabelsteen  (1974b)  examined  the  sera  of  recurrent  aphthae  patients  and 
controls  for  the  presence  of  humoral  antibodies  to  Streptococcus  sanguis,  American 
type  culture  collection  (ATCC)  10556  by  means  of  a  double  layered 
immunoflurescent  technique.  Antibodies  to  the  Streptococcus  sanguis,  strain  2A 
antigen  were  demonstrable  in  both  populations,  but  the  mean  end  point  titres  were 
significantly  higher  among  the  patients  when  compared  to  controls  using  this 
semiquantitive  technique.  They  also  reported  that  no  antibodies  against  Neisseria  were 
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human  IgG,  IgM  and  IgA  fluorescent  antibodies,  reported  that  IgG  antibodies  were 
also  significantly  raised  against  Streptococcus  pyogenes  group  A,  strain  M5  National 
Collection  of  Type  Cultures  (NCTC)  100065.  The  anti-Streptococcus  sanguis 
antibodies  did  not  change  in  relation  to  exacerbation  of  the  disease.  IgM  and  IgA 
antibodies  against  this  organism,  although  present  in  patient  sera,  showed  a  similar 
distribution  of  end  point  titres  to  the  distribution  among  sera  from  controls 
(Donatsky,  1976a;  Donatsky,  1978).  In  addition,  IgG,  IgM  and  IgA  antibodies 
against  Neisseria  subflava  and  IgG  antibodies  against  Staphylococcus  were  often 
detected  in  patient  sera  but  at  the  same  concentration  as  that  found  in  controls 
(Donatsky,  1978).  IgM  and  IgA  antibodies  against  Staphylococcus  were  present  in 
only  a  few  sera  studied  (Donatsky,  1978). 
Viruses 
Humoral  immunity  protects  the  host  against  reinfection  by  the  same  virus. 
Neutralizing  antibody  blocks  the  initiation  of  viral  infection,  probably  at  the  stage  of 
attachment  or  uncoating.  Secretory  IgA  antibody  is  important  in  protecting  against 
infection  by  viruses  through  the  respiratory  or  gastrointestinal  tracts  (Jawetz  et  al. 
1989).  There  are  five  different  classes  of  immunoglobulins.  The  major  serum 
antibodies  are  of  IgG  class.  This  class  can  in  turn  be  divided  into  four  subclasses,  on 
the  basis  of  the  difference  in  the  constant  regions  of  their  heavy  chains.  Much  antiviral 
IgG  is  of  the  IgG3  subclass,  while  IgGi  responses  are  also  particularly  prominent  in 
herpesvirus  infections  (Scully  and  Samaranayake,  1992). 
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vascular  system.  It  has  high  affinity  and  this  together  with  its  early  production,  helps 
curb  the  spread  of  virus  in  the  early  stages.  As  the  immune  response  matures,  the  IgM 
antibodies  are  gradually  replaced  by  IgG.  It  is  noteworthy  that  IgM  antibodies  are  also 
the  first  to  be  detected  in  the  foetus  and  cannot  cross  the  placenta.  Therefore  the 
presence  of  antiviral  IgM  in  sera  suggests  recent  viral  infection  (Scully  and 
Samaranayake,  1992). 
Secretory  IgA  is  the  principal  and  most  important  immunoglobulin  in  secretions  and 
on  mucosal  surfaces  including  oral,  mainly  in  saliva.  IgA  antibodies  are  crucially 
important  in  resistance  to  infection  of  the  mucosal  surfaces  (Scully  and 
Samaranayake,  1992). 
IgD  and  IgE  constitute  a  very  small  proportion  of  immunoglobulins;  IgD  antibodies 
are  present  on  B-cell  surfaces  while  IgE  is  involved  in  allergic  responses  and  defence 
against  parasites.  The  roles  of  IgD  and  IgE  are  otherwise  somewhat  unclear  (Scully 
and  Samaranayake,  1992). 
Specific  antibodies  play  a  critical  role  in  modulating  viral  infections.  They  may  interact 
with  the  virion  itself,  and  either  neutralize  the  virus  or  destroy  the  virus-infected  host 
cell  by  a  number  of  mechanisms.  Viruses  may  well  however,  be  intracellular  and  thus 
inaccessible  to  antibody  (Scully  and  Samaranayake,  1992). 
Adenovirus  have  been  suggested  to  be  of  aetiological  significance  in  recurrent  aphthae 
although  attempts  to  detect  circulating  antibodies  have  been  carried  out  only  for 
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Antibodies  in  sera  from  healthy  controls,  however,  were  not  examined  (Sallay  et  al. 
1971a). 
Antibody  titres  against  Herpes  Simplex  virus  are  not  raised  in  sera  from  patients  with 
recurrent  aphthous  stomatitis  and  end  point  titres  do  not  vary  with  disease  activity. 
Furthermore,  such  patients  do  not  have  positive  skin  tests  to  herpesvirus  (Stark  et  al. 
1954;  Sircus  et  al.  1957). 
In  a  preliminary  study,  serum  IgG  antibody  against  HCMV  was  positive  in  all  patients 
with  recurrent  aphthous  stomatitis  and  controls  except  one  recurrent  aphthous 
stomatitis  patient  in  the  active  stage  (Sun  et  al.  1996).  In  this  investigation,  the  level 
of  serum  anti-HCMV  IgG  antibody  was  significantly  higher  in  the  remission  stage 
compared  with  the  active  period  of  ulceration  (Sun  et  al.  1996).  In  a  study  of  two 
separate  groups  of  patients  with  recurrent  aphthous  stomatitis,  HCMV  IgM  antibody 
was  significantly  increased  only  in  one  of  the  groups,  compared  with  healthy  controls 
(Pedersen  and  Hornsleth,  1993).  No  explanation  was  made  to  indicate  the  two 
different  results  in  the  two  groups  of  patients  with  almost  the  same  stage  of  the 
disease.  Also,  there  was  no  significant  difference  between  patients  and  controls  in 
their  anti-HCMV  IgG,  M  and  anti-HCMV  IgA  (Pedersen  and  Hornsleth,  1993). 
In  another  investigation  on  sera  from  five  patients  in  the  ulcerative  stage  of  recurrent 
aphthous  stomatitis  and  10  to  14  days  later,  none  of  the  patients  had  any  difference  in 
antibody  concentration  for  adenovirus  or  influenza  A,  or  B,  para-influenza,  or 
64 respiratory  syncytial  viruses  in  paired  sera  (Pedersen,  1989b),  while  all  patients  had  at 
least  a  four-fold  difference  in  specific  VZV  antibody  level  between  the  two  samples 
(Pedersen,  1989b).  The  author  concluded  that  a  four-fold  or  more  difference  in  VZV 
antibody  titres  indicated  a  current  infection  (reinfection)  and  it  showed  VZV  as  a 
cause  for  oral  ulceration  in  recurrent  aphthous  stomatitis  (Pedersen,  1989b).  Later  on 
in  a  larger  group  of  patients  this  finding  was  not  confirmed  (Pedersen  and  Hornsleth, 
1993).  In  two  groups  of  patients  with  recurrent  aphthous  stomatitis,  33  per  cent 
(6/18)  in  first  group  and  51  per  cent  (9/17)  of  the  patients  in  second  group  were 
serum  anti-VZV  IgM  antibody  positive  and  there  was  a  significant  difference  between 
patients  and  controls  in  their  VZV  IgM  values  (Pedersen  and  Hornsleth,  1993).  There 
was  not  any  change,  however  between  the  first  sample  in  the  active  period  and  the 
second  one  after  10-14  days  of  initiation  of  the  ulcer  (Pedersen  and  Hornsleth,  1993). 
Anti  Epstein-Barr  virus  IgG  was  not  significantly  different  in  recurrent  aphthous 
stomatitis  patients  compared  with  controls  (Pedersen  and  Hornsleth,  1993).  Anti- 
Epstein  Barr  virus  IgM  also,  did  not  seem  to  be  different  between  patients  and  healthy 
controls  (Pedersen  and  Hornsleth,  1993). 
With  respect  to  circulating  antibody  against  HHV-6  virus,  only  anti  HHV-6  IgG  has 
been  investigated  in  recurrent  aphthous  stomatitis  patients.  In  this  study  the  majority 
of  recurrent  aphthous  stomatitis  patients  and  healthy  controls  were  sero-positive  for 
anti  HHV-6  IgG  and  there  was  no  difference  between  patient  groups  and  controls 
(Pedersen  and  Hornsleth,  1993).  In  addition,  two  of  the  HHV-6  IgG  positive  patients 
65 were  positive  for  HHV-6  IgA,  while  none  of  the  controls  were  HHV-6  IgA  positive 
(Pedersen  and  Hornsleth,  1993). 
e)  Circulating  antibodies  against  tissue  antigens 
Oral  mucosa 
Patients  with  recurrent  aphthous  stomatitis  have  been  reported  to  have  circulating 
antibodies  against  saline  extracts  of  human  oral  mucosal  extract  using 
haemagglutination,  complement  fixation,  and  microprecipitation  (Lehner,  1964; 
Lehner,  1965;  Lehner,  1967b).  In  addition,  indirect  immunofluorescence  has  revealed 
circulating  antibodies  of  the  G  and  M  classes  to  allogenic  foetal  and  oral  mucosa 
(Donatsky  and  Dabelsteen,  1974a;  Donatsky,  1976a;  Donatsky  and  Dabelsteen,  1977; 
Donatsky,  1978).  In  vivo  binding  of  these  isotypes  to  oral  mucosa,  as  demonstrated 
by  direct  immunofluorescence,  has  been  reported  (Lehner,  1969c),  although  this  has 
not  been  confirmed  (Donatsky  and  Dabelsteen,  1977).  These  antibodies  appear  to  be 
able  to  bind  complement  (Lehner,  1969c;  Donatsky  and  Dabelsteen,  1977;  Donatsky, 
1976a;  Donatsky  and  Dabelsteen,  1974a;  Donatsky,  1975;  Lehner,  1969b).  Antibody 
deposition  is  localised  to  the  intra-cytoplasmic  areas  of  the  prickle  cell  layer  of  the 
oral  epithelium  (Lehner,  1969c).  Such  antibody  deposition  is  not  found  in  normal  oral 
mucosa  or  experimentally  induced  oral  wounds  (Donatsky  and  Dabelsteen,  1977). 
Organ  and  species  specificity 
Autoantibodies  in  the  sera  of  patients  with  recurrent  aphthous  stomatitis  exhibit  a 
certain  degree  of  organ  specificity.  Thus  immune  absorption  studies  of  four  sera 
showed  that  antibodies  to  foetal  oral  mucosa  were  absorbed  by  the  mucosa  from 
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mucosa  (Lehner,  1969b).  Haemaglutinating  antibodies,  however,  against  human  skin, 
colon  and  liver  or  antibodies  detected  by  immunofluorescence  against  human  skin  and 
muscle  were  not  found  in  sera  from  patients  with  recurrent  aphthae  (Lehner,  1964; 
Lehner,  1965;  Donatsky  and  Dabelsteen,  1974a).  Other  antibodies  such  as  nuclear, 
thyroid  or  gastric  antibodies  have  not  been  shown  in  recurrent  aphthous  stomatitis 
(Addy  and  Dolby,  1972;  Lehner,  1972).  Immune  absorption  with  the  mucosa  of 
guinea  pig,  mice  or  rabbits  will  absorb  out  haemaglutinating  antibodies  to  foetal  oral 
mucosa  (Lehner,  1969b)  and  patients'  sera  with  positive  antibodies  to  adult  human 
oral  mucosa  will  cross-react  with  guinea  pig  oral  mucosa  using  an  immunofluorescent 
technique  (Donatsky  and  Dabelsteen,  1974a). 
It  appears,  therefore,  that  sera  from  patients  with  recurrent  aphthous  stomatitis 
contain  auto-antibodies  which  have  some  tissue  specificity  but  are  not  specific. 
Antigenic  cross-reactivity  of  antibodies 
Antigenic  cross-reactivity  .  between  adult  and  foetal  human  oral  mucosa  and 
Streptococcus  sanguis,  strain  2A  was  investigated  by  immunofluorescence  (Donatsky, 
1975).  Absorption  studies  indicated  that  there  was  a  significant  cross-reactivity 
between  Streptococcus  sanguis  and  adult  human  oral  mucosa  and  to  a  lesser  extent 
with  foetal  mucosa  (Donatsky,  1975).  Subsequent  immunoelectrophoretic  analysis  of 
these  crude  antigens  mitigates  against  the  possibility  that  the  apparent  cross-reactivity 
is  due  to  bacterial  contamination  of  the  oral  mucosal  extracts  (Donatsky,  1980) 
although  antigenic  determinants,  important  in  the  pathogenesis  of  recurrent  aphthous 
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streptococcal  and  oral  mucosal  antigens  was  not  supported  by  the  findings  of  Hoover 
et  al  (1984). 
Heat  shock  proteins  are  a  group  of  highly  conserved  proteins  found  in  eukaryotic  and 
prokaryotic  cells,  including  Gram-positive  and  Gram-negative  micro-organisms 
(Hasan  et  al.  1995),  therefore  they  may  cause  cross-reactivity  between  microbial  and 
cellular  host  materials  (Hasan  et  al.  1995).  Recently,  cross-reactivity  between  four 
peptides  from  the  65  KD  mycobacteria  heat  shock  protein  and  four  peptides  from  the 
homologous  sequence  of  the  60  KD  human  heat  shock  proteins  has  been  reported  to 
cause  a  lymphoproliferative  response  and  subsequent  to  that  oral  ulceration  in 
Behcet's  syndrome  (Fortune  et  al.  1996).  The  four  peptides  of  mycobacteria  increase 
the  TCR-yö  subsets  of  cells.  These  cells  are  suggested  to  be  involved  in  the 
pathogenesis  of  Behcet's  syndrome  and  recurrent  aphthous  stomatitis  (Pedersen  and 
Ryder,  1994;  Fortune  et  at.  1996).  They  increase  the  expression  of  heat  shock 
proteins  which  cross  react  with  host  stress  protein  and  cause  tissue  damage  (Fortune 
et  al.  1996).  In  a  study  on  stimulation  of  peripheral  blood  mononuclear  cells  with  the 
mycobacterial  65  KD  heat  shock  protein,  there  was  no  statistically  significant 
lymphoproliferative  response  toward  this  heat  shock  protein  in  recurrent  aphthous 
stomatitis  patients  compared  with  control  groups  (Hasan  et  al.  1995).  However,  in  T- 
cell  epitope  mapping  using  29  overlapping  peptides,  derived  from  the  mycobacterial 
65  KD  heat  shock  protein,  only  peptide  91-105  caused  a  significantly  higher 
stimulation  of  lymphocytes  in  recurrent  aphthous  stomatitis  patients  compared  with 
68 controls  (Hasan  et  al.  1995).  The  homologus  60  KD  human  mitochondrial  peptide 
(amino  acid  116-130)  also  yielded  significant  lymphocyte  stimulation  in  specimens 
from  recurrent  aphthous  stomatitis  patients  compared  to  controls  (Hasan  et  al.  1995). 
This  increase  in  T-lymphocytes  responding  to  peptide  91-105  and  to  a  lesser  extent 
peptide  116-130  was  found  to  be  significant  during  ulceration,  especially  the 
prodromal  stage,  compared  with  remission  (Hasan  et  al.  1995).  The  T  cell  epitope 
(91-105)  was  derived  from  the  mycobacterial  heat  shock  protein,  that  is  highly 
conserved  among  Gram-positive  bacteria  which  colonize  in  the  oral  cavity  (Hasan  et 
al.  1995).  Streptococcus  sanguis  contains  one  or  more  B  cell  determinants  (88-123) 
which  overlap  with  the  T  cell  epitope  91-105  (Hasan  et  al.  1995).  Rabbit  anti-sera 
against  the  65-KD  heat  shock  protein  of  Mycobacterium  tuberculosis  display  a 
corresponding  65-KD  band  as  well  as  with  all  six  Streptococcus  sanguis  strains  and 
Streptococcus  pyogenes  but  not  with  Streptococcus  salivarius.  Also,  by  immunoblot 
analyses,  a  65-70  KD  band  was  found  more  frequently  with  Streptococcus  sanguis 
KTH-2  or  KTH-3  and  IgA  antibodies  to  the  mycobacterial  65  KD  heat  shock  protein 
in  serum  from  patients  with  Behcet's  syndrome  than  with  sera  from  controls  (Lehner 
et  al.  1991). 
In  conclusion  it  is  likely  that  the  most  cross-reactivity  between  microbial  and  cellular 
host  material  is  that  between  heat  shock  proteins  which  are  highly  conserved.  The 
increase  of  the  91-105  heat  shock  protein  in  oral  mucosa  may  cause  expansion  of  an 
auto-reactive  T  cell  clone  primed  to  the  homologous  peptide  116-130  which  causes 
antigenic  reaction  and  results  in  mucosal  damage  (Hasan  et  al.  1995). 
69 i)  Immunoglobulin  deposits  within  the  tissues 
Immunoglobulins  deposited  within  the  tissues  in  patients  with  aphthous  stomatitis  and 
the  presence  of  immunoglobulin-bearing  intra-lesional  leukocytes  have  been 
previously  discussed  in  the  section  dealing  with  the  histology  of  recurrent  aphthous 
stomatitis.  (Section  1.3.3) 
1.6.2.  Cell-Mediated  Immunity  in  Recurrent  Aphthous  Stomatitis 
The  literature  pertaining  to  the  cellular  immune  response  in  recurrent  aphthous 
stomatitis  is  extensive.  Early  studies  were  prompted  by  the  intense  lympho-monocytic 
infiltration  seen  on  histological  examination  which  is  consistent  with  a  delayed 
hypersensitivity  reaction  (Graykowski  et  al.  1966). 
The  association  of  recurrent  aphthous  stomatitis  with  immunologically  related 
diseases  and  in  vitro  immunological  studies  strengthen  the  possibility  of  an 
immunopathogenesis  for  recurrent  aphthae  (Roy,  1977). 
In  addition,  in  vivo  studies  of  delayed  hypersensitivity  further  enhance  this  claim. 
a)  Cell-mediated  immunity  to  mitogens 
Lymphocytes  from  patients  with  recurrent  aphthous  stomatitis  have  been  shown,  on 
several  occasions  (Lehner,  1967a;  Francis  and  Oppenheim,  1970;  Martin  et  al.  1979), 
to  proliferate  normally  in  vitro  when  stimulated  by  mitogens  such  as 
phytohaemagglutinin  (PHA)  and  conconcavalin  A  (con  A). 
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early  stage  of  ulceration  suggesting  a  non-specific  immunodepression  in  these  patients 
which  may  be  an  effect  rather  than  a  cause  of  the  ulcerative  lesions  (Greenspan  et  al. 
1981). 
Exacerbation  of  Behcet's  syndrome  and  recurrent  aphthous  stomatitis  has  been 
reported  to  occur  after  the  ingestion  of  English  and  black  walnuts  in  some  patients 
(Marquardt  et  al.  1973).  The  meat  of  these  nuts  appears  to  be  mitogenic  to 
lymphocytes  and  chemotactic  for  mononuclear  leukocytes  in  vitro  in  both  patients  and 
controls  (Oppenheim  et  al.  1973).  Basophils  from  all  patients  with  clinically 
symptomatic  unrelated  allergies  released  a  significant  proportion  of  their  histamine 
when  exposed  to  mitogen  containing  extracts  of  black  walnut  meat.  In  contrast,  non 
allergic  subjects  released  little  or  none  of  their  histamine  (Oppenheim  et  al.  1973).  The 
pellicle  from  these  walnuts  is  rich  in  heat  labile  tannins  which  significantly  depress 
lymphocyte  responses  (Oppenheim  et  al.  1973). 
When  walnuts  are  ingested  they  cause,  within  48  hours,  a  50  per  cent  reduction  in 
lymphocytes  proliferating  in  vitro  to  all  stimulants  in  patients  and  controls  (Marquardt 
et  al.  1973).  It  was  therefore  suggested  that  a  temporary  depression  of  the  functional 
T  cell  population  by  walnuts  may  indirectly  allow  B  cells  to  produce  more 
immunoglobulin  and  exacerbation  of  the  disease  (Marquardt  et  al.  1973). 
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Both  humoral  and  cellular  components  of  the  immune  response  are  involved  in  control 
of  viral  infections.  Virus-encoded  proteins,  usually  capsid  proteins,  serve  as  targets 
for  the  immune  response.  Virus-infected  cells  may  be  lysed  by  cytotoxic  T 
lymphocytes  as  a  result  of  their  recognition  of  viral  polypeptides  on  the  cell  surface 
(Jawetz  et  al.  1989). 
Patients  with  recurrent  aphthous  stomatitis  have  negative  skin  tests  to  herpes  hominis 
(Stark  et  al.  1954).  Herpesvirus  and  adenovirus  have,  however,  been  reported  to 
induce  blastogenesis  of  lymphocytes  from  patients  with  recurrent  aphthae  (Nasz  et  al. 
1971;  Sallay  et  al.  1971b).  Assessing  blastogenesis  morphologically  using  light 
microscopy,  these  studies  found  transformation  in  14  of  28  patients  using  herpesvirus 
and  in  21  of  28  patients  using  adenovirus.  The  figures  observed  for  controls  were  3  of 
12  and  4  of  21  respectively.  On  this  basis  the  authors  suggested  that  these  viruses  may 
be  of  aetiological  significance  in  recurrent  aphthous  stomatitis.  These  findings  await 
confirmation. 
c)  Cell-mediated  immunity  against  bacteria 
In  vivo  studies 
Graykowski  et  al  (1966)  first  reported  that  all  of  30  patients  with  recurrent  aphthous 
stomatitis  showed  a  positive  delayed  hypersensitivity  response  after  intradermal 
injection  with  Streptococcus  sanguis,  strain  2A,  although  this  did  not  occur  so 
consistently  among  controls.  These  authors  were  also  able  to  produce  aphthous-like 
lesions  in  laboratory  animals  experimentally  by  injecting  them  with  this  organism 
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with  recurrent  aphthous  stomatitis  produced  a  skin  reaction  after  intradermal  injection 
with  this  organism;  the  maximum  intensity  of  this  reaction  was  seen  after  24  to  48 
hours.  Only  three  of  six  patients  with  non-aphthous  lesions  and  one  of  six  healthy 
controls  showed  a  similar  response.  Such  intradermal  challenge  caused  exacerbation 
of  the  stomatitis  in  four  patients  with  minor  recurrent  aphthous  stomatitis  and  in  four 
patients  with  major  aphthae,  the  sites  of  the  skin  tests  necrosed  and  healed  with 
scarring  in  a  fashion  similar  to  that  seen  with  major  aphthae  in  the  mouth  (Barile  et  al. 
1968). 
A  pronounced  delayed-type  skin  reaction  to  Streptococcus  viridian  has  also  been 
reported  in  a  patient  with  recurrent  aphthous  stomatitis  (Shore  and  Shelley,  1974), 
and  skin  reactions  have  also  reported  to  be  increased  in  association  with  recurrent 
aphthous  stomatitis  to  several  bacterial  strains  especially  Streptococcus  viridans, 
Streptococcus  pneumonia,  Streptococcus  Lancefield  group  G,  Neisseria  catarrhalis, 
Heamophilus  influenzae,  Staphylococcus  aureus  and  Klebsiella  pneumonia  (Sallay  et 
al.  1971c;  Shore  and  Shelley,  1974). 
In  vitro  studies 
In  vitro  findings  with  regard  to  the  cellular  immune  response  to  bacteria  among 
patients  with  recurrent  aphthous  stomatitis  are  conflicting. 
By  using  leukocyte  migration  inhibition  as  a  parameter  of  cellular  immune  function, 
several  studies  have  shown  that  a  hypersensitivity  to  Streptococcus  Banguis,  strain  2A 
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Donatsky,  1978;  Greenspan  et  al.  1981a).  This  could  not  be  demonstrated  among 
controls  with  other  oral  lesions  or  experimentally-induced  oral  wounds  (Donatsky, 
1976b).  Moreover,  several  other  bacteria  tested,  including  Neisseria  subflava, 
staphylococci,  Brucella  abortus,  and  Escherichia  coli  did  not  reveal  any  differences 
between  patients  and  controls  (Donatsky,  1976b;  Donatsky,  1978).  Streptococcus 
pyogenes  (group  A,  strain  M5,  NCTC  100065)  elicited  a  similar  response  to  that  of 
Streptococcus  sanguis,  strain  2A,  but  a  correlation  with  disease  activity  was  only  seen 
with  Streptococcus  sanguis,  strain  2A  (Donatsky,  1976a;  Donatsky,  1978). 
When  lymphocyte  transformation  was  used  to  measure  the  cell-mediated  response  to 
the  original  isolate  of  Streptococcus  sanguis,  strain  2A  in  patients  with  recurrent 
aphthous  stomatitis,  a  significant  hypo-responsiveness  was  seen  when  compared  with 
controls  (Francis  and  Oppenheim,  1970).  This  work  could  not  be  reproduced  by 
another  group  when  the  American  type  culture  collection  equivalent  (ATCC  10556) 
was  used  (Martin  et  al.  1979). 
More  recently  a  hyporesponsiveness  was  seen  in  the  proliferative  response  to 
Streptococcus  sanguis,  ATCC  10556  in  patients  with  early  lesions,  although  this 
group  also  showed  a  similar  hyporesponsiveness  with  various  mitogens  (Greenspan  et 
al.  1981b). 
When  the  original  study  (Francis  and  Oppenheim,  1970)  on  lymphocyte 
transformation  was  carried  out,  the  hyporesponsiveness  to  Streptococcus  Banguis 
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findings  more  plausible. 
d)  Cell-mediated  immunity  against  tissue  antigens 
Oral  mucosa 
Increased  lymphocyte  transformation  was  induced  by  saline  extracts  of  homogenates 
of  oral  mucosa  in  patients  with  minor  aphthae  and  to  a  lesser  extent  in  herpetiform 
ulcers  (Lehner,  1967a).  Lymphocyte  transformation  was  regarded  as  positive  when 
more  than  400  counts  per  10  minutes  were  observed.  Lymphocyte  transformation  was 
positive  in  10  of  19  patients  with  major  or  minor  aphthae  and  only  two  of  nine 
patients  with  herpetiform  ulcers.  A  negative  response  was  found  in  12  normal  controls 
and  13  patients  with  other  oral  ulcerative  conditions.  On  the  basis  of  data  the  author 
suggested  that  recurrent  aphthous  stomatitis  was  an  autoimmune  disease.  More 
recently  however,  an  enhanced  lymphocyte  proliferative  response  to  oral  mucosa 
could  not  be  confirmed  using  a  microtitre  technique  and  indeed  a  temporary 
hyporesponsiveness  at  the  early  stage  in  recurrent  aphthae  patients  was  reported 
(Greenspan  et  al.  1981  a). 
Leukocyte  migration  inhibition  has  also  been  reported  to  be  enhanced  with  oral 
mucosa  in  patients  with  recurrent  aphthous  stomatitis  (Donatsky,  1976a;  Donatsky, 
1976b;  Donatsky,  1978). 
Further  support  for  the  involvement  of  cell-mediated  immunity  in  the  pathogenesis  of 
recurrent  aphthous  stomatitis  has  been  gained  by  demonstrating  that  lymphocytes 
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of  gingival  epithelial  target  cells  (Dolby,  1969;  Rogers  III  et  al.  1974;  Rogers  III  et  al. 
1976).  Tissue  specificity  of  the  cytotoxic  response  to  oral  epithelium  was  suggested 
by  the  lack  of  cytotoxicity  to  skin,  vaginal  or  colonic  mucosal  cell  (  Dolby,  1970b; 
Dolby,  1972).  This  cytotoxicity  was  blocked  by  pre-incubation  of  the  effector  cells 
with  rabbit  anti-human  lymphocyte  serum  (Dolby,  1970a)  or  the  addition  of 
hydrocortisone  (Dolby,  1970b).  Unfortunately,  gingival  epithelial  target  cells  were 
used  which  is  an  area  of  the  mouth  generally  not  affected  by  aphthous  lesions.  The 
mechanism  of  cytotoxicity  involved  in  these  experiments  is  not  entirely  clear,  although 
it  was  probably  antibody  independent.  More  recently  however,  raised  antibody 
dependent  cellular  cytotoxicity  (ADCC)  has  been  demonstrated  in  patients  with 
recurrent  aphthous  stomatitis  using  chicken  red  blood  cell  as  targets  (Greenspan  et  al. 
1981a).  These  data  indicated  an  increase  in  circulating  killer  (K)  cells  but  did  not 
address  the  question  of  whether  ADCC  was  actually  involved  in  the  destruction  of 
oral  mucosal  cells.  In  a  study  by  Burnett  and  Wray  (1985)  in  an  in  vitro  experiment 
they  showed  that  sera  from  recurrent  aphthous  stomatitis  patients  induced 
significantly  more  cytolysis  than  matched  control  sera.  This  cytolysis  effect  would  be 
demolished  by  inactivating  the  sera  at  56°C  for  30  minutes.  Also  recurrent  aphthous 
stomatitis  mononuclear  leukocytes  showed  no  significant  direct  cytotoxicity.  When 
recurrent  aphthous  stomatitis  leukocytes  combined  with  heat-inactivated  autologous 
serum  were  compared  with  recurrent  aphthous  stomatitis  leukocytes  combined  with 
heat-inactivated  fetal  calf  serum  (FCS),  although  no  significant  difference  was 
observed  between  these  two  groups,  in  two  of  nine  cases,  recurrent  aphthous 
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inactivated  autolougous  serum  than  when  combined  with  heat-inactivated  FCS.  These 
results  suggested  the  presence  of  antibody-dependent  cell-mediated  cytotoxicity 
(ADCC)  in  some  cases  of  recurrent  aphthous  stomatitis.  (Burnett  and  Wray,  1985) 
Other  human  tissues 
A  certain  tissue  specificity  of  the  cell-mediated  immune  response  is  apparent  in 
recurrent  aphthous  stomatitis.  Although  foetal  human  skin  induced  lymphocyte 
transformation  in  patients  with  recurrent  aphthae,  extracts  of  foetal  human  tissues 
from  colon,  striated  muscle,  salivary  glands  and  liver  only  occasionally  stimulated 
lymphocytes  from  these  patients  and  a  similar  response  was  also  seen  in  controls 
(Lehner,  1967a).  In  addition,  extracts  of  kidney  or uterus  did  not  cause  any  significant 
leukocyte  migration  inhibition  in  lymphocyte  cultures  from  patients  with  recurrent 
aphthae  (Donatsky,  1976a;  Donatsky,  1976b;  Donatsky,  1978).  Furthermore,  no 
increased  lymphocyte  cytotoxicity  was  seen  by  patients  lymphocytes  toward  skin, 
vaginal  or  colonic  mucosal  target  cells  (Dolby,  1972;  Rogers  III  et  al.  1974).  No  data 
have  been  reported  with  respect  to  species  specificity  of  the  cellular  immune  response. 
1.6.3.  Virus-Induced  Immune  Dysfunction 
Some  viruses,  particularly  the  herpesviruses  and  HIV,  can  induce  immune  dysfunction 
and  immune  suppression.  Herpesviruses  suppress  cellular  immunity;  mechanisms 
include  inhibition  of  cytokine  production  and  direct  interaction  of  the  virus  with  the 
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function,  antibody  production  and  natural  killer  cell  cytotoxicity  are  not  impaired. 
Environmental,  genetic  and  hormonal  factors  appear  to  be  involved  in  the 
pathogenesis  of  autoimmune  disorders.  No  single  micro-organism  or  mechanism  can 
explain  the  varied  phenomena  of  autoimmune  disorders  but  evidence  is  accumulating 
that  certain  viral  infections  can  be  responsible  by  modifying  or  releasing  sequestered 
cellular  proteins,  altering  the  immune  system  by  polyclonal  B-cell  activation,  so 
disturbing  immunoregulation  or  releasing  lymphokines,  molecular  mimicry,  anti- 
idiotype  antibodies,  or  immune  complex  formation.  Autoantibodies  may  appear  after 
some  viral  infections  or  vaccinations  and  may  herald  autoimmune  disease.  Viral 
infection  may  also  exacerbate  autoimmune  diseases.  Viral  infections  often  disturb  the 
host's  immune  system.  Lymphocytes  are,  for  example,  often  infected  by  HIV, 
hepatitis  B,  mumps  or  herpesviruses  with  profound  consequences  (Scully  and 
Samaranayake,  1992). 
Viruses  may  also  change  infected  cells  and  thereby  trigger  autoantibody  formation. 
Viruses,  or  their  components  (nucleic  acids  or  antigens),  may  be  found  in  autoimmune 
disorders.  This  may  imply  a  pathogenic  role  or  the  virus  may  be  a  mere  passenger.  On 
the  other  hand,  absence  of  these  viral  footprints  does  not  exclude  a  role  for  viruses, 
which  may  have  acted  in  a  hit  and  run  fashion  (Scully  and  Samaranayake,  1992). 
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The  literature  pertaining  to  the  treatment  of  recurrent  aphthous  stomatitis  is  extensive. 
The  majority  of  therapies  used  are  empirical  or  symptomatic  and  the  variety  of 
therapeutic  regimes  reported  indicate  that  none  are  adequately  effective. 
For  the  purposes  of  this  review,  proposed  therapies  for  the  treatment  of  recurrent 
aphthous  stomatitis  will  be  divided  into  those  employed  with  the  intention  of  reducing 
the  number  and  severity  of  lesions  and  those  used  only  to  provide  symptomatic  relief. 
1.7.1.  Preventive  Therapy 
Vitamins  and  minerals 
It  has  been  reported  that  vitamin  B12  injections  in  a  patient  with  pernicious  anaemia 
could  resolve  all  oral  manifestations  of  the  disease  including  the  recurrent  aphthous 
stomatitis  (Hjorting-Hansen  and  Bertram,  1968).  The  same  effect  of  vitamin  B12  was 
seen  in  other  recurrent  aphthous  stomatitis  patients  with  vitamin  B12  deficiency 
(Walker,  1973). 
In  the  study  of  Wray  et  al  (1975)  in  a  series  of  130  patients  with  recurrent  aphthous 
stomatitis,  all  23  patients  with  proven  deficiencies  of  iron,  folic  acid  and  vitamin  B12 
were  improved  or  showed  a  remission  of  their  ulceration  with  haematinic  therapy 
(Wray  et  al.  1975).  When  this  series  was  extended  87  per  cent  of  deficient  patients 
with  recurrent  aphthous  stomatitis  had  a  remission  or  marked  improvement  when  the 
deficiency  was  treated  (Wray  et  al.  1978).  These  studies  were  subsequently 
confirmed,  when  in  a  series  of  200  recurrent  aphthous  stomatitis  patients,  51  patients 
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patients  67  per  cent  with  deficiencies  showed  a  remission  or  marked  improvement 
with  replacement  therapy  (Nally  and  Blake,  1975).  In  all  of  these  groups  of  patients, 
(Nally  and  Blake,  1975;  Wray  et  al.  1975;  Wray  et  al.  1978)  replacement  with  vitamin 
B12  was  most  effective  while  iron  replacement  was  least  effective.  Also  remission  and 
improvement  of  the  ulcers  was  demonstrated  in  other  studies  as  a  response  to  vitamin 
B12,  folate  and  iron  therapy  in  haematological  deficient  recurrent  aphthous  stomatitis 
patients  (Challacombe  et  al.  1977a;  Hutcheon  et  al.  1978;  Challacombe  et  al.  1983; 
Palopoli  and  Waxman,  1990).  However  in  these  reports  a  placebo  effect  was  not 
considered  but  other  workers  showed  that  the  systemic  treatment  with  haematinics  in 
the  absence  of  detected  deficiencies  is  ineffective  (Sircus  et  al.  1957;  Farmer,  1958). 
Although  the  combined  therapy  with  aneurine  hydrochloride  and  folic  acid  was 
reported  to  improve  the  severity  of  the  ulcers  in  approximately  half  the  examined 
subjects  (Farmer,  1958;  Roy,  1966).  Recently,  the  use  of  vitamins  B1,  B2  and  B6  was 
reported  to  be  effective  in  treatment  of  recurrent  aphthous  stomatitis  in  whom  vitamin 
B1,  B2  or  B6  deficiencies  were  diagnosed  (Nolan  et  al.  1991b).  These  findings  have 
not  been  repeated. 
In  a  study  of  63  patients  with  recurrent  aphthous  stomatitis,  nine  patients  were  shown 
to  be  deficient  of  zinc  and  in  an  open  trial  of  systemic  zinc  sulphate  the  majority  of 
patients  were  reported  to  improve  (Merchant  et  al.  1977).  A  mild  effect  of  systemic 
zinc  was  later  reported  in  a  double-blind  trial  when  a  significant  improvement  was 
seen  in  only  a  few  patients  (Merchant  et  al.  1981;  Raeste  et  al.  1981).  Subsequently  in 
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of  zinc  therapy  on  the  incidence  or  severity  of  the  ulceration.  Also,  there  was  no 
correlation  between  zinc  status  and  response  to  therapy  in  any  of  the  patients.  (Wray, 
1982b)  Although  there  is  a  report  which  showed  that  systemic  zinc  therapy  could 
prevent  recurrent  aphthous  stomatitis  in  a  patient  with  zinc  and  cellular  immune 
deficiencies  (Endre,  1991). 
Hormones 
There  is  a  body  of  evidence  which  shows  the  relationship  between  oestrogen  and 
changes  in  oral  mucosa  and  the  vagina  (Ferguson,  1975).  Also  the  relationship  of 
recurrent  aphthous  stomatitis  with  the  menstrual  period  and  pregnancy  prompted  the 
use  of  oestrogen  and  oral  contraceptives  to  treat  recurrent  aphthous  stomatitis 
(Carruthers,  1967).  High  dose  oestrogen  was  found  to  be  effective  for  treating  this 
subgroup  of  patients  (Bishop  et  al.  1967).  Progesterone  in  depot  injection  form,  either 
medroxyprogestrone  acetate  or  gestronal  hexanoate  have  been  used  successfully  in  10 
women  with  pre-menstrual  aphthae  (Ferguson  et  al.  1978).  Gestronal  hexanoate  was 
used  in  addition  to  medroxyprogestrone  acetate  as  the  former  can  not  be  converted  in 
vivo  to  hydrocortisone,  indicating  that  the  effect  seen  was  not  due  to  a  glucocorticoid 
metabolite  of  the  progesterone  used  (Porter  and  Scully,  1990).  In  a  preliminary  study, 
anabolic  corticosteroids  in  combination  with  lysine  were  reported  to  be  effective  in 
eliminating  recurrence  in  eight  patients  (Papanayotou,  1972).  However  the  potential 
side  effects  of  treatment  with  anabolic  corticosteroids  has  been  stressed  (Hyman, 
1972).  In  a  recent  investigation,  an  effect  of  ovarian  hormones  on  concurrent 
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more  likely  to  have  remission  or  improve  their  ulcers  when  receiving  therapeutic 
ovarian  hormones  (McCartan  and  Sullivan,  1996).  Despite  the  effect  of  hormone 
therapy  in  a  few  cases,  the  ultimate  usefulness  of  this  treatment  in  recurrent  aphthous 
stomatitis  remains  in  doubt  due  to  the  undesirable  side  effects  observed. 
Dietary  manipulation 
Food  allergy  and  sensitivity  has  been  suggested  to  be  important  in  the  aetiology  of 
recurrent  aphthous  stomatitis  (See  section  1.5.2).  Some  studies  have  shown  a 
beneficial  effect  from  withdrawing  suspect  foods  from  the  diet  (Ship,  1960;  Spouge 
and  Diamond,  1963;  Copeman,  1978;  Wray  et  al.  1982;  Hay  and  Reade,  1984;  Nolan 
et  al.  1991a),  but  this  has  not  been  a  universal  finding  (Ship  et  al.  1962;  Eversole  et  al. 
1982).  Recently,  the  gluten  fraction  of  flour  has  been  implicated  in  causing  ulceration 
in  some  people  with  recurrent  aphthous  stomatitis.  Also  the  incidence  of  coeliac 
disease  is  increased  in  patients  with  recurrent  aphthae  (see  section  1.5.3.  b).  The  oral 
ulceration  in  such  patients  with  malabsorbtion  resolves  in  response  to  gluten 
withdrawal  (Wray  et  al.  1975;  Ferguson  et  al.  1975;  Wray  et  al.  1978;  Ferguson  et  al. 
1980;  Tyldesley,  1981;  Wray,  1981).  These  findings,  however,  were  not  confirmed  in 
other  reports  (Walker  et  al.  1980;  Hunter  et  al.  1993).  In  addition,  further  groups  of 
patients  without  gluten-induced  enteropathy  were  reported  to  respond  to  a  gluten  free 
diet  (Walker  et  at.  1980;  Wray,  1981;  Wright  et  at.  1986). 
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Lysine  is  one  of  eight  essential  aminoacids  in  man.  It  has  been  found  that  lysine  has 
the  most  inhibitory  effect  on  viruses  between  other  naturally  occurring  amino  acids. 
During  invasion  of  virus  into  the  host  cell,  it  alters  the  cell  metabolism,  causing  the 
cell  to  synthesize  virus-specific  proteins  high  in  arginine  and  low  in  lysine.  From  these 
data,  investigators  postulated  that  a  high  lysine/arginine  ratio  in  cells  might  serve  as  a 
virus  inhibitor.  Recent  studies  concur  with  this  hypothesis  (Kagan,  1974;  Little,  1984; 
Miller  and  Foulke,  1984).  The  lysine/arginine  ratio  could  be  increased  naturally  by 
eating  a  diet  containing  foods  high  in  lysine  and  low  in  arginine,  such  as  milk  and 
meat,  or  decreased  by  a  diet  full  of  nuts,  chocolate  and  wheat  (Miller  and  Foulke, 
1984).  In  a  study  by  Wright  (1994),  the  use  of  lysine  as  a  prophylactic  and  treatment 
agent  caused  improvement  in  recurrence  and  healing  of  the  aphthous  ulcers.  This 
result  could  be  explained  either  by  the  effect  of  lysine  on  the  replication  of  virus  thus 
suggesting  a  viral  aetiology  of  recurrent  aphthous  stomatitis,  or  by  the  withdrawing  of 
wheat  as  a  gluten-free  diet  in  patients.  This  finding  might  therefore,  be  an  explanation 
for  those  studies  (Walker  et  al.  1980;  Wray,  1981;  Hay  and  Reade,  1984)  which 
showed  improvement  in  aphthous  ulceration  during  a  gluten-free  diet  in  patients  with 
normal  jeojunal  biopsies.  Also,  a  trial  of  anabolic  corticosteroids  in  combination  with 
lysine  was  effective  in  causing  remission  of  ulcers  in  recurrent  aphthous  stomatitis 
patients  (Papanayotou,  1972).  However  it  is  not  clear  which  part  of  the  medication 
had  the  more  significant  effect. 
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The  mechanism  whereby  allergy,  especially  to  foods,  exerts  its  effects  on  susceptible 
patients  with  recurrent  aphthae  is  unclear.  IgE  bearing  lymphocytes  are  significantly 
increased  in  aphthous  lesions  (Bays  et  al.  1977)  and  mast  cells  are  increased  in  tissue 
sections  from  the  prodromal  stages  of  recurrent  ulcers  (Lehner,  1969c).  These  mast 
cells  degenerate  within  48  hours  of  new  ulcer  formation  (Dolby  and  Allison,  1969). 
Di-sodium  cromoglycate,  which  prevents  mast  cell  degranulation  (Assem,  1973)  is 
partially  effective  in  reducing  the  pain  and  duration  of  aphthous  lesions  (Frost,  1973; 
Walker  and  Dolby,  1975;  Dolby  and  Walker,  1975;  Kowolik  et  al.  1978;  Vaughan- 
William  and  Dolby,  1981).  Antihistamines,  however,  though  reported  to  be  useful  by 
some  (Lehner,  1967b),  have  been  shown  to  be  without  effect  by  others  (Graykowski 
et  al.  1966;  Dolby,  1968b). 
Immunopotentiating  agents 
Multiple  smallpox  and  influenza  A  and  B  vaccinations  were  not  effective  in  the 
treatment  of  recurrent  aphthous  stomatitis  despite  a  few  reports  which  showed  some 
improvement  in  aphthous  ulcers  (Weichselbaum  and  Derbes,  1957;  Graykowski  et  al. 
.  1966;  Miller  and  Foulke,  1984).  Some  of  the  preparations  of  human  transfer  factor 
given  orally  were  reported  to  be  effective  in  the  treatment  of  recurrent  aphthous 
stomatitis  (Schulkind  et  al.  1984).  Gamma  globulin  injections  have  proved  to  have  no 
benefit  in  recurrent  aphthous  stomatitis  (Fraser-Moodie,  1960;  Graykowski  et  al. 
1966).  An  initial  report  on  the  effectiveness  of  the  immunopotentiator,  levamisole, 
claimed  this  agent  was  effective  in  controlling  recurrent  aphthous  stomatitis  (Symoens 
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frequency  of  recurrent  herpes  infection  (Symoens  and  Brugmans,  1974).  Subsequent 
open  and  double-blind  investigations  into  the  use  of  levamisole  have  issued  conflicting 
results  (Olson  et  al.  1976;  Meyer  et  al.  1977;  Gier  et  al.  1978;  Kaplan  et  al.  1978; 
Drinnan  and  Fischman,  1978;  De  cree  et  al.  1978;  Olson  and  Silverman,  1978;  Miller 
et  al.  1978;  Zissis  et  al.  1983).  The  therapeutic  efficiency  of  this  drug  remains  unclear. 
Antiviral  drugs 
Similarity  between  clinical  and  immunohistochemical  features  of  recurrent  aphthous 
stomatitis  and  some  viral  diseases,  especially  those  from  herpesviruses,  persuaded 
some  investigators  to  try  the  effect  of  antiviral  drugs  in  recurrent  aphthous  stomatitis. 
The  effect  of  oral  aciclovir  was  studied  in  recurrent  aphthous  stomatitis  in  a  double- 
blind  treatment  trial  (Wormser  et  al.  1988).  In  this  study,  25  subjects  who  were  under 
treatment  for  genital  herpes  simplex  infection,  received  oral  aciclovir,  400  mg  daily 
for  one  year  and  19  patients  with  the  same  condition  of  genital  herpes  simplex 
infection,  received  placebo  for  the  same  period  of  time  and  oral  aciclovir  only  at  the 
time  of  infection.  All  patients  were  self  diagnosed  to  have  at  least  one  attack  of 
recurrent  aphthous  stomatitis  every  year  (Wormser  et  al.  1988).  No  significant 
difference  was  observed  between  the  two  groups  of  patients.  Compared  with  patients' 
pervious  history  of  attacks  of  the  recurrent  aphthous  stomatitis  lesions,  21  per  cent  of 
the  group  that  received  aciclovir  intermittently  had  more  attacks  during  the  study,  32 
per  cent  had  fewer  attacks,  32  per  cent  had  the  same  number  of  attacks  and  16  per 
cent  were  unevaluable  for  this  comparison.  Also  frequencies  observed  in  the  group 
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where  24  per  cent  of  the  patients  had  more  attacks,  20  per  cent  had  fewer  attacks,  48 
per  cent  had  the  same  number  of  attacks  and  eight  per  cent  were  unevaluable  for  this 
comparison  (Wormser  et  al.  1988).  In  contrast,  in  another  open  study,  a  high  dose  of 
oral  aciclovir  was  administered  to  find  its  efficiency  in  recurrent  aphthous  stomatitis 
patients  (Pedersen,  1992).  In  this  trial,  that  was  designed  on  the  basis  of  involvement 
of  varicella  zoster  virus  as  an  aetiology  of  recurrent  aphthous  stomatitis,  eight 
otherwise  healthy  patients  with  severe  recurrent  aphthous  stomatitis  were  treated  with 
800  mg  oral  aciclovir  on  a  daily  basis  for  one  year.  Ulcers  disappeared  in  two  patients 
totally,  in  four  patients  their  ulcers  improved  dramatically  and  only  in  two  cases  did 
the  medication  prove  ineffective  (Pedersen,  1992).  These  findings  were  confirmed  by 
an  open  study  with  a  larger  population  of  30  recurrent  aphthous  stomatitis  patients 
(Ozturkcan  et  al.  1996). 
Immune-suppressive  drugs 
Systemic  corticosteroids  in  the  form  of  prednisone,  at  a  dose  of  40  mg  per  day,  will 
suppress  recurrent  aphthous  stomatitis  entirely.  The  long  term  side-effects  of  such  a 
regime  are  unacceptable  and  consensus  among  clinicians  is  that  corticosteroids  should 
only  be  used  in  patients  with  severe  ulceration  where  the  ulcers  cannot  be  controlled 
by  topical  treatment.  When  used,  systemic  corticosteroids  should  be  given  for  limited 
periods  on  an  intermittent  basis  (Francis,  1970;  Lehner,  1977;  Dolby,  1973;  Grossman 
and  Sheagren,  1986;  Burgess  et  al.  1990).  Cyclophosphamide  was  reported  to  be  of 
benefit  in  one  patient  (Francis,  1970),  although  azathioprine  was  found  to  be 
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(Eggleston  and  Nally,  1972). 
Anaiolytic  drugs 
Since  anxiety  is  one  of  the  aetiologic  factors  in  some  patients  with  recurrent  aphthous 
stomatitis  (see  section  1.5.2.  c),  reduction  of  anxiety  can  be  a  major  step  in  the 
management  of  these  patients.  Low-doses  of  benzodiazepine  medication  such  as 
alphazolam  or  lorazepam  (0.5  to  2  mg)  or  diazepam  (5  mg)  prescribed  daily  for  not 
more  than  two  weeks  was  reported  to  be  quite  helpful  in  some  cases  (Burgess  et  al. 
1990),  but  prolonged  use  of  these  medications  is  discouraged  since  they  may  lead  to 
psychological  dependence  (Burgess  et  al.  1990). 
Thalidomide,  first  used  as  a  good  hypnotic  and  sedative  medication,  was  withdrawn 
from  the  market  in  1961  because  of  its  tetratogenic  effects.  Recent  evidence  suggests 
that,  patients  with  Behcet's  syndrome  and  severe  aphthous  ulcers  in  HIV-positive 
patients  may  benefit  from  thalidomide  (Burgess  et  al.  1990;  Radeff  et  al.  1990; 
Ghigliotti  et  al.  1993;  Paterson  et  al.  1995;  Schuler  and  Ehninger,  1995;  Minor  and 
Piscitelli,  1996;  Youle  et  al.  1996;  De  Vincenzo  and  Burchet,  1996;  Weidle,  1996). 
However  a  thalidomide-resistant  HIV-associated  case  of  oral  ulceration  has  been 
reported.  This  patient  was  finally  treated  by  granulocyte  colony-stimulating  factor 
(Manders  et  al.  1995). 
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Symptomatic  therapy  is  the  main  method  of  treatment  for  the  majority  of  patients  with 
recurrent  aphthous  stomatitis.  The  spectrum  of  agents  used  indicates  a  transient  relief 
of  symptoms.  In  general,  symptomatic  therapy  is  claimed  to  reduce  the  pain  or 
duration  of  lesions  but  not  the  number  or  frequency. 
Antibacterial  agents 
Regardless  of  the  role  of  bacteria  as  primary  aetiological  agents  in  recurrent  aphthous 
stomatitis,  secondary  infection  of  the  ulcers  from  oral  bacteria  may  prolong  the 
ulceration  and  increase  the  discomfort  experienced.  In  addition,  oral  hygiene  is 
frequently,  by  necessity,  neglected  by  the  patients,  which  further  increases  the 
possibility  of  infection  of  the  ulcers  (Addy  et  al.  1974).  For  these  reasons,  and  on  a 
purely  empirical  basis,  a  range  of  anti-bacterial  agents  have  been  investigated  for  their 
efficiency  in  recurrent  aphthous  stomatitis.  The  use  of  topical  chlortetracycline  was 
initially  reported  in  1942  (Distelheim  and  Sulzberger,  1949).  Since  that  time  several 
studies  have  shown  that  oral  tetracycline  rinses  are  somewhat  effective  in  decreasing 
the  duration  of  the  ulceration  and  reducing  the  associated  pain  but  are  ineffective  in 
reducing  recurrences  of  the  oral  lesions  (Graykowski  et  al.  1966;  Lehner,  1967b; 
Stanley,  1973;  Graykowski  and  Kingman,  1978;  Burgess  et  al.  1990). 
Chloramphenicol  and  oxytetracycline  have  not  been  proven  to  be  clinically  effective 
(Kutscher  et  al.  1953).  Chlortetracycline  oral  suspension  was  reported  to  be  most 
effective  especially  when  combined  with  either  topical  or  systemic  corticosteroids 
(Distelheim  and  Sulzberger,  1949;  Francis,  1970;  Stanley,  1973).  In  addition, 
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suspension  of  the  antibiotic  (Shore  and  Shelley,  1974).  Topical  tetracycline  was 
reported  to  be  the  drug  of  choice  in  herpetiform  ulcers  (Cooke,  1960).  Also, 
demeclocycline  has  been  of  some  benefit  in  recurrent  aphthous  stomatitis  patients  in 
an  open  trial  (Cottone  and  Langlais,  1977). 
The  commercial  anti-microbial  called  Listerine  antiseptic  mouthrinse  (Warner- 
Lambert  Co.  )  was  reported  to  be  beneficial  in  the  reduction  of  duration  and  severity 
of  recurrent  aphthous  stomatitis  (Meiller  et  al.  1991).  The  antiseptic,  chlorhexidine 
gluconate  reduced  the  incidence,  duration  and  severity  of  ulcers  when  compared  to 
placebo  (Addy  et  al.  1974;  Burgess  et  al.  1990)  and  the  gel  preparation  of 
chlorhexidine  was  also  effective  (Addy  et  al.  1976).  Oxygenating  agents  have  been 
shown  to  be  of  no  benefit  in  a  double-blind  study  (Miller  and  Chalton,  1980)  and  it  is 
discouraged  since  it  has  been  reported  to  cause  intra-oral  ulceration  (Burgess  et  al. 
1990). 
Topical  anaesthetics 
Topical  lignocaine  is  the  most  widely  used  local  anaesthetic.  It  provides  partial 
anaesthesia  of  the  mucous  membranes  for  up  to  30  minutes.  In  a  comparison  of 
various  solutions  of  antihistamine  or  dyclonine  hydrochloride  with  lignocaine  a 
combination  of  dyclonine  hydrochloride,  0.5  per  cent  in  saline  produced  superior 
symptomatic  relief  (Ship  et  al.  1960;  Dolby,  1973).  Benzydamine  hydrochloride  (HCI) 
also,  has  been  reported  to  have  an  analgesic  effect  on  recurrent  aphthous  stomatitis 
lesions.  (Yankell  et  al.  1981;  Matthews  et  al.  1987) 
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Hydrocortisone  ointment  was  reported  to  show  good  results  in  lesions  of  recurrent 
aphthous  stomatitis  (Hillman,  1956;  Morton,  1957).  Late  reports  on  the  topical 
application  of  pellets  of  hydrocortisone  hemisuccinate  recorded  approximately  a  50 
per  cent  reduction  in  the  incidence  of  ulcers  (Truelove  and  Morris-owen,  1958; 
Cooke  and  Armitage,  1960)  and  since  then,  a  similar  improvement  in  patients  given 
topical  triamcinolone  acetonide  in  dental  paste  (BPC)  has  been  reported  (Zegarelli  et 
al.  1959;  Zegarelli  et  al.  1960;  Rushton,  1962;  Stoy,  1966;  Brown  et  al.  1968; 
Macphee  et  al.  1968).  Betamethasone-17-benzoate  has  also  been  reported  to  be 
effective  by  reducing  the  healing  time  of  ulcers  (Merchant  et  al.  1978).  Triamcinolone 
0.1  per  cent  in  dental  paste  (BPC)  and  2.5  mg  tablets  of  hydrocortisone  (BPC)  are  the 
most  useful  preparations  (Roy,  1966;  Annon.  Editorial.  1974).  Suppression  of  the 
adrenal  cortex  does  not  occur  if  the  dosage  is  kept  within  reasonable  limits  (Lehner, 
1967b;  Lehner  and  Lyne,  1969;  Lehner  and  Lyne,  1970).  Corticosteroids  such  as 
desoxycorticosterone  0.25  per  cent  and  fluocinonide  0.05  per  cent  appear  to  be 
effective  for  single  ulcers  (Pimlott  and  Walker,  1983;  Burgess  et  al.  1990).  Use  of  a 
corticosteroid  in  combination  with  an  antibiotic  and  antifungal  medication  may  be 
beneficial  in  some  cases  (Burgess  et  al.  1990).  For  numerous  widely  distributed  ulcers 
use  of  a  rinse  such  as  dexamethasone  elixir  (0.5  mg  dexamethasone  per  5  ml)  may  be 
more  effective  (Burgess  et  al.  1990).  Intra-lesional  injection  of  triamcinolone 
acetonide  recently  was  reported  in  major  aphthous  ulcers  in  AIDS  patients  (Friedman 
et  al.  1994).  Use  of  a  double-layer  film  containing  triamcinolone  acetonide  (SIM-990) 
for  application  on  to  the  ulcers  on  the  oral  mucosa  shows  a  good  result  in  reduction 
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acetonide  inhaler  also  has  been  reported  to  be  of  benefit  in  aphthous  ulcers  in  HIV 
positive  patients  (Scott  and  Bender,  1996).  A  new  topical  adhesive  containing, 
triamcinolone  acetonide  and  Eudisper  ointment  was  effective  and  well  tolerated  in 
recurrent  aphthous  stomatitis  patients  in  a  clinical  trial  (Sveinsson  and  Holbrook, 
1993). 
Other  symptomatic  therapies 
Orabase  (dental  paste  BPC)  which  is  a  methylcellulose  based  vehicle  protects  the 
ulcers  but  it  has  been  shown  to  be  of  no  value  alone  in  the  treatment  of  recurrent 
aphthous  stomatitis  (Rushton,  1962;  MacPhee  et  al.  1968).  However  the  combination 
of  orabase  and  corticosteroids  (Adcortyl  in  Orabase)  was  reported  to  be  the  topical 
medication  of  choice  in  the  management  of  recurrent  aphthous  stomatitis  (Lehner, 
1967b).  Bioadhesive  patches  made  of  pharmaceutical  grade  cellulose  are  reported  to 
have  a  great  effect  on  reducing  the  pain  and  healing  time  of  the  ulcers  (Mahdi  et  al. 
1996).  Chemical  cautery  has  long  been  used  for  symptomatic  relief  and  to  encourage 
healing  (Antoon  and  Miller,  1980;  Burgess  et  al.  1990),  although  damage  to  the  tissue 
ensues  and  gangrene  of  the  tongue  has  been  reported  after  application  of  silver  nitrate 
(Frost  et  al.  1978;  Burgess  et  al.  1990).  Astringent  mouthwashes  have  also  been  used 
extensively,  although  in  a  double-blind  trial  of  a  zinc  sulphate  and  zinc  chloride  mouth 
wash  (BPC)  was  found  to  be  less  effective  than  placebo  for  symptomatic  relief  (Addy 
et  al.  1974). 
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stomatitis,  in  some  cases  laser  therapy  could  reduce  the  pain  and  healing  time  of  the 
ulceration  (Colvard  and  Kuo,  1991). 
Recently,  the  effect  of  topical  5-amino  salicylate  in  the  treatment  of  Behcet's 
syndrome  (Ranzi  et  al.  1986)  and  recurrent  aphthous  stomatitis  (Bagg,  1985;  Collier 
et  al.  1992;  )  was  investigated.  Some  of  these  reports  indicate  the  efficiency  of  this 
medication  in  treatment  of  the  mucosal  ulceration  in  Behcet's  syndrome  and  recurrent 
aphthous  stomatitis  (Rani  et  al.  1986;  Collier  et  al.  1992)  but  in  another  report  this 
effect  was  not  found  (Bagg,  1985). 
1.8.  Aims  of  Thesis 
Aims  of  the  present  thesis  are: 
a)  To  investigate  the  current  management  of  patients  with  recurrent  aphthous 
stomatitis  and  epidemiologic  aspects  of  the  disease  in  Glasgow  Dental  Hospital  and 
School. 
b)  To  investigate  the  effect  of  a  topical  non-corticosteroid  drug,  5  aminosalicylate 
cream  in  aphthous  lesions. 
c)  To  investigate  the  involvement  of  HHV-6,  HCMV  and  VZV  in  the  aetiology  of 
recurrent  aphthous  stomatitis  by  the  molecular  biology  technique,  PCR,  and 
serological  experiments.  Also,  the  presence  of  Mycobacterium  paratuberculosis  was 
investigated  in  aphthous  lesions  by  the  PCR  technique. 
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93 2.1.  Introduction 
Audit  is  increasingly  essential  in  medical  subjects.  Clinical  audit,  in  addition  to 
improving  the  quality  of  patient  care,  permits  a  more  effective  use  of  resources  in 
other  clinical  studies  and  research.  Those  who  employ  medical  audit,  can  use  the 
information  to  identify  areas  of  a  particular  clinical  problem  that  may  require 
improvement,  then  set  realistic  standards,  discuss  any  noted  discrepancies  and  finally 
implement  necessary  changes  (Porter  et  at.  1993). 
The  aim  of  this  study  was  to  audit  all  information  about  each  patient  with  recurrent 
aphthous  stomatitis  using  a  computer  software  package,  and  test  the  ability  of  the 
program  to  provide  information  for  clinical  investigations.  In  addition,  this  program 
allowed  the  clinician  to  monitor  patients'  improvement  during  different  courses  of 
medication,  without  the  use  of  the  patients'  medical  records. 
As  a  result,  all  information  about  different  aspects  of  recurrent  aphthous  stomatitis 
can  be  analysed  and  a  comparison  of  these  data  with  previous  reports  is  possible.  Also 
this  analysis  can  assess  the  quality  of  the  clinical  management  of  the  patients  who 
attended  the  Oral  Medicine  Clinic. 
2.2.  Materials  and  Methods 
2.2.1.  Subjects 
To  investigate  the  clinical  features  of  recurrent  aphthous  stomatitis,  252  patients  who 
were  referred  to  the  Oral  Medicine  Clinic  in  Glasgow  were  personally  reviewed  and 
treated  in  the  period  from  September  1995  to  September  1996.  In  addition,  a  further 
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Oral  Medicine  Clinic  in  the  period  of  April  1993  till  April  1994  were  retrospectively 
studied  and  then  prospectively  reviewed  for  further  investigations. 
Added  to  these,  90  patients  with  normal  oral  mucosa,  who  attended  the  Oral 
Medicine  Clinic  for  temporomandibular  joint  pain,  were  studied  as  a  control  group. 
Also,  295  patients  who  initially  were  diagnosed  as  having  recurrent  aphthous 
stomatitis,  were  referred  to  the  Contact  Dermatitis  Unit  in  the  Royal  Infirmary  for 
identification  of  possible  allergic  components  involved  in  the  disease  process.  These 
patients  were  studied  retrospectively.  One  hundred  volunteers  derived  from  dental 
staff  and  students  were  also  tested  for  allergic  reactions  in  the  Oral  Medicine  Clinic  as 
a  control  group.  These  data  were  part  of  a  study  conducted  by  Dr.  S.  Rees. 
In  all  patients  with  recurrent  aphthous  stomatitis  who  are  presented  in  this  study, 
initially,  oral  lesions  were  not  related  to  any  systemic  diseases  on  presentation, 
however  the  possibility  of  underlying  systemic  disease  was  investigated. 
2.2.2.  Clinical  Observations  and  Investigations 
At  the  first  appointment,  all  information  about  medical  history,  history  of  the  disease, 
clinical  examination,  and  treatment  plan,  was  recorded  on  a  special  form  (Figure  2.1, 
2.2).  This  information  was  then  put  in  to  a  computer  data  base  package  specific  to 
oral  ulceration  (Appendix  I).  Review  appointments  and  further  treatment  and 
investigations  were  also  recorded  in  the  same  manner. 
95 This  computer  software  (Oral  Ulceration  Software)  was  designed  by  the  NHS 
Computer  Office  and  Clinical  Audit  Unit  in  Glasgow  Dental  Hospital  and  School. 
At  the  end  of  the  study,  information  related  to  the  first  group  of  patients  was 
extracted  and  compared  with  previous  observations  by  other  investigators  on 
aphthous  patients.  (Details  about  other  software  packages  used  in  this  part  will  be 
explained  in  the  statistical  method  section) 
In  first  group  of  252  patients,  all  information  about  full  blood  count,  assays  of  ferritin, 
folic  acid,  vitamin  B12  and  anti-gliadin  antibodies  were  recorded  in  the  Oral  Ulceration 
Software.  Complementary  tests  were  added  according  to  the  patient's  needs,  such  as 
anti-intrinsic  factor  and  anti-parietal  cell  antibodies.  Replacement  therapy  and  re- 
investigations  for  any  persistent  haematological  deficiencies  were  also  recorded. 
In  the  second  group  of  213  patients,  the  haematological  investigations  were 
retrospectively  studied  and  then  patients  were  followed  up  to  assess  the  effect  of 
previous  replacement  therapy. 
Venous  blood  was  removed  from  all  the  patients  and  controls  (90  patients  with 
normal  oral  mucosa  who  were  referred  to  Oral  Medicine  Clinic  for 
temporomandibular  joint  pain)  for  haematological  investigation  (full  blood  count, 
serum  ferritin,  red  blood  cell  folate  and  serum  vitamin  B12). 
Vitamin  B12  deficiencies  were  diagnosed  if  the  results  were  repeatedly  below  the 
normal  range  (Table  2.1).  Patients  with  diagnosed  deficiencies  were  questioned  to 
identify  a  cause  for  the  deficiency.  Where  clinical  concern  or  doubt  remained,  patients 
were  referred  for  medical  investigation. 
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SURNAME  CHRISTIAN  NAMEISI  UNIT  NUMBER 
CONSULTANT  REFERRED  BY 
CO  Recurrent  Oral  Ulcers 
HPC 
Age  of  Onset  m  Duration  F7  Years  m  Months 
Size  (mm)  From  =  Tom  Average 
Number  From  J  Tom  Average  m 
Time  to  Heal  Fromm  Tom  Average  m 
(in  days) 
No.  Ulcer  cers/Monlh 
0 
Sites  Affected:  inside  lips  Precipitating  factors:  trauma 
buccal  foods(specify) 
sulcue  menses 
floor  of  mouth  other  (specify) 
under  tongue 
dorsum  tongue  Social  History:  married 
soft  palate  single 
other  (specify)  other  (specify) 
extra  oral  (specify)  alcohol  (units/wk) 
tobacco(amomVday) 
Relevant  Medical  History: 
Drugs  i't. 
te( 
t 
`', 
' 
PDH  F/-  0 
CIF 
Q  P/  Q 
-/P 
Q 
P.  ."Z 
Regular  artender  Yes  0  No 
°t 
x 
Family  HI  t  (specify) 
Figure  2.1.  First  page  of  the  special  form  provided  for  the  first  appointment  of  all 
patients  with  RAS.  This  form  should  be  completed  by  the  clinician. 
97 
oral  Hygiene  good  Q  fair  p  poor  Q Other  Conditions  candidiasie  (specdy) 
angular  cheilitis 
glossilis 
other  (specdy) 
Relevant  Oral  Signs 
Diagnosis  Recurrent  Aphthaus  Stomatitis 
Minor 
Major 
Herpetiform 
Behcet's 
Other(specify) 
Treatment  Plan 
1.  Investigations 
FBC 
ferritm 
vit  13  12 
foiate 
glucose 
serum 
patch  test 
biopsy 
ulcer  diary 
other  (specify) 
2.  Therapy 
none  dose 
chiorhexidine 
tetracycline  m/w 
xylocaine  spray 
dimam 
adcortyl 
becotide 
betnesol 
predmsolone 
anldlmgata 
aniivirala 
dietary  elimination 
clinical  tnal  (specify) 
3.  Review  0  tiros 
Figure  2.2.  Second  page  of  the  special  form  provided  for  first  appointment  of  all 
patients  with  RAS.  This  form  should  be  completed  by  the  clinician. 
98 Patients  with  iron  deficiency  were  treated  with  ferrous  sulphate,  600  mg.  daily  (200 
mg  eight  hourly),  for  a  period  of  three  months. 
Identified  vitamin  B12  deficient  patients  were  also  investigated  for  anti-parietal  cell 
antibodies  and  anti-intrinsic  factor  antibodies.  Investigation  and  replacement  therapy 
for  these  patients  were  done  by  a  haematologist  or  their  general  medical  practitioner. 
In  the  case  of  folate  deficiency,  patients  were  also  referred  to  a  haematologist. 
All  patients  with  haematological  deficiencies  were  reviewed  after  three  months  of 
replacement  therapy  and  in  most  cases,  patients  reviewed  in  a  further  3,6  and  12 
months  to  assess  the  results  of  replacement  therapy  on  the  severity  of  the  aphthous 
ulcers.  The  criterion  for  the  effect  of  replacement  therapy  was  the  patient's 
satisfaction.  If  patients  reported  a  decrease  in  healing  time  and  pain  only,  but  the 
ulcers  were  still  present  as  before,  slight  improvement  was  recorded  as  number  one. 
Mild  improvement  was  a  decrease  in  the  number  of  ulcers  in  addition  to  a  reduction  in 
pain  and  healing  time  (number  two).  Improvement  of  ulceration  was  when  only  one  or 
two  small  ulcers  with  a  short  period  of  healing  time  appeared  during  the  review  period 
(number  three).  Patients  who  had  no  ulcers  during  follow-up  were  regarded  as  having 
had  a  remission  due  to  replacement  therapy  (number  four). 
Venous  blood  was  removed  to  find  the  effect  of  replacement  therapy.  In  the  case  of 
persisting  iron  deficiency  after  treatment  with  Ferrous  Sulfate  tablets,  patients  were 
referred  to  a  haematologist  for  further  investigations. 
99 Table  2.1.  The  normal  range  of  routine  Haematological  elements  tested. 
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Ferritin  (ng/ml)  20  330 
Vitamin  B12  (pg/ml)  175  800 
Folate  (ng/ml)  75  400 
Haemoglubolin  Male  12.5  18.0 
(gldl)  Female  12.0  16.5 
MCV  (fl)  80  100 
100 In  addition,  the  sex  and  age  of  this  group  of  patients  was  studied  separately  to 
compare  them  with  the  first  group  of  252  patients.  Data  from  second  group  of  213 
patients  were  not  recorded  on  the  Oral  Ulceration  Software,  because  at  that  period  of 
time  the  software  was  not  available. 
To  estimate  the  real  difference  in  sex  and  age  of  the  recurrent  aphthous  stomatitis 
patients  compared  with  a  control  group,  the  whole  patient  population  who  attended 
the  Oral  Medicine  Clinic  in  Glasgow  were  chosen  as  control  group. 
All  patients  received  a  topical  medication  for  symptomatic  relief.  In  severe  cases, 
patients  received  systemic  corticosteroids.  These  patients  were  reviewed  on  a  regular 
basis.  Topical  medication  was  prescribed  depending  on  severity,  site  and  number  of 
ulcers.  For  instance,  in  patients  with  major  and  long  lasting  ulcers,  tetracycline 
mouthwash  was  the  medication  of  choice.  When  the  patient  suffered  minor  ulcers  on 
the  tongue,  soft  palate  or  roof  of  the  mouth,  beclomethasone  spray  (BPC)  or 
betamethasone  mouthwash  (BPC)  was  prescribed.  For  ulcers  located  in  the  buccal 
mucosa,  buccal  or  labial  sulcus,  triamcinolone  in  dental  paste  (BPC)  was  the 
medication  of  choice.  On  the  next  appointment,  if  a  medication  was  not  effective, 
another  one  was  prescribed.  Combined  drug  therapy,  such  as  tetracycline  mouthwash 
and  a  topical  corticisteroid  were  prescribed  in  some  severe  cases. 
2.2.3.  Allergy  Investigation  (Patch  Testing) 
Patients  were  tested  to  the  items  listed  in  table  2.2.  All  materials  were  applied  under 
Finn  chambers  to  the  back  or  left  arm  for  48  hours.  Then  they  were  removed  and  after 
one  hour  examination  was  made  for  redness,  blistering  or  weeping  and  patient  was 
101 asked  whether  there  was  any  itching.  These  reactions  were  graded  according  to  how 
severe  they  were  and  a  further  48  hours  later,  another  examination  was  made  to  see 
whether  any  reaction  was  still  present.  Itching  and  persistent  reactions  were  taken  to 
be  positive  and  allergic.  Other  reactions  might  be  considered  to  be  irritant  and  non- 
specific. 
In  addition  to  the  above  testing  technique,  all  the  reagents  were  also  applied  to  the 
inner  aspect  of  the  forearm  under  occlusion  on  Finn  chambers.  This  time  the  tests 
were  only  left  on  for  20  minutes.  A  few  minutes  after  removal,  examination  was  made 
for  a  red  or  white,  itching,  or  palpable  area  with  a  red  flare  around  it  (urticaria). 
Symptoms  might  be  itchy,  stinging  or  burning  sometimes.  The  sites  of  the  tests  were 
marked  and  the  patient  was  asked  to  observed  this  area  during  a  period  of  6  hours 
thereafter.  Patients  kept  a  note  of  the  period  of  time  which  any  red  or  itchy  marks 
lasted  and  further  similar  reactions  which  were  not  evident  immediately  after 
removing  the  test.  A  positive  reaction  was  considered  to  be  those  which  gave  visible 
sensations  at  that  site  experienced  by  the  patient.  The  symptoms  and  visible  changes 
required  to  be  present  for  a  period  of  two  hours  before  the  test  was  considered  to  be 
positive.  The  control  group  was  tested  to  the  same  allergen  materials  except  mercury 
and  amalgam. 
102 Table  2.2.  The  materials  tested  in  RAS  patients  in  Patch  Testing. 
Mercury 
Amalgam 
Nickel 
Cobalt 
Formaldehyde 
Neomycin 
Antimicrobial  agents 
Perfume 
Domestic/Personal  materials. 
Benzoic  acid 
Sorbic  acid 
Sodium  metabisulphate 
Cinnamonaldehyde 
Chocolate 
Salicylic  acid 
Tartrazine 
Glutamic  acid 
Butylated  hydroxytoluene 
Butylated  hydroxyanisole 
103 2.2.4.  Statistics 
The  statistical  significance  of  differences  between  clinical  observations  in  patients  with 
recurrent  aphthous  stomatitis  and  the  total  patient  population  who  attended  the  Oral 
Medicine  Clinic  in  the  same  period  of  time  was  analysed  by  non-parametric  Chi- 
square  tests  using  Minitab  software  (PC  computer).  For  extracting  the  data  from  the 
Oral  Ulceration  Software,  Access  Software  was  applied  and  then  the  data  was  stored 
and  analysed  in  Excel  version  five  Software. 
2.3.  Results 
The  results  of  these  observations  are  separately  presented  for  different  clinical  features 
related  to  the  disease. 
2.3.1.  Age 
Data  from  first  group  of  252  patients  indicated  that  there  were  14  patients  under  the 
age  of  fifteen  years,  and  86  patients  with  recurrent  aphthous  stomatitis  aged  between 
sixteen  and  thirty  years  at  the  time  of  presentation.  Also,  114  patients  with  recurrent 
aphthous  stomatitis  were  referred  for  treatment  between  the  age  of  thirty  and  fifty 
years.  Only  38  patients  were  referred  for  treatment  over  the  age  of  fifty  years.  (Table 
2.3) 
In  the  second  group  of  213  patients  at  presentation,  24  were  under  15  years  of  age, 
65  patients  were  between  16  and  29  years  of  age,  90  patients  were  in  third  and  fourth 
decade  of  their  lives.  Only  34  patients  were  older  than  50  years  at  presentation.  A 
104 similar  pattern  of  age  distribution  therefore  was  observed  in  the  second  group  of  the 
patients.  (Table  2.3) 
The  age  distribution,  in  all  patients  who  attended  the  Oral  Medicine  Clinic  in  the  same 
period  of  time  as  the  first  group,  showed  more  patients  in  the  fourth  decade  of  life, 
however  from  8180  patients  3737  of  them  were  over  50  years  old. 
In  general,  in  both  groups  of  patients  with  recurrent  aphthous  stomatitis,  the 
prevalence  of  the  disease  was  increased  in  the  third  and  fourth  decade  of  life  (Figure 
2.3)  as  compared  with  the  whole  patient  population  attending  the  Oral  Medicine 
Clinic,  whose  numbers  were  increased  in  the  fourth  decade  of  life  and  over  50  years. 
There  was  no  statistical  significant  difference  in  distribution  of  age  at  presentation 
between  male  and  female  patients.  (Table  2.3) 
2.3.2.  Sex 
From  the  total  number  of  252  patients  in  the  first  group  190  were  females  and  62 
were  males.  (Table  2.3) 
These  patients  were  part  of  the  8180  patients,  comprising  2519  males  and  5661 
females  attended  the  Oral  Medicine  Clinic. 
In  second  group  of  213  patients  with  recurrent  aphthous  stomatitis,  68  males  and  145 
females  underwent  investigations  and  treatment  for  recurrent  aphthous  stomatitis. 
(Table  2.3) 
105 Table  2.3.  Age  at  presentation  and  sex  distribution  in  two  groups  of  patients  with 
RAS. 
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2nd.  group  4  20  19  46  61  29  34  213 
Male  1  9  6  10  23  11  8  68 
Female  3  11  13  36  38  18  26  145 
Total  11  27  42  109  138  66  71  465 
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Figure  2.3.  Age  at  presentation  and  sex  distribution  of  first  252  and  second 
213  patients  with  RAS.  The  age  and  sex  distribution  is  the  same  in  both 
groups. 
107 2.3.3.  Diagnosis 
Recurrent  aphthous  stomatitis  was  diagnosed  clinically  according  to  the  definition  of 
Lehner  (1968)  for  major  and  minor  aphthae  and  Cooke  (1960)  for  herpetiform  ulcers. 
In  this  thesis,  from  a  total  number  of  252  patients,  241  patients  were  diagnosed  as 
having  minor  aphthae,  six  patients  had  major  aphthae  and  three  had  herpetiform  ulcers 
(See  section  1.2).  In  two  other  patients,  ulcers  were  suspected  to  be  related  to 
denture  trauma  rather  than  recurrent  aphthous  stomatitis.  (Table  2.4) 
In  some  patients  the  diameter  of  ulcers  was  more  than  ten  millimetres  and  healing  time 
took  more  than  four  weeks.  However  no  scar  tissue  was  clinically  observed  after  the 
healing  process.  These  ulcers  were  categorized  as  minor  recurrent  aphthous  ulcers. 
2.3.4.  Smoking 
From  a  total  number  of  252  patients,  230  were  non-smokers  and  20  patients  smoked 
less  than  15  cigarettes  a  day.  Only  two  patients  were  heavy  smokers  (30-40  cigarettes 
per  day).  Three  patients  strongly  believed  that  their  ulcers  initially  started  when  they 
stopped  their  smoking  habit. 
2.3.5.  Haematological  Deficiencies 
All  patients  with  recurrent  aphthous  stomatitis  underwent  haematological 
investigations.  Venous  blood  was  removed  from  all  patients  on  the  first  visit  for  full 
blood  count  and  assays  of  plasma  ferritin,  red  cell  folate  and  serum  vitamin  B12. 
108 Table  2.4.  Distribution  of  sub-groups  of  RAS  in  first  group  of  252  patients 
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109 In  first  group  of  252  patients,  69  aphthous  patients  had  iron  deficiency 
(ferritin  level  <  20  ng/ml).  (Table  2.5) 
In  the  69  patients  with  a  low  level  of  ferritin  only  13  patients  had  overt  deficiency 
with  a  low  haemoglobin,  10  patients  had  a  low  MCV  (Table  2.1)  and  three  patients 
had  anaemia  with  a  low  haemoglobin  and  a  low  MCV.  Persistent  iron  deficiency  was 
observed  in  seven  patients  who  were  referred  to  either  their  general  practitioner  or  a 
haematologist  for  further  investigations.  (Table  2.5) 
No  folate  deficiency  was  observed  in  this  group  of  patients.  (Table  2.5) 
Fifteen  patients  were  diagnosed  as  having  vitamin  B12  deficiency  (vitamin  B12  level  < 
175  pg/ml).  These  patients  were  investigated  for  the  presence  of  anti-intrinsic  factor 
antibodies  and  anti-parietal  cell  antibodies.  Three  patients  had  at  least  one  of  these 
antibodies  present  in  their  serum.  Vitamin  B12  deficiency  with  an  abnormal  blood  film 
was  observed  in  one  patient  with  a  low  MCV,  one  patient  with  a  low  haemoglobulin. 
(Table  2.6) 
All  patients  with  vitamin  B12  deficiency  were  referred  to  haematologist  for  further 
investigations.  None  of  them  were  diagnosed  to  have  pernicious  anaemia. 
In  the  group  of  252  patients,  venous  blood  of  66  individuals  (17  males,  49  females) 
were  tested  for  presence  of  IgA  anti-gliadin  antibody.  In  seven  patients,  IgA  anti- 
gliadin  antibodies  were  positive,  however  anti-endomysial  antibody  were  negative 
indicating  that  these  patients  did  not  have  coeliac  disease.  It  has  been  reported  that 
these  patients  however  may  develop  gastrointestinal  tract  dysfunction  in  the  future 
(Koninckx  et  al.  1984;  O'mahony  et  al.  1990). 
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.ý r. r. Table  2.6.  Patients  with  vitamin  B12  deficiency  and  their  full  blood  screen  and  auto- 
antibodies  results. 
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112 The  second  group  of  213  patients  who  attended  the  Oral  Medicine  Clinic  during  the 
period  of  April  1993  until  April  1994  were  investigated  for  the  same  haematological 
deficiencies. 
In  addition  to  this  group  with  recurrent  aphthous  stomatitis,  90  patients  with  normal 
oral  mucosa  were  also  investigated  as  a  control  group. 
Folate,  vitamin  B12  and  ferritin  deficiencies  were  identified  in  68  patients  (11  male,  57 
females)  with  recurrent  aphthous  stomatitis  (31.92%)  and  40  (1  male,  39  females) 
patients  with  normal  mucosa  (44.44%).  (Table  2.5,  Figure  2.4) 
Latent  deficiencies  were  identified  in  51  patients  with  recurrent  aphthous  stomatitis 
and  27  individuals  in  control  group.  In  these  patients  haematological  deficiencies 
could  not  be  diagnosed  with  only  a  full  blood  count  assay.  (Table  2.7) 
2.3.6.  Allergy 
The  results  of  allergic  reactions  to  relevant  materials  such  as  food  additives  were 
compared  with  controls  (Table  2.8).  In  the  present  study,  only  food  additives  which 
are  more  related  to  oral  ulceration  were  analysed  in  285  patients. 
Benzoic  acid  caused  skin  allergic  reactions  in  26  of  285  (9  per  cent)  recurrent 
aphthous  stomatitis  patients.  Positive  reactions  to  sorbic  acid  were  observed  in  one  of 
the  285  (0.3  per  cent)  of  the  recurrent  aphthous  stomatitis  patients.  Sodium 
metabisulphate  and  cinnamaldehyde  caused  allergic  reactions  in  10  (3.5  per  cent)  and 
seven  (2.5  per  cent)  of  285  patients  respectively.  Also,  allergic  reactions  to  chocolate 
113 Table  2.7.  Prevalence  of  haematological  deficiencies  in  the  second  group  of  213 
RAS  patients 
.................................................  ...................................................................... 
folate  1  (0)  0 
B12  4(4)  2(2) 
ferritin  54  (39)  33  (23) 
fol.  &fer.  2(1)  0 
B12  &  fer.  7  (7)  5  (2) 
Abnormal  FBC  17  13 
TOTAL  Pts.  213  90 
*Latent  deficiencies  shown  in  bracelets. 
**  There  is  no  significant  difference  between  RAS  and  control  patients. 
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Figure  2.4.  Haematological  deficiencies  in  the  second  group  of  213  RAS  patients 
compared  with  the  control  group.  Haematological  deficiencies  are  not  increased  in 
RAS  patients  compared  with  controls. 
."  shows  that  there  is  no  folic  acid  deficiency  in  the  control  group. 
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Heamatological  deficiencies were  identified  in  only  one  of  the  247  (0.4  per  cent)  recurrent  aphthous  stomatitis 
patients  tested  for  this  material.  (Table  2.8) 
These  results  were  not  significantly  different  in  the  control  group  with  the  exception 
of  allergy  to  benzoic  acid  which  was  significantly  higher  in  the  control  group.  Allergy 
to  benzoic  acid  was  observed  in  28  of  100  control  subjects.  Sorbic  acid,  sodium 
metabisulphate,  cinnamaldehyde  and  chocolate  caused  allergic  reactions  in  three,  six, 
seven  and  one  of  the  100  control  subjects.  (Table  2.8) 
The  length  of  time  was  not  enough  to  do  appropriate  review  and  investigate  the  effect 
of  withdrawing  allergens  from  those  patients  with  a  positive  allergic  reaction. 
Therefore  the  role  of  allergy  in  the  aetiology  of  recurrent  aphthous  stomatitis  could 
not  be  entirely  excluded. 
2.3.7.  Treatment 
After  primary  investigation,  patients  with  haematological  deficiencies  were  treated  to 
replace  the  deficient  factors. 
In  iron  deficient  patients  Ferrous  Sulfate  (600  mg.  daily)  for  three  months  was 
prescribed.  Patients  with  vitamin  B12  deficiency  were  treated  by  either  their  general 
practitioner  or  a  haematologist.  In  addition,  all  patients  with  milder  ulcers,  were 
symptomatically  treated  by  topical  medications  such  as  triamcinolone  in  dental  paste 
(BPC),  beclomethasone  spray  (BPC),  betamethasone  mouthwash  (BPC), 
chlorhexidine  gluconate  (BPC)  mouthwash,  benzydamine  hydrochloride  mouthwash 
116 Table  2.8.  Allergic  reactions  to  some  food  additives  in  RAS  and  Controls. 
Benzoic  acid  26  (11%)  28  (%)  S 
Sorbic  acid  1  (0.4%)  3  (%)  NS 
Sodium  Metabisulphate  10  (4%)  6  (%)  NS 
Cinnamaldehyde  7  (3%)  7  (%)  NS 
Chocolate  1  (0.4%)  1  (%)  NS 
Total  285  100 
`  Chi-squre  test  and  Fisher's  exact  test  (p<0.05) 
117 and  spray,  tetracycline  hydrochloride  (BPC)  mouthwash  or  lignocaine  hydrochloride 
(BPC).  Those  patients  with  severe  ulceration  were  prescribed  systemic 
corticosteroids.  (Table  2.9)  From  a  total  of  252  patients,  beclomethasone  spray  (BPC) 
was  the  most  pleasant  medication  for  recurrent  aphthous  stomatitis  patients.  This  was 
because  of  ease  of  application  of  the  drug  especially  in  children  and  those  with 
handicaps. 
Beclomethasone  spray  (BPC)  was  prescribed  in  45.6  per  cent  of  the  patients  in  the 
first  group.  Betamethasone  mouthwash  (BPC)  (0.5  mg  per-tablet)  was  used  by  24.2 
per  cent  of  the  patients.  Benzydamine  hydrochloride  mouthwash,  usually  prescribed 
for  very  mild  ulcers,  was  used  by  22  per  cent  of  the  patients.  Triamcinolone  in  dental 
paste  (BPC)  was  given  to  19.4  per  cent  of  the  patients.  Tetracycline  mouthwash  was 
prescribed  to  17  per  cent  of  patients  with  more  severe  ulceration.  Chlorhexidine 
gluconate  (BPC)  mouthwash  was  prescribed  to  11.5  per  cent  of  the  patients  for 
prophylaxis  and  treatment  of  secondary  infection,  usually  combined  with  other  topical 
medication.  Lignocaine  hydrochloride  (BPC)  spray  was  given  to  2.8  per  cent  of  the 
patients  who  did  not  find  other  medication  effective  for  relief  of  severe  pain  from  the 
ulcers.  Systemic  prednosolone  was  prescribed  only  for  2  per  cent  of  the  patients  with 
very  severe  and  constant  ulceration.  (Table  2.9) 
In  addition,  66  patients  were  treated  in  a  clinical  trial  with  5  aminosalicylate 
(Mesalazine)  cream,  which  will  be  explained  in  chapter  three. 
118 Table  2.9.  Medications  used  for  treatment  of  RAS  patients  in  this  study. 
Beclomethasone  spray  1  45.6 
Betamethasone  M.  W.  1  24.2 
Benzydamine  hydrochloride  1  21.8 
Triamcinolone  in  dental  paste  1  19.4 
Tetracycline  hydrochloride  M.  W.  1  17.0 
Chlorhexidine  gluconate  M.  W.  1  11.5 
Lignocaine  hydrochloride  1  2.8 
Systemic  prednisolone  1  2.0 
119 In  the  second  group  of  patients  the  effect  of  replacement  therapy  was  assessed.  This 
assessment  was  only  applied  in  the  second  group  who  were  studied  from  April  1993, 
while  the  length  of  the  time  was  not  enough  for  reviewing  the  first  group  of  patients. 
Twenty-five  patients  diagnosed  with  iron  deficiency  showed  some  degree  of 
improvement  in  the  severity  of  ulceration.  Twelve  patients  had  no  response  to 
replacement  therapy. 
In  patients  with  vitamin  B12  and  folic  acid  deficiencies,  seven  patients  reported  some 
improvement  in  their  ulceration.  In  14  patients,  in  whom  replacement  therapy  did  not 
decrease  the  severity  of  ulceration,  three  had  persistent  haematological  deficiencies 
and  they  were  referred  to  the  haematologist  for  further  investigations.  (Table  2.10) 
2.4.  Discussion 
Recurrent  aphthous  stomatitis  affects  individuals  of  all  ages.  The  prevalence  of 
recurrent  aphthous  stomatitis  in  this  study  was  increased  in  the  third  and  fourth 
decades  of  life,  however,  previous  reports,  showed  an  increased  prevalence  of  the 
disease  in  the  second  and  third  decades  of  life  (Farmer,  1958;  Lehner,  1968;  Brody 
and  Silverman,  1969;  Donatsky,  1973;  Scully  and  Porter,  1989).  This  might  be  due  to 
a  higher  degree  of  contact  with  predisposing  factors  such  as  food  additives  in  the 
adult  population  or  higher  numbers  of  adults  in  the  fourth  decade  of  life  seeking 
treatment  than  a  younger  population. 
Also  it  has  been  reported  that  the  severity  of  ulcers  in  male  subjects  increases  in  the 
first  and  third  decades  of  life  whereas  in  females,  ulcers  are  more  severe  in  the  second 
and  third  decades  (Farmer,  1958).  But  in  this  study  the  severity  of  ulcers  were 
120 Table  2.10.  Response  to  replacement  therapy  after  3-6  months  review. 
..:..:  y"{"':  y': 
i 
:::::::::::::::  ýi}ý: 
j  i.:  i<::::  i"j'::::: 
"""""":  i:  ýý  :::  i:::::::::::::::::::::  '::,:::  "::  r'/:  Y"": 
}": 
ij: 
ý::: 
i:: 
i::::  i:  ":  i"'i:  ",  i:: 
"::::,:::: 
i:::::  "::::::: 
":  ":  ýi'ý 
iii:::  i:  j:: 
ýýýýý:......... 
"j: 
"f::::  i:::  i::  i: 
"ý'iý: 
ýlFý! 
": 
ýýýýi: 
iti:  ir"  ý  ý}: 
r"  Ff  :r 
. 
ýýJ.  '.:  iii:  ý:  ti: 
":? 
ti:  i:  "ii:: 
i::  i::  i"i:  "i:  "::  ý:  "'t:  "i:  "i:  ":  ":  "}:  ":  ":  ":  ":  ti":  ":  iS:  ii:.:  L::  tii:  i::  ":  i:  ý'tii'ti:  i:  ¢}:  "i:  "ii:  "i:  "i:  v::  "::  "i:  "i'"i:.:  "?::  tip:  ti"}:  "Y:.  "L:  ":  ":  ":  ':  ý:  n:  "}:  ":  ":  "S:  n:  "}:  "}:  "S}:  "T:  "}i::  titi"}}}:  ": 
.......................... 
ii't:  ":  "i::  "i: 
"}i: 
":  ý:  G}:  "}:  ":  "}ri>:: 
$:::  i: 
ýýjf  i::  F:;  'F.  i4i::  ^i::  ":::::?: 
C{4iii:  ":  ý  $:  ":  ii::::  ":  ý  i:  "r:  ":  ':  j.  L4i'ti:  i:  i::  nL?  {ii:  {i::  i::::  tiv:  $$y$$;  {  $::  I,  yIý  ý} 
}": 
ý:  ý:::: 
?.  i:.  iii:.  i:.  i:.  i:.  i:  ":.  }:.  }:  '  +:  }'  .::  :  i:,.:  ::::;: 
2:  F::  "::  }2::::  r:  j::  {:  ti:  j{j:  }jjjj:: 
i': 
",, 
+.: 
k::::  ti?  i;  ', 
":: 
ý:, 
+.  iý::.  ý.;:  }ýýi::  C: 
ýy 
Yiiiiii::::::  }:::::  j:::  i::::  ":  ".:  "i:  ":  'r,:  5:::  `v:: y::  i::::::  ii:  C;:::  ii::  i}ij: 
": 
"j;:;:::  i::  %2:  iji::  i}ij:   }ý 
...  ..................................  ...  ...:...  ý:.  ý:::::.  ý::::::::::::::::.:  ".::.:.  ý:::::::: 
ýý 
TwY73.? 
F: 
>{<CLL:  L:  ý:?  <: 
ý"ýfiýýý 
. 
iii?::::.  ý:  ".  ý.!.?::.:  L::.  iii:  3:.  ii:  $::: 
yi:.?:  ". 
0  12  1  1  3 
1  6  1  0  0 
2  5  1  0  0 
3  5  1  1  0 
4  9  3  0  0 
patients  in  whom  replacement  therapy  was  not  effective. 
121 increased  in  the  third  and  fourth  decade  of  life  in  both  sexes  (Figure  2.5).  This  may  be 
due  to  an  increased  number  of  all  patients  in  the  fourth  decade  who  attended  the  clinic 
in  the  same  period  of  time.  However  the  pattern  of  age  distribution  was  significantly 
different  (p<0.002)  between  the  first  group  of  252  patients  and  whole  patients 
population.  The  number  of  patients  aged  over  50  years  was  significantly  increased  in 
the  whole  patient  population  compared  with  the  first  group  of  252  aphthous  patients. 
Many  investigators  have  claimed  that  recurrent  aphthous  stomatitis  involves  female 
subjects  more  than  males  (Brody  and  Silverman,  1969;  Donatsky,  1973;  Farmer, 
1958;  Sircus  et  al.  1957). 
Compared  with  all  patients  who  attended  the  Oral  Medicine  clinic,  there  was  no 
significant  difference  between  aphthous  patients  and  total  patients  according  to  sex. 
This  result  shows  that  in  general  female  patients  may  attend  the  clinic  more  than 
males,  or  males  do  not  pay  enough  attention  to  their  disease  unless  it  becomes  very 
severe. 
All  together,  this  data  can  not  demonstrate  a  real  significance  between  male  and 
female  patients  with  respect  to  the  prevalence  of  recurrent  aphthous  stomatitis. 
The  prevalence  of  minor  recurrent  aphthous  stomatitis  was  higher  than  major  and 
herpetiform  ulceration.  These  results  support  the  other  reports  about  the  prevalence 
of  different  types  of  recurrent  aphthous  stomatitis  (Tyldesley,  1973;  Stokes  and 
Koprince,  1982;  Bagan  et  al.  1991). 
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Figure  2.5.  Sex  distribution  with  respect  to  age  in  first  group  of 
252  RAS  patients.  There  is  no  significant  difference  between  sex 
distribution  in  respect  to  the  age. 
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012 Haematological  deficiencies  are  not  the  main  aetiologic  factors  in  recurrent  aphthous 
stomatitis  but  as  many  investigators  reported  (Walker,  1973;  Wray  et  al.  1975;  Wray 
et  al.  1978;  Hutcheon  et  al.  1978;  Challacombe  et  al.  1983;  Tyldesley,  1983;  Porter  et 
al.  1988;  Miller  et  al.  1994)  haematological  deficiencies  play  a  major  part  in  the 
management  of  recurrent  aphthous  stomatitis.  In  both  groups  of  patients  with 
recurrent  aphthous  stomatitis  almost  the  same  results  were  obtained. 
In  first  group  of  252  patients  33.33  per  cent  of  the  patients  had  haematological 
deficiencies  and  in  second  group  31.91  per  cent. 
In  second  group  of  213  patients,  however,  there  was  not  any  significant  differences  in 
haematological  deficiencies  compared  with  the  control  group,  (Figure  2.4)  but 
replacement  therapy  decreased  the  severity  of  ulceration  in  up  to  41  per  cent  in 
patients.  Complete  remission  was  reported  in  18.2  per  cent  of  the  patients  with 
different  haematological  deficiencies. 
In  addition,  only  5.16  per  cent  of  the  patients  in  the  first  group  (252  patients)  and 
7.98  per  cent  of  the  patients  in  the  second  group  (213  patients)  had  identified  overt 
deficiencies  with  abnormal  blood  films.  These  results  showed  the  importance  of  full 
haematological  investigations  including  assays  of  ferritin,  folic  acid  and  vitamin  B12,  in 
the  management  of  recurrent  aphthous  stomatitis.  The  same  conclusion  was  made 
from  previous  studies  (Hutcheon  et  al.  1978;  Wray  et  al.  1978;  Tyldesley,  1983; 
Porter  et  al.  1988).  Although  in  the  study  by  Porter  et  al  (1988)  latent  deficiency  of 
iron  was  significantly  higher  in  recurrent  aphthous  stomatitis  patients  compared  with 
124 controls.  This  difference  was  not  found  in  the  present  study  between  the  second  group 
of  patients  and  controls.  (Table  2.7) 
The  incidence  of  folic  acid  deficiency  has  been  dramatically  decreased  during  the  last 
decade,  but  the  potential  involvement  of  coeliac  disease  in  recurrent  aphthous 
stomatitis  cannot  be  ignored.  There  was  not  any  significant  increase  in  the  number  of 
patients  with  positive  IgA  anti-gliadin  antibodies  and  also  patients  with  positive  anti- 
gliadin  antibodies  were  not  diagnosed  as  having  coeliac  disease.  Such  a  result  may 
however  lead  the  clinician  to  investigate  the  possiblity  that  patients  may  develop 
coeliac  disease  in  future  despite  a  normal  folic  acid  level. 
This  study  indicates  not  only  that  treatment  of  haematological  deficiencies  might 
reduce  the  severity  of  recurrent  aphthous  stomatitis,  but  also  it  may  lead  the  clinician 
to  detection  of  possible  underlying  systemic  diseases. 
Allergies  may  not  play  a  major  role  in  patients  with  recurrent  aphthous  stomatitis. 
However  patients  who  have  undergone  dermatology  allergic  testing  (Patch  Testing) 
and  allergies  were  identified,  and  who  then  avoided  the  allergens,  showed  some 
improvement  in  their  ulceration.  In  the  present  study,  there  was  no  increase  in  the 
prevalence  of  allergy  to  food  additives  in  recurrent  aphthous  stomatitis,  and  the 
difference  between  recurrent  aphthous  stomatitis  and  control  subjects  in  the 
prevalence  of  allergic  reactions  to  food  additives  was  not  significant.  However  the 
prevalence  of  allergic  reactions  to  benzoic  acid  in  control  subjects  was  significantly 
higher  than  recurrent  aphthous  stomatitis  patients.  A  high  percentage  of  recurrent 
aphthous  stomatitis  patients  were  allergic  to  dental  materials  (67  per  cent),  but  this 
125 test  was  not  applied  in  control  subjects.  Indeed,  there  were  patients  whose  ulcers 
improved  as  the  result  of  replacing  dental  restoration  with  mercury-free  materials.  A 
case  of  allergy  to  materials  such  as  intrauterine  contraceptive  device  (Saf-T-coil  32-s) 
and  contact  lenses  (soflens)  has  been  reported  (Gordon  and  Gordon,  1974).  However 
the  allergen  components  of  these  materials  was  not  mentioned.  In  a  recent  study, 
Patch  Testing  (standard  European  series)  was  undertaken  in  21  recurrent  aphthous 
stomatitis  patients  (Nolan  et  al.  1991a).  From  21  patients  20  showed  a  positive 
reaction  to  a  number  of  materials  which  clinically  are  considered  to  be  relevant.  As  the 
result  of  dietary  advice,  18  patients  showed  an  improvement  in  the  severity  of  the 
disease.  Despite  the  absence  of  a  control  group,  the  authors  concluded  that  food 
sensitivity  and  allergies  to  other  materials  could  be  considered  as  a  possible  aetiologic 
factor  in  recurrent  aphthous  stomatitis.  (Nolan  et  al.  1991a)  In  a  double-blind  trial,  30 
per  cent  of  foods  which  caused  histamine  release  (in  vitro),  were  correlated  to  an 
increased  incidence  of  oral  lesions  (Wray  et  al.  1982).  However,  in  this  study,  dietary 
manipulation  did  not  eliminate  the  ulceration  in  any  patients.  The  increased  serum 
antibodies  to  some  food  antigens  such  as  cow's  milk  proteins  and  food  antigens  has 
been  reported  to  be  significantly  different  in  recurrent  aphthous  stomatitis  patients 
compared  to  a  healthy  population  but  this  difference  was  not  observed  when 
compared  to  other  ulcerative  conditions  (Taylor  et  al.  1964;  Thomas  et  al.  1973).  It  is 
possible  that,  the  local  breakdown  of  oral  mucosa  allows  increased  absorption  of 
immunogenic  materials  in  foods  which  might  increase  the  tendency  to  develop  IgE 
antibodies  to  foodstuffs. 
126 In  the  present  study,  the  prevalence  of  allergy  to  the  tested  foodstuffs  was  not 
increased  in  recurrent  aphthous  stomatitis  patients,  but  the  effect  of  withdrawing 
allergen  in  patients  with  a  positive  allergic  reaction  has  shown  that  allergy  may  play  a 
minor  role  in  the  aetiology  of  recurrent  aphthous  stomatitis.  Inadequate  follow-up 
time  was  available  to  answer  this  question. 
However  most  of  the  topical  medications  had  some  benefit  for  the  patients,  but  in 
some  severe  cases  systemic  cortocosteroids  were  prescribed. 
Treatment  is  a  very  important  part  of  the  management  of  patients  with  recurrent 
aphthous  stomatitis,  but  without  complete  investigation  and  follow  up  of  their  current 
medications,  needs  cannot  be  fully  satisfied. 
Because  there  is  no  predictable  cure  for  this  disease,  in  any  treatment  plan,  a  safe, 
effective  and  pleasant  medication  seems  to  be  desirable  for  symptomatic  relief  of 
ulceration. 
In  a  recent  report  (Porter  et  al.  1993)  of  audit  of  information  about  patients  with 
recurrent  aphthous  stomatitis,  20  per  cent  of  the  patients  with  abnormal 
haematological  and  serologic  findings  were  not  appropriately  investigated  or  referred 
to  a  suitable  medical  specialist  while  in  the  present  study,  although  a  larger  number  of 
patients  were  studied,  complete  investigation  and  medical  management  were  carried 
out  in  all  patients  with  haematological  deficiencies  unless  patients  did  not  wish  to 
continue  the  treatment  process. 
127 Chapter  Three.  The  Effect  of  Topical  5  Amino- 
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128 3.1.  Introduction 
5-aminosalicylic  acid  is  a  salicylate  that  is  used  for  its  local  effects  in  the  treatment  of 
inflammatory  bowel  disease  (Azad  Khan  et  al.  1977;  Insel,  1990).  Generally, 
salicylates  relieve  those  types  of  low  intensity  pain  that  arise  from  integumental 
structures  rather  than  from  viscera,  especially  headache,  myalgia  and  arthralgia.  They 
alleviate  pain  by  virtue  of  peripheral  action.  Direct  effects  on  the  CNS  also  may  be 
involved  (Insel,  1990). 
Salicylates  also  can  influence  the  metabolism  of  connective  tissue,  and  these  effects 
may  be  involved  in  their  anti-inflammatory  action.  For  example,  salicylates  can  affect 
the  composition,  biosynthesis  or  metabolism  of  connective  tissue 
mucopolysaccharides  in  the  ground  substance  that  provide  barriers  to  the  spread  of 
infection  and  inflammation  (Insel,  1990). 
Although  the  mechanism  of  action  in  5  amino-salicylate  is  unknown  and  probably 
complex,  it  is  likely  to  have  a  local  action  by  analogy  with  ulcerative  colitis  (Azad 
Khan  et  al.  1977). 
Mesalazine  (5  amino-salicylate)  has  been  of  benefit  in  the  treatment  of  inflammatory 
bowel  disease  for  over  40  years,  principally  because  of  its  local  actions  (Insel,  1990). 
Collier  et  al  (1992)  investigated  the  effect  of  5  amino-salicylate  in  22  patients  (age  18- 
75  years)  with  recurrent  aphthous  stomatitis.  In  this  double-blind  study,  patients  were 
assessed  before  treatment  and  after  seven,  14  and  28  days  of  treatment.  Pain  and 
difficulty  with  eating  were  assessed  using  a  100  millimetres  linear  scale  marked  by  the 
129 subjects.  The  number  and  location  of  ulcers  were  recorded  by  the  authors.  The  results 
showed  80  per  cent  reduction  in  pain  in  the  treatment  group  compared  with  placebo 
by  day  seven,  and  by  day  15,  none  of  the  ulcers  in  treatment  group  was  painful  while 
six  out  of  eight  patients  in  the  placebo  group  were  complaining  of  the  pain  (Collier  et 
al.  1992).  In  this  study  5  amino-salicylate  significantly  reduced  the  healing  time, 
number  of  ulcers  and  difficulty  in  eating  as  well  as  pain  compared  with  placebo 
(Collier  et  al.  1992). 
However,  Bagg  et  al.  (1985)  reported  that  5  amino-salicylate  was  ineffective  in 
treatment  of  recurrent  aphthous  stomatitis,  compared  with  placebo.  In  this  study,  25 
patients  with  recurrent  aphthous  stomatitis  entered  a  double-blind  trial  with  crossover 
Patients  randomly  used  5  amino-salicylate,  200  mg  or  an  identical  placebo  (to  be 
dissolved  in  10  mis  of  water)  as  a  mouthwash  for  six  weeks.  After  a  subsequent 
period  of  two  weeks  of  no  treatment,  the  alternative  preparation  was  used  for  a  final 
six weeks.  Patients  recorded  the  number  of  ulcers  present,  the  number  of  new  ulcers 
and  a  score  for  pain  or  discomfort  on  a  visual  analogue  scale  (Pimlott  and  Walker, 
1983).  At  the  end  the  ulcer  incidence  (mean  of  number  of  new  ulcers)  and  ulcer 
prevalence  and  duration  of  lesions  (sum  of  daily  counts  of  ulcers  present)  and  the 
period  of  remission  (mean  number  of  ulcer-free  days)  were  measured.  The  analysis  of 
obtained  data  did  not  show  any  statistically  significant  beneficial  effect  of  the  5  amino- 
salicylate. 
5  amino-salicylate  has  immunosuppressive  properties  (Insel,  1990).  There  is  also 
evidence  that  autoimmmune  processes  may  play  a  role  in  ulcerative  colitis  (Basu  and 
130 Chesner,  1990)  and  recurrent  aphthous  stomatitis  (Wray,  1984).  Therefore  this 
clinical  investigation  was  aimed  at  assessing  the  therapeutic  effect  of  topical  5  amino- 
salicylate  in  recurrent  aphthous  stomatitis. 
3.2.  Materials  and  Methods 
3.2.1.  Subjects 
From  252  patients  with  recurrent  aphthous  stomatitis  (see  section  2.2.1),  66  patients 
entered  a  clinical  trial  with  more  than  three  ulcers  per-month.  Selection  was  based 
solely  on  a  history  of  recurrent  aphthous  stomatitis  and  availability  and  willingness  to 
participate  in  the  study.  The  age  of  the  patients  was  between  17  and  57  years.  Fifty 
two  of  the  patients  were  female  subjects  and  14  males.  Patients  were  investigated  to 
exclude  any  haematological  deficiency,  renal  and  hepatic  impairment.  They  were 
asked  about  any  history  of  salicylate  hypersensitivity  and  any  regular  anti- 
inflammatory  analgesics,  other  analgesics,  steroid  therapy,  anti-cancer  or 
immunosuppressive  therapy.  Female  patients  were  not  pregnant  or  nursing  mothers 
and  all  claimed  to  practice  contraception. 
During  the  treatment,  patients  received  clinical  advice  on  elimination  of  any  possible 
environmental  factors,  such  as  trauma  of  the  oral  mucosa,  possible  allergic 
components  and  dental  hygiene. 
3.2.2.  Ethical  Approval 
The  study  was  approved  by  the  local  ethical  committee,  in  Glasgow  Dental  Hospital 
and  School. 
131 Before  the  start  of  trial,  all  patients  were  fully  informed  about  the  clinical  trial  and 
possible  side  effect  of  medication  and  informed  consent  was  obtained.  They  were  all 
reassured  that  they  could  withdraw  during  the  study  for  any  reason  without  affecting 
their  current  treatment  in  the  clinic.  A  direct  phone  number  was  given  to  all  patients  in 
case  of  any  possible  side  effects  arising  or  necessary  information  being  required. 
3.2.3.  Experimental  Design 
The  design  was  a  randomised  double-blind  therapeutic  trial  of  5  amino-salicylate 
against  placebo  lasting  four  weeks  in  each  limb  of  the  study,  with  cross  over  after  a 
two-week  period  of  time  as  a  wash-out  stage.  Pre-packaged  randomised  and  coded 
supplies  of  5  amino-salicylate  cream  and  identically  packaged  placebo  medications 
were  supplied  by  Harefield  Pharma  Associates  Limited.  A  code  book  identifying  the 
numbered  cream  supplies  was  available  after  the  trial  was  ended. 
3.2.4.  Subjects'  Daily  Records 
All  patients  kept  a  careful  daily  record,  noting  the  localization,  number,  size,  pain  and 
duration  of  ulcers  during  the  trial.  In  a  provided  chart  (Figure  3.1),  patients  recorded 
a  number  between  zero  to  three  (severity  of  ulcer)  to  illustrate  the  pain.  To  record  the 
size,  '  patients  were  given  some  figures  in  a  form  which  indicated  the  size  of  ulcers 
from  one  to  ten  millimetres  in  diameter.  In  addition,  a  figure  of  an  open  mouth,  helped 
the  patients  to  locate  the  ulcers  on  the  figure  (Figure  3.2).  These  daily  records  of 
ulcers  were  collected  in  all  three  stages  of  the  trial. 
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Figure  3.1:  First  page  of  diary  card  provided  for  RAS  patients  to  record  the  number, 
size,  pain  and  location  of  their  ulcers.  A  diagram  helps  patients  measure  the  size  and 
pain  of  each  ulcer.  (see  figure  3.2) 
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Figure  3.2.  Second  page  of  diary  card  provided  for  RAS  patients  to  record  the 
number,  size,  pain  and  location  of  their  ulcers. 
134 3.2.5.  Pre-Treatment  Procedure 
In  this  period  of  study,  patients  were  not  prescribed  any  topical  medication  or 
systemic  analgesics.  Patients  were  asked  to  write  any  topical  medication  or  systemic 
analgesics  which  they  may  use  during  this  period  of  the  trial.  In  this  first  four  weeks, 
222  patients  received  a  form  to  record  their  ulcers  as  has  been  explained  in  the 
previous  section  (section  3.2.4).  Venous  blood  was  removed  for  haematological 
investigation  from  all  patients  at  their  first  attendence. 
3.2.6.  First  Treatment  Procedure 
Patients  who  had  any  haematological  deficiencies  were  excluded  from  the  trial.  Also, 
those  who  had  less  than  three  ulcers  did  not  continue  into  the  first  treatment  period. 
Sixty  six  patients  received  the  randomized  creams  of  whom  33  used  the  5  amino- 
salicylic  acid  cream  and  33  placebo.  Patients  were  asked  to  apply  the  cream  three 
times  daily  on  the  ulcers  for  a  maximum  period  of  four  weeks.  In  addition  to  the 
cream,  all  patients  were  given  a  new  form  to  record  their  ulcers  during  this  period  of 
the  trial. 
3.2.7.  Wash  Out  Period 
,  Between  the  first  and  second  period  of  the  trial,  patients  were  not  given  any 
medication,  to  avoid  any  effect  of  the  first  treatment  on  the  second  part  of  treatment. 
This  two  weeks  was  called  the  wash-out  period. 
135 Patients  returned  the  first  cream  and  the  ulcer  diary.  At  this  visit,  an  appointment  was 
made  for  the  second  part  of  the  treatment. 
3.2.8.  Second  Treatment  Procedure 
Fifty  two  patients  finished  the  first  period  of  the  trial  and  47  of  them  agreed  to 
continue  with  the  second  treatment.  Patients  received  the  second  cream  and  a  new 
ulcer  diary  form  to  record  their  ulcers  as  they  did  before.  In  this  period  of  study,  24 
patients  received  the  5  amino-salicylate  and  23  the  placebo. 
At  the  end  of  this  period,  patients  returned  the  second  cream  and  ulcer  diary. 
3.2.9.  Measurement 
All  indices  which  were  recorded  on  the  provided  PC  computer  program  for  oral 
ulceration  (see  section  2.2.2)  as  follows: 
a)  The  mean  number  of  ulcers  in  the  pre-treatment  period  and  each  period  of  the 
treatment. 
b)  The  mean  of  size  score  in  all  three  periods  of  the  trial. 
c)  The  mean  of  pain  score  in  all  three  periods  of  the  trial. 
d)  The  mean  of  healing  time  in  all  three  periods  of  treatment, 
e)  The  mean  score  for  efficiency  of  the  cream  on  reduction  of  pain  which  patients 
reported  after  each  period  of  treatment. 
136 f)  The  mean  score  for  efficiency  of  the  cream  on  reduction  of  healing  time  which 
patients  reported  after  each  period  of  treatment. 
3.2.10.  Statistics  and  Data  Analysis 
Data  were  analysed  using  Minitab  Software  (PC  computer).  First,  the  statistical 
significance  of  observed  data  from  each  period  of  the  trial  was  assessed  by  the  non- 
parametric,  Fridman  test.  This  test  was  selected  because  of  its  power  to  show  the 
statistical  differences  within  one  group  of  subjects. 
Then,  data  from  the  first  group  of  patients  who  applied  the  5  amino-salicylate  cream 
in  first  treatment  was  analysed  with  data  from  second  group  of  patients  who  applied 
placebo  in  their  first  treatment,  using  the  non-parametric  Mann-Whitney  U  test.  This 
test  initially  is  helpful  in  analysing  data  in  two  sets  of  subjects. 
3.3.  Results 
At  the  end  of  the  trial  the  code  of  each  package  of  the  medication  was  opened. 
Forty-two  out  of  66  patients  completed  the  trial.  Three  patients  used  none  of  the 
creams  because,  they  did  not  have  any  ulcers  after  entering  the  trial,  four  patients  did 
not  have  any  ulcers  to  continue  in  the  second  period  of  the  trial.  One  patient  became 
pregnant  during  the  study,  six  patients  could  not  use  the  cream  because  of  the  taste 
and  colour  of  the  cream  and  the  rest  of  the  patients  who  did  not  complete  the  study, 
failed  to  attend  the  clinic  for  their  appointments  as  scheduled.  (Table  3.1) 
Three  of  the  patients  who  did  not  have  any  ulcers  after  the  first  period  of  the 
treatment,  just  applied  the  placebo.  In  total,  out  of  ten  patients  who  failed  to  attend 
137 the  clinic,  five  received  the  active  cream  and  five  placebo.  Of  those  six  patients  who 
did  not  like  the  cream,  only  two  used  the  placebo  and  the  other  four  patients  were  not 
happy  with  the  active  cream. 
The  first  data  obtained  during  active  treatment  was  compared  with  the  placebo,  then 
data  from  the  active  treatment  and  placebo  were  compared  with  the  pre-treatment 
data  separately. 
These  results,  did  not  show  any  significant  difference  between  5  amino-salicylate 
cream  and  placebo  on  their  effect  on  healing  time  (p=0.12).  Also  5  amino-salicylic 
acid  cream  was  not  statistically  effective  in  decreasing  the  healing  time  compared  with 
the  pre-treatment  period  (p=0.75).  The  same  result  was  obtained  on  the  effects  of 
placebo  in  decreasing  the  healing  time  compared  with  the  pre-treatment  period 
(p=0.35).  (Table  3.2,  Figure  3.3) 
The  topical  active  cream  was  not  statistically  effective  in  reduction  of  pain,  compared 
with  placebo  (p=1.0)  and  the  pre-treatment  period  (p=0.06).  The  placebo  cream  had 
the  same  lack  of  effect  as  the  active  cream  compared  with  the  pre-treatment  period 
(p=0.06).  (Table  3.2) 
The  results  did  not  show  any  significant  effect  of  the  active  cream  on  the  number  of 
ulcers  compared  with  placebo  (p=0.38)  and  the  pre-treatment  data  (p=0.4).  However 
placebo  had  a  significant  effect  on  the  reduction  of  the  number  of  ulcers  compared 
with  the  pre-treatment  period  (p=0.008).  (Table  3.2) 
138 Table  3.1.  Patients  who  did  not  complete  the  trial. 
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Patients  with  no  ulcers  3 
Patients  with  no  ulcers  in  the  2nd  treatment  3 
Failed  to  attended  patients  10 
Pregnant  1 
Dislike  of  the  cream  6 
Total  23 
139 The  data  obtained  from  patients  after  each  treatment  also  did  not  show  any  significant 
differences  in  efficiency  of  active  cream  in  healing  time  (p=0.84)  and  reduction  of  pain 
(p=0.31)  compared  with  placebo.  (Table  3.2) 
Therefore,  in  this  first  analysis  of  the  data,  the  results  did  not  show  any  significant 
difference  between  the  medication  and  placebo,  and  also  no  differences  between  each 
of  the  first  and  second  treatments  when  compared  with  the  pre-treatment  period 
except  the  effect  of  placebo  on  decreasing  the  number  of  ulcers.  (Figure  3.3) 
To  address  the  complexities  in  the  first  analysis,  data  obtained  in  each  period  of  the 
trial  were  analysed  without  any  knowledge  about  the  codes  of  the  creams.  Each 
period  of  treatment  was  compared  with  all  other  periods.  The  results  showed 
significant  differences  in  decreasing  the  pain  (p  =  0.014)  and  significant  differences  (p 
=  0.016)  in  decreasing  the  number  of  ulcers  between  the  data  obtained  in  the  pre- 
treatment  period  compared  with  the  second  treatment  period  regardless  of  whether  it 
was  active  or  placebo.  There  was  no  significant  difference  in  reduction  of  size 
(p=0.53)  and  healing  time  (p=0.35)  in  this  analysis.  These  results  did  not  observe  any 
difference  in  the  first  period  of  treatment  compared  with  the  pre-treatment  period. 
The  effect  of  the  active  cream  on  the  size  of  the  ulcer  was  not  significant  compared 
with  the  placebo  (p=0.1)  and  the  pre-treatment  period  (p=1.0).  Neither  was  the  effect 
of  placebo  compared  with  the  pre-treatment  period  (p=0.2)  (Table  3.2).  However, 
from  the  pre-treatment  period  onwards  an  increased  difference  was  observed  in  each 
subsequent  period. 
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Figure  3.3.  The  effect  of  5  amino-salicylate  cream  in  aphthous  ulcers 
compared  with  before  treatment  (no  medication)  and  placebo  in  a  double- 
blind  cross-over  trial.  (n=42)  There  is  no  significant  difference  on  aphthous 
lesions  in  patients  before  treatment  and  when  patients  were  using  placebo 
or  active  cream. 
141 These  differences  were  postulated  to  be  as  the  result  of  clinical  advice  and  maybe 
because  of  the  effect  of  the  base  of  the  cream  which  covers  the  ulcers  and  reduced  the 
pain  and  protected  the  ulcers  from  secondary  infection.  Therefore,  it  was  concluded 
that  a  double  blind  cross  over  trial  was  not  the  appropriate  way  to  study  the  effect  of 
this  topical  medication  in  recurrent  aphthous  stomatitis. 
On  this  basis,  patients  were  thus  divided  in  two  groups  to  analyse  the  results  as  a 
double  blind  study.  Patients  were  divided  in  two  groups,  22  patients  who  applied  the 
medication  cream  in  the  first  period  of  treatment  were  in  group  one  and  the  rest  of 
patients  who  took  the  placebo  in  first  treatment  were  in  group  two.  In  this  analysis, 
the  difference  between  the  effect  of  5-amino  salicylate  cream  and  placebo  was  not 
statistically  significant.  The  difference  between  active  cream  in  first  group  and  placebo 
in  second  group  on  healing  time  was  not  significant  (p=0.73).  Also,  there  was  no 
significant  difference  in  reducing  the  pain  (p=0.99),  size  (  p=0.85)  and  number  of 
ulcers  (p=0.90)  in  two  groups.  (Table  3.3) 
When  comparison  of  the  groups  who  took  active  or  placebo  cream  in  the  second 
period  were  analysed  there  was  also  no  significant  difference  in  healing  time  (p=0.06), 
pain  (p=0.73),  size  (p=0.29)  and  number  of  the  ulcers  between  the  two  groups  (p  = 
0.28).  (Table  3.4,  Figure  3.4) 
142 Table  3-2.  Summary  of  the  data  collected  from  diary  cards.  (Double  blind  cross  over) 
Mean  no.  of  ulcers  7.00±0.61  **  6.02±0.59  5.48±0.57 
Mean  of  healing  7.27±0.61  7.00±0.62  8.13±0.60 
time  (day) 
Mean  of  size  score  2.38±0.13  2.37±0.11  2.58±0.14 
(mm) 
Mean  of  pain  1.19±0.07  1.31±0.11  1.37±0.07 
score  (Oto  3  units) 
Mean  of  the  -  1.19±0.18  0.93±0.17 
efficiency  of  the 
cream  on  pain  (0 
to  3  units) 
Mean  of  the  -  0.45±0.08  0.43±0.08 
efficiency  of  the 
cream  on  healing 
time(0  to  1  units) 
ivumoer  or  patients  =  4l 
**  Standard  error 
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Figure  3.4.  The  effect  of  5  ASA  in  aphthous  lesions  compared  to  placebo  in 
two  groups  of  patients.  First  those  who  used  the  active  cream  in  first  period  of 
the  trial  and  second  those  who  used  the  active  cream  in  the  second  period  of 
the  trial 
*shows  a  significant  difference  on  relief  of  pain  between  patients  who  used  the 
active  cream  in  the  second  period  of  their  treatment  compared  to  placebo 
which  has  been  used  in  the  first  period  This  difference  was  reported  by 
patients  There  is  no  significant  difference  between  the  active  cream  and 
olacebo  in  other  asoects  of  the  disease 
144 Table  3-3.  Summary  data  collected  from  patients'  diary  form.  (Double  blind  study) 
Active  l'I:  icf  ho 
lät,  2nd,  1  t,  2nd, 
trextºnent  `'reatrimellt  treatment  tre;  tt"lent 
Mean  no.  of  ulcers  6.23±0.87  5.80±0.81  6.25±0.88  4.77±0.71 
Mean  of  healing  7.45±1.10  6.51±0.50  7.01±0.51  9.15_+_1.01 
time  (day) 
Mean  of  size  score  2.36±0.15  2.38±0.16  2.41±0.19  2.73±0.21 
(mm) 
Mean  of  pain  score  1.28±0.11  1.34±0.12  1.31±0.10  1.44±0.10 
(0  to  3  units) 
Mean  of  efficiency  1.14±0.25  1.25±0.27  0.45±0.15  1.36±0.25 
of  the  cream  on 
pain  (0  to  3  units) 
Mean  of  efficiency  0.27±0.10  0.65±0.11  0.25±0.1  0.59±0.1  1 
of  the  cream  on 
healing  time  (0  to  1 
units) 
*  In  first  active  treatment  and  second  placebo  treatment  number  of  patients=22,  in 
second  active  treatment  and  first  placebo  treatment  number  of  patients=20 
145 However,  the  information  obtained  from  patients  on  preference  after  each  period  of 
treatment  in  reduction  of  pain  and  healing  time  indicated  a  significant  effect  of  5 
amino-salicylate  cream  in  decreasing  the  pain  (p  =  0.04)  but  not  a  statistically 
significant  effect  on  healing  time  (p=0.88),  compared  with  the  placebo  in  group  of 
patients  who  used  the  active  cream  in  second  period  of  their  treatment.  (Table  3.3, 
Figure  3.4) 
3.4.  Discussion 
Topical  5  amino-salicylic  acid  has  been  effective  in  the  treatment  of  ulcerative  colitis 
and  Behcet's  syndrome  (Azad  Khan  et  al.  1977;  Ranzi  et  al.  1986).  However  this  anti- 
inflammatory  medication  was  not  reported  to  be  significantly  effective  in  recurrent 
aphthous  stomatitis  when  it  was  used  as  a  mouthwash  (Bagg,  1985),  while  its  topical 
cream  was  effective  in  reduction  of  pain,  number  and  duration  of  ulcers  (Collier  et  al. 
1992). 
In  this  study,  a  statistically  significant  effect  of  the  5  amino-salicylate  cream  was  not 
detected  in  patients'  daily  record  of  ulceration.  However,  patients  could  distinguish 
the  medication  from  placebo  and  they  reported  a  significant  reduction  in  the  pain  of 
the  ulcers  as  the  result  of  the  medication  in  second  period  in  treatment.  This  effect,  in 
the  second  period  of  treatment  might  be  the  effect  of  other  factors  such  as  avoiding 
the  environmental  predisposing  factors,  as  well  as  medication.  (Figure  3.4) 
In  this  clinical  trial  of  topical  5  amino-salicylate  cream,  the  results  suggest  that  in 
diseases  like  recurrent  aphthous  stomatitis,  it  may  not  be  appropriate  to  use  a  cross- 
146 over  study.  The  reason  for  this  is  the  process  of  the  disease  is  not  predictable  in 
different  individuals,  and  in  the  second  period  of  treatment  the  severity  of  the 
condition  may  be  totally  different  for  reasons  other  than  the  effects  of  the  medication. 
For  instance,  5  amino-salicylate  cream  has  been  studied  in  another  clinical  trial,  using 
a  double-blind  method  (Collier  et  al.  1992).  In  that  study,  the  significant  effect  of  5 
amino-salicylic  acid  was  reported  to  decrease  the  number,  duration,  pain  and  size  of 
the  ulcers  (Collier  et  al.  1992).  While  in  another  double-blind  cross-over  study,  there 
was  no  significant  difference  between  5  amino-salicylate  and  placebo  on  the  oral 
ulceration  (Bagg,  1985).  Although,  despite  different  clinical  designs,  fundamental 
differences  between  these  two  studies  was  in  the  method  of  applying  the  medication. 
When  the  medication  was  used  as  a  mouth  wash,  (Bagg,  1985)  the  duration  of  activity 
of  5  amino-salicylate  may  be  very  short  while  in  the  format  of  the  cream  not  only 
would  this  duration  of  activity  increase  but  also,  the  cream  covered  the  ulcers  and 
separated  them  from  any  aggravating  factors  or  infection  and  this  would  not  only  help 
the  relief  of  pain  but  also  decrease  the  healing  time. 
In  the  study  by  Collier  et  al  (1992)  subjects  were  volunteers  who  understood  the  aim 
of  the  study  while  in  the  present  study,  subjects  were  patients  referred  to  the  Oral 
Medicine  Clinic  for  treatment  of  recurrent  aphthous  stomatitis.  However  patients 
were  fully  informed  about  the  trial,  but  it  was  not  possible  to  avoid  giving  clinical 
advice  to  exclude  environmental  aetiologic  factors  in  some  patients.  As  a  result,  the 
cross-over  study  was  not  successful  in  distinguishing  any  effects  of  5  amino-salicylate. 
147 There  was  no  significant  difference  between  the  amount  of  the  placebo  and  active 
cream,  used  by  patients.  The  average  weight  of  the  cream,  used  by  patients,  was  4.64 
g.  for  placebo  and  4.19  g.  for  active  medication.  The  maximum  amount  of  cream  was 
used  by  those  patients  with  seven  or  more  ulcers  per  month. 
In  this  trial,  no  side  effects  were  observed  as  result  of  using  the  5  amino-salicylate. 
However  the  present  results  do  not  strongly  support  the  previous  study  on  the  effect 
of  5  amino-salicylate  (Collier  et  al.  1992),  but,  the  effect  may  be  extended  in  the  use 
of  the  cream  for  longer  periods  of  time.  Given  this,  5  amino-salicylate  cream  can  be 
beneficial  for  patients  with  moderate  symptoms,  but  to  assess  the  benefits  of  the 
cream  in  recurrent  aphthous  stomatitis,  this  medication  should  be  compared  with 
other  current  medications  for  treatment  of  recurrent  aphthous  stomatitis  such  as 
Adcortyl  in  Orabase. 
148 Chapter  Four.  Search  for  Human  Herpes  Virus-6, 
Varicella  Zoster,  Cytomegalovirus  and 
Mycobacterium  paratuberculosis  DNA 
149 4.1.  Introduction 
Despite  many  investigations  toward  the  aetiology  of  recurrent  aphthous  stomatitis, 
none  of  the  aetiologic  factors  mentioned  in  the  previous  chapters,  could  explain  the 
initiation  or  the  cause  of  this  disease.  The  majority  of  oral  mucosal  ulcerations,  other 
than  recurrent  aphthous  stomatitis,  result  from  viral  infections.  (Gajdusek,  1977) 
Immunological  features  have  mainly  referred  to  either  autoimmunity  or  viral 
pathogenicity  (Pedersen,  1993).  The  autoimmune  hypothesis  is  based  on  a 
hypersensitivity  reaction  to  human  oral  mucosal  cells  and  cross-reactivity  between 
streptococci  and  oral  mucosal  cells  (Pedersen,  1993).  However  the  clinical  and 
laboratory  investigations  do  not  support  an  autoimmune  theory.  Autoimmune  diseases 
are  more  prevalent  in  females  and  increase  with  advancing  age,  (Oilier  and  Symmons, 
1992;  Pedersen,  1993),  whereas  the  prevalence  of  recurrent  aphthous  stomatitis  is 
increased  in  the  second  and  third  decades  of  life,  and  the  disease  affects  the  two  sexes 
almost  equally  (Pedersen,  1993).  There  is  not  strong  evidence  to  establish  an  auto- 
antigen  in  patients  with  aphthous  ulcers  (Pedersen,  1993).  Like  recurrent  aphthous 
stomatitis,  viral  infections  are  usually  self-limiting  (Jawetz  et  al.  1989).  On  the  other 
hand,  recurrent  aphthous  stomatitis,  as  mentioned  under  aetiologic  factors,  may  have 
a  genetic  background,  as  does  autoimmune  disease  (Oilier  and  Symmons,  1992). 
However,  this  similarity  exists  in  other  viral  diseases  such  as  recurrent  herpes  labialis 
(Russell  and  Schlaut,  1977).  One  of  the  early  hypotheses  for  HLA  disease 
associations  is  that  the  cell  surface  HLA  molecule  could  act  as  a  receptor  for  a 
specific  virus  and  provide  a  means  for  it  to  infect  the  cell.  Several  examples  have  been 
150 described  in  the  mouse  where  H-2  molecules  can  specifically  bind  to  viruses  (Oilier 
and  Symmons,  1992),  although  there  is  no  evidence  in  man  for  HLA  being  a  viral 
receptor.  However,  it  is  clear  that  cell  surface  markers  in  man,  such  as  CD4,  can  act 
in  this  capacity  e.  g.  as  a  receptor  for  human  immunodeficiency  virus  (Oilier  and 
Symmons,  1992).  This  hypothesis  could  explain  the  genetic  and  environmental 
component  in  the  aetiology  of  many  diseases  such  as  recurrent  aphthous  stomatitis. 
As  viruses  are  the  strongest  infective  candidates  for  a  role  in  the  production  of 
autoimmune  disease  (Oilier  and  Symmons,  1992),  the  immune  imbalances  may  be  the 
result  of  viral  involvement.  Despite  the  inability  to  isolate  viruses  from  recurrent 
aphthous  stomatitis  lesions  (Hooks,  1978),  a  viral  involvement  cannot  be  excluded  in 
the  aetiology  of  recurrent  aphthous  stomatitis.  Indeed,  support  for  the  involvement  of 
herpesviruses  in  recurrent  aphthous  stomatitis  has  come  from  serological  studies. 
Serum  levels  of  total  immunoglobulins  in  patients  with  recurrent  aphthous  stomatitis 
have  been  reported  to  be  higher  than  normal  values  and  this  humoral  abnormality  was 
of  a  non-specific  nature  in  recurrent  aphthous  stomatitis  (Sun  et  al.  1986).  Increased 
serum  IgM  antibody  against  varicella  zoster  virus  (VZV)  and  human  cytomegalovirus 
(HCMV)  have  been  reported  in  patients  with  recurrent  aphthous  stomatitis,  and  serum 
IgG  antibody  against  VZV  and  HCMV  were  also  increased  in  patients,  especially  at 
the  time  of  remission  (Pedersen  and  Hornsleth,  1993).  Antibody  levels  of  serum  anti- 
VZV  IgM  antibody  were  statistically  significantly  higher  in  the  patients  compared 
with  the  control  group  (Pedersen  and  Hornsleth,  1993).  Although,  there  was  no 
statistically  significant  difference  in  the  level  of  serum  anti-HCMV  IgG  antibody 
between  patients  in  the  active  stage  of  ulceration  and  the  control  group,  the  serum 
151 anti-HCMV  IgG  antibody  concentrations  in  patients  in  the  remission  stage  were 
statistically  significantly  higher  than  those  of  controls  and  those  in  patients  in  the 
active  stage  (Pedersen  and  Hornsleth,  1993),  and  a  similar  finding  has  been  reported 
in  another  study  (Sun  et  al.  1996).  The  level  of  serum  IgG  antibody  against  human 
herpesvirus-6  (HHV-6)  was  not  different  from  the  control  group  (Pedersen  and 
Hornsleth,  1993). 
Previous  microbiological  investigations  were  not  successful  in  isolating  any  viruses  in 
recurrent  aphthous  stomatitis.  The  polymerase  chain  reaction  (PCR)  however,  allows 
for  sensitive  and  specific  detection  of  viral  DNA  or  RNA. 
Recently,  the  exquisitely  sensitive  PCR  technique  has  been  successfully  used  to  detect 
herpes  viral  DNA  in  aphthous  lesions.  VZV  DNA  has  been  found  in  most  tissue  from 
recurrent  aphthous  stomatitis  patients  (Pedersen,  1993;  Pedersen  et  al.  1993)  and 
another  study  has  identified  HCMV  DNA  in  2  of  4  pre-ulcerative  oral  aphthae  from 
Behcet's  syndrome  patients  and  in  3  of  9  pre-  ulcerative  recurrent  aphthous  stomatitis 
specimens  but  not  in  any  of  5  control  samples  (Sun  et  al.  1996).  HSV-1  DNA  has 
been  detected  in  the  peripheral  blood  leucocytes  of  patients  with  Behcet's  syndrome 
who  demonstrated  aphthous  ulceration  but  not  in  oral  ulcer  biopsies  from  these 
patients  (Studd  et  al.  1991).  To  date,  there  have  been  no  other  reports  in  which  PCR 
has  been  used  to  identify  other  viruses  in  recurrent  aphthous  stomatitis.  Previous 
studies  have  not  detected  HSV-1  DNA.  As  the  result  it  did  not  seem  to  be  necessary 
to  repeat  those  investigations.  However,  the  lack  of  information  on  detection  of  VZV, 
152 HCMV  and  HHV-6  was  encouragment  to  design  an  experiment  to  investigate  the 
involvement  of  these  herpesviruses  in  recurrent  aphthous  stomatitis. 
Biopsy  samples  and  blood  were  removed  from  21  recurrent  aphthous  stomatitis 
patients  in  the  early  stage  of  ulceration.  Serum  samples  were  tested  for  detection  of 
antibodies  against  herpesviruses  tested  in  PCR  which  will  be  explained  in  detail  in  next 
chapter.  The  purpose  of  the  study  presented  here  was  to  investigate  the  possible 
presence  of  HHV-6,  HCMV  and  VZV  in  aphthous  lesions  by  a  nested  PCR  method. 
In  most  of  the  bacteriological  studies  L-form  Streptococcus  sanguis,  Neisseria  and 
staphylococcus  were  obtained  from  major  and  minor  recurrent  aphthous  stomatitis, 
(Barile  et  al.  1963;  Graykowski  et  al.  1964;  Stanley  et  al.  1964)  and  the  cross- 
reactivity  between  Streptococcus  sanguis  and  human  oral  mucosa  has  been  discussed 
as  a  pathologic  factors  in  recurrent  aphthous  stomatitis  (Donatsky,  1975).  There  has 
been  no  report  to  indicate  the  presence  of  Mycobacterium  para-luberculosis. 
Recently,  Hassan  et  al  (1995)  reported  73  percent  homology  between  mycobacterial 
peptide  91-105  and  human  mitochondrial  116-130  peptide.  It  is  also  reported  that 
four  peptides  from  the  65  KD  mycobacterias  heat  shock  proteins  and  four  peptides 
from  the  homologous  sequence  of  the  60  KD  human  heat  shock  proteins  can  cause 
lymphoproliferative  response  in  Behcet's  syndrome  (Fortune  et  al.  1996). 
Heat  shock  proteins  are  very  conserved  and  may  cause  cross-reactivity  between 
microbial  and  cellular  host  materials  (Hasan  et  al.  1995).  However  this  raises  the 
question  that  if  molecular  mimicry  between  microbial  and  human  cellular  heat  shock 
proteins  were  damaging  the  immune  response,  it  would  be  expected  to  involve  other 
153 parts  of  the  human  body.  The  author  suggested  that  the  involvement  of  oral  mucosa  is 
because  of  the  high  load  of  micro-organisms  in  oral  cavity  which  increases  this  cross- 
reactivity  and  causes  tissue  damage  (Hasan  et  al.  1995). 
The  presence  of  Mycobacterium  paratuberculosis  was  also  investigated  as  described 
later. 
4.2.  Polymerase  Chain  Reaction,  Nested  Polymerase  Chain 
Reaction  and  Hot  Start 
The  polymerase  chain  reaction  (PCR)  is  an  in  vitro  technique  which  allows  the 
amplification  of  a  specific  deoxyribonucleic  acid  (DNA)  region  that  lies  between  two 
regions  of  known  DNA  sequences  (Newton  and  Graham,  1994).  This  method  allows 
for  sensitive  and  specific  detection  of  trace  copies  of  particular  genetic  sequences 
against  a  large  background  of  irrelevant  DNA.  This  makes  PCR  ideally  suited  for 
detecting  viruses  in  human  tissue. 
Nested  PCR  primers  are  ones  that  are  internal  to  the  first  primer  pair.  The  larger 
fragment  produced  by  the  first  round  of  PCR  is  used  as  the  template  for  the  second 
PCR.  Nested  PCR  can  also  be  performed  with  one  of  the  first  primer  pair  and  a  single 
nested  primer.  The  sensitivity  and  specificity  of  both  DNA  and  RNA  amplification  can 
be  dramatically  increased  by  using  the  nested  PCR  method.  The  specificity  is 
particularly  enhanced  because  this  technique  almost  always  eliminates  any  spurious 
non-specific  amplification  products  (Newton  and  Graham,  1994). 
Hot  start  is  a  modification  of  PCR  which  is  a  separation  of  one  or  more  important 
components  of  the  PCR  by  wax  such  that  all  reaction  components  are  mixed  after 
154 denaturation  of  the  template.  It  is  more  efficient  to  separate  the  reaction  component 
physically  with  a  material  that  can  be  used  as  a  barrier  but  which  will  melt  on  raising 
the  temperature,  therefore  causing  mixing  of  all  reaction  components  at  the  start  of 
the  PCR  (Newton  and  Graham,  1994). 
4.3.  Materials  and  Methods 
4.3.1.  Materials 
Consumables  used  during  the  course  of  the  studies  presented  in  this  chapter  were 
obtained  from  the  sources  listed  in  appendix  II. 
4.3.2.  Subjects  and  Ethical  Approval 
Twenty-one  patients  referred  to  the  Oral  Medicine  Clinic  were  informed  and  asked  to 
undergo  biopsy  for  research  purposes.  Informed  consent  was  obtained  from  all 
patients  . 
According  to  the  classification  of  recurrent  aphthous  stomatitis  (Lehner, 
1968),  all  patients  were  diagnosed  as  having  the  minor  type  of  the  disease.  The 
average  age  of  the  patients  was  36  years  (22-63  years)  and  there  were  six  males  and 
15  females  (Table  4.1). 
In  addition  20  patients  diagnosed  as  having  oral  lichen  planus,  who  underwent  biopsy 
for  their  management  in  the  Oral  Medicine  Clinic,  were  used  as  disease  controls  in  this 
study.  The  mean  age  in  this  group  was  45  years  (24-71)  and  they  were  eight  males 
and  12  females  (Table  4.1). 
155 Table  4.1.  RAS  and  OLP  patients  and  control  subjects  who  underwent  biopsy  for 
PCR  experiment. 
156 Healthy  control  subjects  were  those  who  attended  Oral  Surgery  for  dental  extraction 
under  surgical  operation.  A  piece  of  mucosa  flap  removed  for  study  purposes  during 
operation.  This  group  included  13  individuals  with  no  history  of  oral  ulceration.  The 
consent  was  obtained  from  these  patients  by  the  surgeon  in  charge  of  the  operation 
and  all  patients  were  fully  informed  about  the  purpose  of  the  study.  The  mean  age  in 
this  group  was  43.2  years  (21-79  years)  and  five  males  and  eight  females  were  in  this 
group.  (Table  4.1) 
4.3.3.  Collection  of  Samples 
Biopsy  specimens  from  patients  with  recurrent  aphthous  stomatitis  were  collected 
within  48  hours  of  ulceration,  biopsy  specimens  of  oral  lichen  planus  and  13  normal 
oral  mucosa  samples  were  obtained  as  controls.  The  biopsy  samples  of  aphthous 
patients  were  generally  smaller  than  oral  lichen  planus  and  control  specimens.  Tissue 
biopsies  were  stored  at  -70°C  prior  to  DNA  extraction. 
4.3.4.  DNA  Extraction 
Frozen  tissue  samples  were  manually  homogenised  in  1  ml  of  TEN  buffer  (50  mM 
Tris-HCI,  100  mM  EDTA,  150  mM  NaC1)  per  200  mg  of  tissue.  To  each  200  mg  of 
homogenised  tissue  was  added  250  µ16M  guanidinium  isothiocyanate  (in  0.1  M  Tris 
HCI,  pH  7.6)  and  this  was  incubated  overnight  at  37°C.  The  mixture  was  boiled  for 
20  minutes,  an  equal  volume  of  molecular  biology  grade  water  was  added,  and  then 
the  sample  was  centrifuged  at  12.500  RPM  for  one  minute  using  an  Eppendorf 
centrifuge  (model  5415c).  The  supernatant  was  retained  and  the  genomic  DNA  was 
157 purified  using  the  Wizard  DNA  Clean  Up  Kit  in  accordance  with  the  manufacturer's 
instructions.  For  each  extraction,  tissue  DNA  was  eluted  in  a  final  volume  of  50  µl. 
To  confirm  successful  extraction  of  PCR-amplifiable  DNA  from  tissues,  PCR  was 
carried  out  on  each  DNA  sample  with  nested  primers  specific  for  the  human  ß- 
haemoglobin  gene  for  which  the  method  will  be  described. 
4.3.5.  Selection  of  Primers  for  Nested  PCR 
The  nested  primer  pairs  for  use  in  PCR  were  those  previously  described  for  HHV-6, 
HCMV  and  VZV  (Wakefield  et  al.  1992).  The  primer  sequences,  annealing 
temperatures  used  and  expected  size  of  amplification  products  are  shown  in  Table  4.2. 
The  `  nested  primers  for  Mycobacterium  paratuberculosis  were  those  described  in 
another  investigation  (Lisby  et  al.  1994).  The  primer  sequences  and  expected  size  of 
amplification  products  are  demonstrated  in  Table  4.3. 
4.3.6.  Nested  Polymerase  Chain  Reaction  Using  Viral  Primers 
For  nested  PCR  analysis,  5  pl  of  extracted  DNA  was  added  to  95  µl  of  1X  PCR 
buffer  (10  mM  Tris-HCl  pH  8.8,1.5  mM  MgC12,50  mM  KC1,0.1%  Triton  X-100), 
2.0  U  of  Dynazyme  I  DNA  polymerase  (Flowgen  Instruments  Ltd,  Lichfield, 
England),  0.2  mM  dNTPs  and  200  ng  of  each  "outer"  primer  pair.  Primers  were 
separated  from  other  components  of  the  reaction  mixture  by  a  layer  of  wax 
(Dynawax;  Flowgen),  thus  preventing  the  reaction  from  starting  until  melting  of  the 
wax  upon  commencement  of  thermal  cycling.  This  `hot  start'  PCR  method  improves 
the  specificity  and  yield  of  reaction  products.  Amplification  was  carried  out  in  an 
158 OmniGene  Thermal  Cycler.  After  an  initial  denaturation  step  at  94°C  for  five  minutes, 
35  cycles  of  denaturation  at  94°C  for  one  minute,  annealing  of  primers  at  50-60°C  for 
two  minutes  and  primer  extension  at  72°C  for  one  minute  was  carried  out,  followed 
by  a  final  extension  step  at  72°C  for  10  min.  For  the  second  round  of  PCR,  25  cycles 
of  amplification  were  carried  out  using  two  µl  of  first  round  product  as  the  source  of 
template  DNA  and  200  ng  of  each  "inner"  primer  pair.  The  annealing  temperatures 
used  for  each  set  of  "outer"  and  "inner"  primers  is  indicated  in  Table  4.2. 
4.3  7.  Nested  PCR  Using  Mycobacterium  paratuberculosis  Primers 
A  fragment  of  the  IS900  multi-copy  insertional  gene  element  of  Mycobacterium 
paratuberculosis  (Lisby  et  al.  1994)  was  selected  for  this  study  and  two  sets  of 
primers  were  collected  (Table  4.3)  for  use  in  a  nested  PCR.  One  µL  of  extracted 
DNA  was  added  to  99  µL  of  solution  containing  50  mM  KCI,  10  mM  Tris-HCl  (PH 
8.3),  0.01  per  cent  (w/v)  gelatin,  1.0  nM  MgC12,200  µM  of  each  deoxynucleotide 
(dNTP,  2  units  Ampli  TAQ  (Perkin  Elmer  Cetus)  and  0.6  µM  each  of  the  outer 
primers  (Table  4.3).  PCR  was  performed  for  25  cycles  of  denaturation  at  94°C  for  45 
seconds,  annealing  of  primers  at  56°C  for  90  seconds,  and  primer  extension  at  72°C 
for  45  seconds.  For  the  second  round  of  PCR,  5  µL  of  the  first  round  products  as  a 
template  was  transferred  to  a  new  PCR  reaction  identical  to  the  first  one  with  the 
exception  of  using  0.4  pM  each  of  the  inner  primers  (Table  4.3).  PCR  for  the  second 
round  was  performed  for  40  cycles  using  the  same  profile  as  in  the  first  reaction. 
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-° 4.3.8.  Nested  PCR  Using  Human  P  Haemoglobin  Primers 
For  nested  PCR  for  the  detection  of  human  0  haemoglobin,  the  same  PCR  solution  as 
the  previous  experiment  was  used.  A  2.5  µL  volume  of  a  one  µg/.  tL  solution  of  each 
first  round  oligonucleotide  was  added  to  the  solution  in  the  first  round  as  outer 
primers.  In  the  second  round,  2.5  µL  of  a1  µg/µL  solution  of  each  of  the  second 
round  oligonucleotide  primers  (inner  primers)  was  used.  A2  gL  volume  of  first  round 
product  was  added  to  the  solution  as  the  template  for  second  round.  Amplification 
was  carried  out  with  initial  denaturation  step  at  94  °C  for  five  minutes,  35  cycles  of 
denaturation  at  94°C  for  one  minute,  annealing  of  primers  at  64°C  for  two  minutes 
and  primer  extension  at  72°C  for  two  minutes,  followed  by  a  final  extension  step  at 
72°C  for  10  minutes. 
For  the  second  round  of  nested  PCR,  amplification  was  repeated  for  35  cycles  with 
the  same  time  and  temperature  parameters  as  above  except  for  a  55°C  annealing 
temperature  in  the  second  step. 
4.3.9.  PCR  Quality  Control 
In  order  to  avoid  contamination,  strict  procedures  were  employed  when  carrying  out 
PCR.  Separate  rooms  were  used  for  sample  preparation,  setting  up  of  PCR  reactions 
and  post-PCR  analysis.  Filter  tips  were  used  at  all  stages,  except  when  adding  samples 
to  the  reaction  mixture  when  positive  displacement  tips  were  used.  Positive  and 
negative  controls  were  used  with  each  batch  of  samples  being  analysed.  The  positive 
control  was  10  ng  of  plasmid  DNA  containing  the  cloned  herpesviral  gene  against 
162 which  the  primers  were  targeted  instead  of  the  sample.  Positive  control  in  nested  PCR 
for  Mycobacterium  paratuberculosis  was  plasmid  containing  the  cloned  IS900 
insertion  element  of  paratuberculosis  against  which  the  primer  for  nested-PCR  were 
targeted,  whereas  the  negative  control  contained  sterile  water  instead  of  the  sample. 
For  detection  of  human  0  haemoglobin  the  positive  control  was  not  employed. 
4.3.10.  Analysis  of  PCR  Products 
15  µl  of  each  reaction  product  was  electrophoresed  on  a  2%  agarose  gel  containing 
ethidium  bromide  (0.5  pg/ml),  using  a  100  base  pair  (bp)  DNA  ladder  (Pharmacia 
Biotech,  Milton  Keynes,  England)  as  a  size  marker,  and  visualized  under  UV 
illumination.  PCR  positivity  for  HHV-6,  HCMV,  VZV  and  Mycobacterium 
paratuberculosis  was  indicated  by  the  appearance  of  DNA  bands  of  173-  bp,  100-  bp, 
208-bp  and  289-  bp  respectively.  (Figure  4.1,4.2,4.3,4.4) 
4.3.11.  Statistics 
The  statistical  significance  of  observed  differences  was  assessed  by  Fisher's  exact 
probability  test.  A  level  of  p<0.05  was  chosen  to  reflect  statistical  significance. 
4.4.  Results 
All  tissue  DNA  samples  demonstrated  PCR  positivity  for  the  human  ß-haemoglobin 
gene,  which  was  indicated  by  the  amplification  of  a  165-bp  product  (Figure  4.5).  For 
each  batch  of  samples  being  analysed  by  PCR,  positive  controls  were  always  positive 
and  negative  controls  always  negative,  thereby  excluding  the  possibility  of 
contamination  and  validating  the  results  obtained. 
163 Figure  4.1,  Two  per  cent  agarose  gel  electrophoresis  of  selected  products  obtained 
following  nested  PCR  with  HHV-6  primers.  100-bp  DNA  ladder  (lanes  I  and  16), 
RAS  samples  (lane  2  to  8),  oral  lichen  planus  samples  (lanes  9  to  13),  negative  control 
(lane  14)  and  positive  control  (lane  15). 
164 
12345  (i  7  tý  ýý  10  11  12  13  14  15  16 Figure  4.2.  Two  per  cent  agarose  gel  electrophoresis  of  selected  products  obtained 
following  nested  PCR  with  HCMV  primers.  100-bp  DNA  ladder  (lane  I  and  16), 
RAS  samples  (lane  2  to  7),  oral  lichen  planus  samples  (lane  8  to  13),  negative  control 
(lane  14)  and  positive  control  (lane  15). 
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l-igure  4.3  Two  per  cent  agarose  gel  electrophoresis  of  selected  products  obtained 
following  nested  PCR  with  VZV  primers.  100-bp  DNA  ladder  (lane  M),  positive 
control  (lane  P)  and  the  remaining  lanes  are  negative  control  and  biopsy  samples 
which  all  show  negative  results. 
166 Figure  4.4.  Two  per  cent  agarose  gel  electrophoresis  of  selected  products  obtained 
following  a  nested  PCR  with  Mycobacterium  paratuberculosis  primers.  100-bp  DNA 
ladder  (lane  1),  RAS  samples  (lanes  2,3,4,7,9,10),  oral  lichen  planus  samples  (lanes 
5,6,8),  positive  control  (lane  11)  and  negative  control  (lane  12). 
167 Figure  4.5.  Two  per  cent  agarose  gel  electrophoresis  of  selected  products  of  a  nested 
PCR  with  human  ß  haemoglobin  primers.  Negative  control  (lane  1),  DNA  samples 
extracted  from  RAS,  oral  lichen  planus  and  control  biopsies  (lane  2  to  8,1  1,13,14,15), 
empty  lanes  (lanes  9,10,12)  and  100-bp  DNA  ladder  (lane  15). 
168 4.4.1.  Human  Herpes  Virus  6,  Human  Cytomegalovirus  and 
Varicella  Zoster  Virus 
The  PCR  results  obtained  are  summarized  in  Table  4.4.  HHV-6  DNA  was  present  in 
six  samples  from  recurrent  aphthous  stomatitis  patients  and  four  samples  from 
patients  with  oral  lichen  planus.  HCMV  DNA  was  detected  in  two  oral  lichen  planus 
samples,  whereas  VZV  DNA  was  not  detected  in  any  type  of  sample  (Figure  4.3). 
None  of  the  healthy  controls  were  positive  for  either  HHV-6,  HCMV  or  VZV. 
The  difference  of  detection  rate  of  HHV-6  DNA  in  recurrent  aphthous  stomatitis 
DNA  compared  with  lichen  planus  biopsies  was  not  significant  (p=0.77)  also  there 
was  no  statistically  significant  difference  in  the  presence  of  HHV-6  DNA  in  recurrent 
aphthous  stomatitis  patients  compared  with  normal  controls  (p=0.08).  (Figure  4.6) 
4.4.2.  Mycobacterium  paratuberculosis 
A  total  of  32  samples  were  investigated  for  the  presence  of  Mycobacterium 
paraluberculosis  DNA.  Mycobacterium  paratuberculosis  DNA  was  present  in  four 
samples  from  a  total  of  15  patients  with  recurrent  aphthous  stomatitis.  There  were  no 
DNA  positive  for  this  micro-organism  in  13  samples  of  oral  lichen  planus  patients  and 
four  normal  biopsies.  (Figure  4.4)  There  was  no  statistically  significant  difference 
between  recurrent  aphthous  stomatitis  patients  and  oral  lichen  planus  group  (p=0.18) 
and  normal  samples  (p=0.7). 
169 Table  4.4.  Number  of  RAS,  lichen  planus  and  normal  biopsies  positive  for  HHV-6, 
HCMV  and  VZV  DNA  as  determined  by  PCR.  N  denotes  the  number  of  biopsies 
analysed  for  each  tissue  type. 
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Figure  4.6.  PCR  positivity  in  RAS  patients  compared  to  oral  lichen  planus 
(OLP)  patients  and  normal  subjects  to  HCMV,  VZV  and  HHV-6  DNA. 
No  DNA  of  VZV  and  HCMV  was  detected  in  RAS  lesions.  VZV  DNA 
was  not  found  in  any  of  the  samples.  HCMV  DNA  was  found  only  in  10 
per  cent  of  samples  obtained  from  oral  lichen  planus. 
"..  Shows  the  PCR  negative  groups. 
171 4.5.  Discussion 
The  clinical  signs  and  histological  features  of  recurrent  aphthous  stomatitis  and 
Behcet's  syndrome  have  suggested  a  possible  viral  aetiology,  although  virus  has  never 
been  successfully  isolated  (Hooks,  1978).  The  application  of  the  PCR  technique  has 
revolutionized  our  approach  for  investigating  possible  viral  involvement  in  recurrent 
aphthous  stomatitis  and  other  related  conditions.  In  one  study,  PCR  detected  VZV 
DNA  in  all  20  recurrent  aphthous  stomatitis  biopsies  examined  (Pedersen  et  al.  1993) 
but  an  unusual  finding  of  that  study  was  that  VZV  DNA  was  only  amplifiable  using 
one  set  of  primers  tested,  which  targeted  the  protein  kinase  66  (PK66).  Two  other 
primer  sets,  one  targeting  another  region  of  the  VZV  PK66  gene  and  the  other 
targeting  the  VZV  thymidine  kinase  gene,  gave  negative  PCR  results.  Whilst  the 
authors  offered  no  explanation  for  this  discrepancy,  their  results  are  clearly  at  odds 
with  the  findings  of  the  present  study,  which  was  unable  to  identify  VZV  DNA  in  any 
of  the  samples  examined,  despite  using  two  rounds  of  PCR  with  nested  primers  for 
increased  sensitivity  and  specificity. 
In  another  study  it  was  reported  that  PCR  detected  HCMV  DNA  in  three  of  nine  (33 
per  cent)  recurrent  aphthous  stomatitis  biopsies  (Sun  et  al.  1996)  but  not  in  any 
control  samples.  Using  in  situ  hybridisation,  HCMV  DNA  was  found  in  three  of  29 
(10  per  cent)  oral  mucosal  ulcers  (Leimol-Virtanen  et  al.  1995)  but  not  in  any 
recurrent  aphthous  stomatitis  biopsies  (Sun  et  al.  1996).  In  this  study,  it  was  not 
possible  to  demonstrate  the  presence  of  HCMV  DNA  in  any  recurrent  aphthous 
stomatitis  samples  but  the  study  demonstrated  its  presence  in  two  oral  lichen  planus 
172 samples.  The  combined  evidence  from  these  studies  suggests  that  HCMV  can  be 
found  in  a  small  proportion  of  oral  ulcers,  and  therefore  cannot  be  entirely  dismissed 
as  an  aetiological  agent  in  some  cases  of  recurrent  aphthous  stomatitis. 
In  the  present  study,  HHV-6  DNA  was  detected  in  six of  21  (29  per  cent)  recurrent 
aphthous  stomatitis  biopsies.  This  is  the  first  study  to  investigate  the  possible 
involvement  of  HHV-6  in  recurrent  aphthous  stomatitis  biopsy  tissue  by  PCR.  There 
is  currently  some  controversy  as  to  the  true  prevalence  of  HHV-6  in  saliva  of  healthy 
donors.  Using  both  isolation  and  PCR  detection  methods,  some  studies  have  reported 
a  prevalence  rate  of  approximately  90  per  cent  (Jarrett  et  al.  1990;  Levy  et  al.  1990; 
Cone  et  al.  1993)  whereas  others  have  reported  a  much  lower  frequency  of  detection 
of  between  three  and  7  per  cent  (Kido  et  al.  1990;  Saito  et  al.  1991;  Di  Luca  et  al. 
1995).  Although  it  is  difficult  to  fully  explain  the  different  detection  rates  of  HHV-6  in 
the  saliva  of  healthy  persons  in  these  studies,  it  is  possible  that  the  culture  and  PCR 
methods  employed  also  detected  HHV-7  or  simply  that  the  amount  of  saliva  analysed 
in  the  various  studies  was  variable,  and  if  the  viral  load  is  low  then  small  amounts  of 
saliva  would  give  negative  results.  In  one  particular  study  using  PCR,  HHV-6  was 
found  in  63  per  cent  of  salivary  gland  biopsies  and  3  per  cent  of  saliva  samples  from 
healthy  persons,  and  in  17  per  cent  of  saliva  samples  from  patients  with  a  history  of 
recurrent  aphthous  stomatitis.  However,  HHV-7  was  found  at  markedly  higher 
frequencies,  being  detected  in  75  per  cent  of  salivary  gland  biopsies  and  55  per  cent  of 
saliva  samples  from  healthy  persons,  and  in  66  per  cent  of  saliva  samples  from 
recurrent  aphthous  stomatitis  patients  (Saito  et  al.  1991).  PCR  did  not  detect 
significant  differences  in  the  presence  of  HHV-6  and  HHV-7  and  their  viral  loads 
173 between  saliva  from  recurrent  aphthous  stomatitis  patients  and  from  healthy  persons 
and  the  authors  concluded  that  HHV-6  and  HHV-7  probably  do  not  play  a  role  in  the 
pathogenesis  of  recurrent  aphthous  stomatitis.  Although  we  did  not  look  at  the  saliva 
of  recurrent  aphthous  stomatitis  patients  in  our  study  for  the  presence  of  HHV-6,  the 
low  incidence  found  in  some  of  the  studies  described  above,  taken  together  with  the 
observation  that  all  of  the  normal  control  tissues  in  our  study,  and  indeed  the  vast 
majority  of  the  recurrent  aphthous  stomatitis  and  lichen  planus  tissues  analysed,  were 
PCR-negative  for  HHV-6,  suggests  that  salivary  contamination  of  biopsy  specimens  is 
unlikely  to  be  a  problem. 
In  summary,  the  results  of  this  study  suggest  that  HCMV  and  VZV  are  not 
aetiological  agents  of  recurrent  aphthous  stomatitis.  Although  there  is  not  any 
identified  clinical  manifestation  for  HHV-6  in  the  oral  cavity,  recurrent  aphthous 
stomatitis  may  be  one  of  the  features  of  HHV-6  reactivation,  in  some  cases. 
In  the  present  study,  four  patients  with  recurrent  aphthous  stomatitis  also 
demonstrated  Mycobacterium  paratuberculosis  in  their  oral  ulceration.  Although 
there  was  no  significant  difference  between  recurrent  aphthous  stomatitis  patients  and 
controls,  the  presence  of  this  micro-organism  only  in  recurrent  aphthous  stomatitis 
samples,  could  not  exclude  mycobacteria  from  the  aetiology  of  recurrent  aphthous 
stomatitis.  However  the  recurrent  nature  of  the  disease  cannot  be  explained  with  the 
hypothesis  of  cross-reactivity  of  heat  shock  proteins  of  oral  mucosa  and 
mycobacterium. 
174 Chapter  Five.  Antibodies  to  Human  Herpes  Virus-6, 
Cytomegalovirus  and  Varicella  Zoster  Virus 
175 5.1.  Introduction 
Humoral  immunity  is  a  main  system  for  protecting  the  host  against  infection  by  micro- 
organisms.  Immunoglobulins  as  the  important  part  of  this  system,  are  classified  in  to 
five  major  groups  according  to  their  size,  charge,  carbohydrate  content  and  amino 
acid  composition  (IgG,  M,  A,  E  and  D)  (Oilier  and  Symmons,  1992).  The  major 
serum  antibodies  are  of  IgG  class.  IgM  protects  the  host  in  the  early  stages  of 
infection,  while  IgG  replaces  the  IgM  in  later  stages  of  infection  and  it  can  be  detected 
very  late  after  the  infection  has  disappeared.  IgM  antibodies  are  the  first  to  be 
detected  after  infection  and  the  presence  of  anti-viral  IgM  is  a  sign  of  recent  infection 
(Scully  and  Samaranayake,  1992).  Secretory  IgA  is  the  principal  and  most  important 
immunoglobulin  in  secretions  and  on  mucosal  surfaces  including  the  oral  mucosa 
(Scully  and  Samaranayake,  1992). 
Specific  antibodies  play  an  important  role  in  modulating  viral  infections.  They  may 
interact  with  the  virion  itself,  and  either  neutralize  the  virus  or  destroy  the  virus- 
infected  host  cell  by  a  number  of  mechanisms.  Viruses  may  well  however,  be 
intracellular  and  thus  inaccessible  to  antibody  (Scully  and  Samaranayake,  1992). 
In  recurrent  aphthous  stomatitis,  there  have  been  no  raised  antibodies  against  herpes 
simplex  virus  using  neutralization  tests  reported  (Stark  et  al.  1954).  Recently,  raised 
specific  human  cytomegalovirus  (HCMV)  IgM  was  identified  in  recurrent  aphthous 
stomatitis  patients,  especially  in  the  remission  period  of  the  disease  (Pedersen  and 
Hornsleth,  1993;  Sun  et  al.  1996).  These  results  are  in  agreement  with  recent  findings 
which  show  antibody  production  in  cells  infected  with  HCMV  are  too  late  to  prevent 
176 initiation  of  persistent  infection  (Mims  and  White,  1984).  However,  specific  HCMV 
IgG  +  IgM  was  not  different  in  recurrent  aphthous  stomatitis  and  control  subjects 
(Pedersen  and  Hornsleth,  1993). 
At  least  a  four-fold  increase  in  specific  VZV  IgM  antibody  was  reported  (Pedersen, 
1989b),  although,  the  antibody  titre  against  VZV  was  less  raised  in  a  subsequent 
study  (Pedersen  and  Hornsleth,  1993). 
Specific  HHV-6  IgG  antibody  was  detected  in  most  of  the  patients  with  recurrent 
aphthous  stomatitis  and  controls  (Pedersen  and  Hornsleth,  1993),  but  there  has  been 
no  investigation  in  to  specific  HHV-6  IgM  antibody  in  recurrent  aphthous  stomatitis 
to  distinguish  the  stage  of  infection  in  this  disease. 
Recent  investigation  has  shown  the  involvement  of  HCMV  or  VZV  in  the  aetiology  of 
recurrent  aphthous  stomatitis  (Pedersen,  1989b;  Pedersen  and  Hornsleth,  1993;  Sun 
et  al.  1996),  however  the  previous  section  of  this  thesis  could  not  support  this 
hypothesis. 
Viral  involvement  in  the  aetiology  of  recurrent  aphthous  stomatitis  is  one  of  the  most 
plausible  hypotheses,  and  clinical  features  and  laboratory  findings  increase  the 
possibility  for  herpesvirus  involvement  (see  section  4.1).  The  aim  of  this  part  of  the 
present  study,  subsequent  to  the  molecular  biological  investigation,  was  to  evaluate 
the  involvement  of  human  herpes  virus-6,  cytomegalovirus  and  varicella  zoster  virus 
in  recurrent  aphthous  stomatitis  by  detection  of  specific  immunoglobulins  against 
these  viruses. 
177 5.2.  Materials  and  Methods 
5.2.1.  Materials 
Enzygnost,  anti-HCMV  IgG,  anti-VZV  IgG,  anti-HCMV  IgM,  anti-VZV  IgM  ELISA 
kits  and  supplementary  reagents  for  Enzygnost/TMB  were  obtained  from  Behring, 
Hoechst  UK  Ltd.,  50  Salisbury  Road,  Hounslow,  Middlesex,  UK. 
HHV-6  IgG  ELISA  (Abi),  HHV-6  IgM  IFA  (Abi)  were  obtained  from  AutoGen 
Bioclear  UK  Ltd,  Butts  Farm,  Potterne,  Devizes,  Wiltshire,  UK. 
5.2.2.  Ethical  Approval 
The  study  was  approved  by  the  local  ethics  committee  of  Glasgow  Dental  Hospital 
and  School.  Consent  was  obtained  for  the  collection  of  samples  from  all  patients. 
5.2.3.  Subjects 
a)  Venous  blood  was  obtained  from  22  patients  with  recurrent  aphthous  stomatitis, 
who  attended  the  Oral  Medicine  Clinic  (within  48  hours  of  initiation  of  the  ulcer 
episode).  Twenty-one  patients  were  those  whose  biopsy  samples  were  used  in  PCR 
experiment  explained  in  the  previous  chapter. 
b)  Venous  blood  samples  were  obtained  as  disease  controls  from  24  oral  lichen  planus 
patients,  who  had  undergone  biopsy  and  haematological  investigation  as  part  of  their 
treatment.  Twenty  of  these  patients  were  those  whose  biopsies  were  tested  in  the 
PCR  experiment  described  in  previous  chapter. 
c)  Fifteen  patients  were  individuals  without  a  history  of  recurrent  aphthous  stomatitis, 
who  attended  the  oral  surgery  unit  for  removal  of  their  wisdom  teeth.  This  group 
178 were  also  included  as  an  additional  control  group.  Also,  13  of  these  individuals  were 
those  whose  biopsy  specimens  were  used  in  PCR  tests  which  previously  have  been 
described. 
5.2.4.  Collection  of  Blood 
Ten  mis  of  venous  blood  were  collected  from  subjects  using  a  plain  10  ml  vacutainer 
tube.  The  blood  was  allowed  to  clot  and  subsequently  centrifuged  for  10  minutes  at 
1000  RPM  using  a  MSE,  super  minor  centrifuge.  The  serum  was  then  separated  and 
aliquoted  to  sterile  microtubes.  The  sera  were  stored  at  -70°C. 
5.2.5.  Detection  of  IgG  Antibody  to  HCMV 
The  ELISA  kit,  Enzygnost  anti-HCMV  IgG  (Behring)  was  employed  according  to  the 
manufacturer's  instructions.  The  serum  samples  and  reference  were  pre-diluted  1  to 
20  by  adding  0.02  ml of  the  serum  to  0.4  ml  of  pre-coloured  sample  buffer  POD  (Tris 
buffer  0.3  moll  which  is  pre-coloured  1  to  20  by  blue  colour  provided  by  the 
supplementary  kit)  and  mixed  well.  In  to  each  reaction  well,  0.20  ml  of  sample  buffer 
POD  (Tris  buffer  0.3  mol/1)  was  introduced,  then  0.020  ml  of  the  pre-diluted 
reference  P/N  (human  IgG  specific  for  HCMV  in  Tris  buffer  solution  of  20  mmol/1)) 
was  pipetted  in  to  first  pair  of  reaction  wells  coated  with  antigen  (derived  from 
HCMV-infected  cells)  and  control  antigen  (derived  from  non-infected  cells) 
respectively.  The  same  amount  of  pre-diluted  test  samples  were  pipetted  into  the  next 
pairs  of  reaction  wells  respectively  and  finally  into  the  last  pair  of  the  wells,  in  each  set 
of  the  experiment,  0.020  ml  reference  P/N  was  introduced.  Then  plate  was  sealed  and 
179 incubated  in  a  moist  chamber  for  60  minutes  at  37°C.  After  incubation,  the  plate  was 
washed  in  a  plate  washer  for  four  times  using  the  washing  solution  provided  in  the 
supplementary  reagent  kit  (Behring).  The  amount  of  0.10  ml  of  the  diluted  enzyme 
conjugate  (Fab's  component  of  rabbit  antibody  which  has  been  conjugated  with 
peroxidase)  was  added  to  each  well  and  the  plate  was  sealed  and  immediately 
incubated  in  a  moist  chamber  for  60  minutes  at  37°C.  After  this  second  incubation  the 
plate  was  washed  as  before.  After  that,  0.10  ml  of  diluted  substrate  was  added  to  each 
well  and  the  plate  incubated  for  30  minutes  at  room  temperature  (18-25°C)  protected 
from  light.  After  this  period,  the  enzyme  reaction  was  stopped  by  adding  0.10  ml  of 
stopping  solution  peroxidase  to  each  well.  The  yellowish-green  colour  reaction  was 
evaluated  by  using  a  microplate  reader  (Dynatech  MR5000)  at  a  wavelength  of  450 
mn. 
5.2.6.  Detection  of  IgG  Antibody  to  VZV 
The  ELISA  kit  employed  was  Enzygnost  anti-VZV  IgG  (Behring),  used  according  to 
the  manufacturer's  instructions.  Method  for  this  test  was  exactly  the  same  as  to  the 
one  for  anti-HCMV  IgG  which  was  explained  in  the  previous  section  with  the 
exception  of  the  specific  VZV  reference  P/N  and  the  specific  VZV  antigen  and 
control  antigen  coated  plate  were  used  in  this  experiment. 
5.2.7.  Detection  of  IgG  Antibody  to  HHV-6 
The  ELISA  kit,  HHV-6  IgG  antibody  (Abi)  was  employed  and  run  according  to 
manufacturer's  instructions.  Positive  and  negative  controls  as  well  as  samples  were 
180 diluted  in  a  separate  dilution  plate  by  adding  0.010  ml  of  each  of  the  controls  in  each 
of  the  wells  (three  wells  for  negative  and  two  wells  for  positive  controls)  and  also 
0.010  ml  of  the  test  samples  to  the  rest  of  the  wells  (two  wells  for  each  test  sample). 
Then  0.20  ml  of  sample  diluent  was  added  to  each  well  in  addition  to  a  blank  well.  By 
using  a  multichannel  pipette,  0.10  ml  of  each  of  the  diluted  controls,  samples  and 
blank  were  transferred  to  the  antigen-coated  plate,  after  they  were  mixed  properly. 
The  coated-plate  was  sealed  and  incubated  at  37°C  for  30  minutes.  In  the  next  step, 
plate  was  washed  three  times  by  an  automatic  plate  washer.  Then  0.10  ml  of  pre- 
diluted  horseradish  peroxidase  (HRP)  conjugate  was  added  in  each  well  and  incubated 
at  3  7°C  for  30  minutes.  Washing  was  repeated  in  the  same  manner  as  before  and  0.10 
ml  of  HRP  substrate  was  introduced  to  each  well.  The  plate  was  incubated  at  room 
temperature  (20-25°C)  for  30  minutes  in  the  dark.  The  reaction  was  stopped  by 
addition  of  0.10  ml  of  stopping  solution  in  to  each  well  and  the  yellowish  colour  of 
reaction  was  measured  within  thirty  minutes  at  wavelength  of  450  nm.  using  a 
microplate  reader  (Dynatech  5000).  The  microplate  reader  was  blanked  on  the 
reagent  blank  well.  (Figure  5.1) 
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Figure  5.1.  HHV-6  IgG  antibody  ELISA  plate,  coated  with  HHV-6  antigen,  showing 
the  yellowish  colour  change  after  addition  of  stopping  solution.  Al  is  a  blank  well, 
A2,  B1  and  B2  are  negative  controls,  Cl,  C2,  Hi  I  and  H12  are  positive  controls.  In 
each  pair  of  wells  (for  instance  DI  and  D2),  one  sample  test  was  incubated.  All 
yellowish  coloured  wells  show  positive  IgG  antibodies  against  HHV-6  in  sera  of 
subjects.  Un  changed  coloured  wells  (such  as  G7  and  G8)  show  negative  IgG 
antibody  against  HHV-6  in  sera  of  subjects. 
182 5.2.8.  Detection  of  IgM  Antibody  to  HCMV 
The  ELISA  kit,  Enzygnost  anti-HCMV  IgM  (Behring)  was  employed  according  to 
the  manufacturer's  instructions.  The  serum  samples  and  reference  P/N  (human 
monoclonal  antibodies  to  HCMV  in  Tris  buffer  solution  of  20  mmol/1)  and  reference 
P/P  (anti-HCMV  IgG  together  with  rheumatoid  factor  in  Tris  solution  of  20  mmol/1) 
were  diluted  the  same  way  as  was  explained  for  Enzygnost  anti-HCMV  IgG  antibody. 
The  amount  of  0.20  ml  of  pre-diluted  test  samples  were  treated  with  0.20  ml  of 
reconstituted  RF  absorbent  (lyophilized,  consists  of  sheep  antibodies  directed  against 
human  IgG  Fc  fragment,  in  phosphate  buffered  saline  of  10  mmol/l)  and  incubated  for 
15  minutes  at  room  temperature  (18-25°C).  In  first  and  second  pairs  of  wells  0.150  ml 
of  the  pre-diluted  reference  P/N  and  P/P  were  introduced  in  to  each  well  respectively. 
In  last  pair  of  wells  of  each  test  plate  or  in  a  larger  set  of  tests,  in  the  last  pair  of  wells, 
0.150  ml  of  diluted  reference  P/P  was  introduced.  The  test  plate  was  sealed  and 
incubated  at  37°C  in  a  moist  chamber.  After  60  minutes  incubation,  the  plate  was 
washed  in  a  plate  washer,  four  times  using  washing  solution  provided  with  the 
supplementary  reagent  kit  (Behring).  In  next  stage,  test  plate  was  incubated  with  0.10 
ml  of  diluted  anti-human  IgM/POD  conjugate  (Goat  antibody  conjugated  with 
peroxidase  in  Tris  buffer  solution  of  0.05  mol/1)  in  each  well,  for  60  minutes  at  37°C 
in  a  moist  chamber.  The  next  step  immediately  started  with  washing  the  plate  as 
before,  then  0.10  ml  of  diluted  substrate  was  introduced  in  to  each  well.  The  plate  was 
sealed  and  incubated  for  another  30  minutes  at  room  temperature  protected  from 
light.  Finally  the  reaction  was  stopped  by  adding  0.10  ml  of  stopping  solution  POD 
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Figure  5.2.  ELISA  antigen-control  antigen  coated  plate  showing  the  Enzymatic  colour 
change  for  specific  IgM  antibodies  positivity  in  sera  of  subjects  against  HCMV  (first 
two  pairs  of  columns)  and  VZV  (second  two  pairs  of  columns)  after  addition  of  the 
stopping  solution.  The  odd-number  columns  contain  test  antigen  and  even-number 
contain  control  antigen.  Al/2  were  incubated  with  reference  P/N,  BI/2  and  H3/4  were 
incubated  with  reference  P/P  of  the  specific  HCMV  IgM  ELISA  kit.  B3/4  show  the 
presence  of  IgM  antibody  in  sera  of  a  subject.  A5/6  were  incubated  with  reference 
P/N,  B5/6  and  H7/8  were  incubated  with  reference  P/P  of  the  specific  VZV  IgM 
ELISA  kit. 
184 to  each  well.  Photometric  evaluation  was  carried  out  by  using  a  microplate  reader 
(Dynatech  MR  5000)  at  wavelength  450  nm.  (Figure  5.2) 
5.2.9.  Detection  of  IgM  Antibody  to  VZV 
The  ELISA  kit  used  was  Enzygnost  anti-VZV  IgM  (Behring).  The  manufacturer's 
instructions  were  exactly  the  same  as  to  Enzygnost  anti-HCMV  IgM  which  was 
explained  in  the  previous  section,  with  the  exception  of  the  specific  VZV  reference 
P/N  and  PIP 
,  and  the  antigen  ,  control  antigen  coated  plate  which  were  used  in  this 
experiment.  (Figure  5.2) 
5.2.10.  Detection  of  IgM  Antibody  to  HHV-6 
The  immunofluorescent  assay  (IFA)  kit,  HHV-6  IgM  IFA  (Abi)  was  employed 
according  to  the  manufacturer's  instructions.  Positive  and  negative  controls  as  well  as 
serum  samples  were  diluted  by  IgG  sorbant  by  adding  0.004  ml  samples  to  two  drops 
(approximately  0.070-0.080  ml)  of  IgG  sorbant.  After  one  to  two  minutes  incubation 
at  room  temperature  and  centrifugation  for  30  seconds  in  a  table-top  MSE-MLES 
centrifuge  (>_1500  RPM),  0.015-0.020  ml  (-1/2  drop)  of  the  IgG  depleted  positive 
control  and  negative  control  were  placed  on  wells  number  one  and  two  respectively. 
On  well  number  three,  0.020  ml  of  IgG  sorbant  was  placed.  IgG  depleted  and  diluted 
patients  sera  were  placed  on  the  remaining  wells.  Slides  were  incubated  in  a  moist 
chamber  for  three  hours  at  37°C.  In  the  next  step,  slides  were  rinsed  in  a  gentle 
stream  of  washing  buffer  (provided  with  the  kit),  then  washing  was  continued  for  five 
to  10  minutes  in  a  washing  buffer  using  a  staining  dish  while  slowly  stirring  on  a 
magnetic  stir  plate.  Slides  were  dried  with  the  provided  blotter  and  approximately 
185 0.020  ml  (-1/2  drop)  of  FITC  anti-human  IgM  conjugate  was  deposited  on  each  well. 
After  that,  slides  were  incubated  for  30  minutes  in  a  moist  chamber  at  37°C.  In  the 
next  stage  slides  were  washed  and  dried  as  before  and  approximately  0.010  ml  of 
mounting  solution  was  placed  on  each  well.  The  slides  were  then  covered  with  a 
cover  slip  and  their  positivity  was  examined  under  a  fluorescence  microscope  using 
20x  magnification.  The  slides  were  examined  blind  by  two  observers.  Results  were 
compared  and  in  the  case  of  disagreement,  sera  was  retested. 
5.2.11.  Test  Quality  Control 
Enzygnost  anti-HCMV  and  anti-VZV  IgG 
According  to  manufacturer's  instruction  each  pair  of  reference  P/N  wells  must  reach 
or  exceed  a  value  of  0.5  AA  (AA  is  the  difference  in  absorbance  between  antigen  and 
control  antigen  wells).  Anti-HCMV  was  considered  negative  when  AA  of  the  sample 
is  less  than  0.1  and  positive  when  AA  exceeds  0.2.  The  test  samples  with  a  AA  value 
between  0.1  and  0.2  were  retested  and  if  the  result  still  did  not  show  the  appropriete 
quality,  it  was  classified  as  an  equivocal  result. 
HHV-6  IgG  antibody 
To  obtain  the  optical  density  of  the  samples,  a  simple  calculation  was  done.  To 
calculate  the  cut-off  value,  the  average  reading  values  of  three  negative  was  obtained 
and  then  the  result  was  multiply  by  two.  An  optical  density  (OD)  ratio  for  each  sample 
was  calculated  by  dividing  the  mean  of  the  reading  values  of  each  sample  by  the  cut- 
off  value.  If  the  OD  ratio  was  equal  to  or  less  than  0.75,  the  result  was  considered  as 
negative  and  if  the  OD  ratio  was  equal  or  more  than  one,  the  result  was  considered  as 
186 positive.  An  OD  ratio  of  between  0.76-0.99  was  counted  as  an  equivocal  (borderline) 
result.  Both  of  the  positive  control  wells  should  have  a  reading  of  51.0.  All  three 
negative  control  wells should  have  a  reading  of  60.125.  If  any  of  the  negative  control 
results  deviate  from  the  average  of  the  three  by  greater  than  50  per  cent,  the  assay  is 
invalid  and  should  be  repeated. 
Enzygnost  anti-HCMV  and  VZV  IgM 
Each  pair  of  reference  P/P  must  reach  or  exceed  a  minimum  absorbance  value  of  0.2 
DA.  Also  DA  for  the  reference  P/N  must  be  within  the  negative  result  (DA<0.1).  A 
positive  result  is  when  the  DA  value  is  more  than  0.2.  The  samples  with  a  AA  value  of 
between  0.1  and  0.2,  must  be  retested  and  if  still  DA  still  does  not  reach  the  positive 
or  negative  values,  the  test  result  is  classed  as  equivocal. 
HHV-6  IgM  IFA 
The  control  IgM  positive  should  show  diffuse  to  restricted  green  staining  of  the 
infected  cell.  The  uninfected  cells  should  exhibit  a  red  colour  due  to  counter  stain. 
The  negative  control  serum  should  only  show  red  coloured  cells  and  the  IgG  sorbant 
control  should  only  show  red  colour  staining  of  cells  demonstrating  that  FITC 
conjugate  was  not  detected  (Figure  5.3).  The  HHV-6  antibody  positive  test  serum  for 
IgM  should  show  punctuate  diffuse  staining  of  the  infected  cells  as  observed  in  the 
control  IgM  positive  serum  (Figure  5.4). 
During  all  experiments,  test  samples  were  coded  and  the  diagnosis  of  the  samples  was 
not  clear,  until  the  end  of  the  test. 
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t. Figure  5.3.  Positive  staining  of  cells  affected  by  addition  of  HHV-6  IgM  antibody 
positive  sera  of  a  RAS  patients.  Bright  green  coloured  cells  show  a  positive  reaction 
with  IgM  antibody  against  HHV-6.  Positive  control  should  also  produce  the  same 
colour  as  the  above  picture. 
188 Figure  5.4.  Negative  staining  of  cells  unaffected  by  addition  of  HHV-6  IgM  antibody 
negative  sera.  Also,  addition  of  IgG  sorbant  and  negative  control  stain  the  same 
colour  as  negative  results. 
189 5.2.12.  Statistics 
The  statistical  significance  of  difference  in  data  obtained  from  each  test  was  assessed 
by  non-parametric,  Fisher's  exact  test  or  Chi-square  test.  A  level  of  p:  50.05  was 
chosen  as  indicative  of  statistical  significance. 
5.3.  Results 
5.3.1.  IgG  Class  Antibodies  Against  VZV,  HCMV  and  HHV-6 
For  HCMV,  the  prevalence  of  IgG  class  antibody  was  less  than  the  other  two  viruses. 
Eight  sera  (36  per  cent)  from  recurrent  aphthous  stomatitis  patients  were  positive. 
Also  in  11  (46  per  cent)  oral  lichen  planus  patients  and  seven  (47  per  cent)  healthy 
individuals  IgG  antibody  against  HCMV  was  detected  (Table  5.1).  By  applying  a  chi- 
square  test  the  difference  in  specific  HCMV  IgG,  between  recurrent  aphthous 
stomatitis  patients  and  the  two  other  groups,  was  not  significant  (df=1,  p>0.05) 
(Figure  5.5). 
All  patients  with  oral  lichen  planus  and  all  in  the  control  group  were  sero-positive  to 
specific  VZV  IgG  class  antibody.  From  22  patients  with  recurrent  aphthous  stomatitis 
only  in  two  of  them  was  specific  VZV  IgG  class  antibody  not  detected  and  the  rest  of 
the  patients  (91  per  cent)  were  sero-positive  against  VZV  IgG  class  antibody.  (Table 
5.1)  There  was  no  statistically  significant  difference  in  specific  IgG  class  antibody 
against  VZV,  between  recurrent  aphthous  stomatitis  patients  and  oral  lichen  planus 
(p=0.45).  Also  no  significant  difference  was  observed  between  recurrent  aphthous 
stomatitis  patients  and  controls  (p=0.69).  (Figure  5.5) 
190 Specific  IgG  class  antibody  to  HHV-6  was  detected  in  all  patients  suffering  from 
recurrent  aphthous  stomatitis  and  all  healthy  individuals  in  the  control  group.  Also,  in 
the  oral  lichen  planus  group  22  patients  (92  per  cent)  were  sero-positive  for  specific 
IgG  class  antibody  against  HHV-6  (Table  5.1).  The  differences  in  specific  HHV-6 
IgG  class  antibody  between  recurrent  aphthous  stomatitis  patients  and  oral  lichen 
planus  (p=0.53)  and  also  with  healthy  individuals  (p>1.00)  were  not  significant. 
(Figure  5.5) 
5.3.2.  IgM  Class  Antibodies  Against  VZV,  HCMV  and  HHV-6 
Specific  HCMV  IgM  class  antibody  was  detected  in  one  (five  per  cent)  recurrent 
aphthous  stomatitis  patient,  two  (eight  per  cent)  oral  lichen  planus  patients  and  two 
(13  per  cent)  controls.  (Table  5.1)  Specific  HCMV  IgM  class  antibody  also  was  not 
statistically  different  between  recurrent  aphthous  stomatitis  patients  and  oral  lichen 
planus  patients  (p>1.00)  and  healthy  individuals  (p=0.66).  (Figure  5.5) 
Specific  VZV  IgM  class  antibody  was  negative  in  all  patients  and  controls.  (Table  5.1) 
Specific  HHV-6  IgM  was  strongly  positive  in  21  (95  per  cent)  recurrent  aphthous 
stomatitis  patients,  17  (71  per  cent)  lichen  planus  patients  and  eight  (53  per  cent) 
controls.  (Table  5.1)  Although  the  difference  in  specific  HHV-6  IgM  class  antibody 
between  recurrent  aphthous  stomatitis  patients  and  oral  lichen  planus  was  not 
significant  (p=0.29),  there  was  a  statistically  significant  difference  between  the 
prevalence  of  specific  HHV-6  IgM  antibody  in  recurrent  aphthous  stomatitis  patients 
and  the  control  group  (p=0.0076).  (Figure  5.5) 
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Figure  5.5.  Specific  antibodies  against  HCMV,  VZV  and  HHV-6  in  sera  of  RAS  patients 
compared  to  oral  lichen  planus  (OLP)  and  normal  subjects.  The  antibodies  against 
HCMV  and  VZV  was  not  significantly  different  between  RAS  patients  and  the  two  other 
groups. 
*  shows  that  there  was  a  significant  difference  between  IgM  antibodies  against  HHV-6  in 
sera  from  RAS  patients  and  normal  individuals. 
.  shows  sera  negative  for  specific  IgM  antibodies  against  VZV. 5.4.  Discussion 
Routine  serological  investigation  is  not  of  diagnostic  value  in  the  diagnosis  of  herpesvirus 
infection,  however,  the  detection  of  specific  IgM  antibody  or  an  increase  of  specific  IgG 
antibody  in  relation  to  disease  activity,  is  usually  indicative  of  an  infection  or  reactivation 
of  the  virus  (Pedersen,  1993).  The  nature  and  extent  of  humoral  immune  responses  to 
recurrent  herpetic  lesions  may  be  different  in  different  patients.  IgM  appears  in  some 
patients  but  is  not  a  consistent  marker  in  recurrent  genital,  mucosal  or  ocular  herpes 
simplex  virus  infection  or  other  diseases  caused  by  HCMV  or  VZV  (Lopez  et  al.  1993). 
In  the  present  study,  there  was  no  significant  difference  in  the  detection  of  specific 
HCMV  IgG  or  IgM  antibodies  between  the  sera  from  recurrent  aphthous  stomatitis 
patients  and  the  other  two  groups.  The  elevation  of  specific  HCMV  IgM,  especially  in 
the  remission  period  of  the  recurrent  aphthous  stomatitis  may  suggest  a  reactivation  of 
HCMV  as  a  cause  of  recurrent  aphthous  stomatitis  (Pedersen  and  Hornsleth,  1993). 
However,  this  elevation  was  not  statistically  significant  in  another  group  of  recurrent 
aphthous  stomatitis  patients  compared  with  controls  in  the  same  study  (Pedersen  and 
Hornsleth,  1993).  A  study  on  anti-HCMV  IgG  antibody  showed  increased  levels  of 
specific  HCMV  IgG  antibody  in  the  sera  of  recurrent  aphthous  stomatitis  patients 
compared  with  control  group  (Sun  et  al.  1996). 
The  ELISA  kit  employed  in  this  study  was  a  diagnostic  kit,  routinely  used  to  measure  the 
level  or  positivity  of  sera  against  VZV.  Almost  all  sera  were  sero-positive  to  specific  IgG 
antibody  which  is  the  reaction  of  the  immune  system  after  primary  infection  or 
reactivation  of  the  virus  or  the  effect  of  vaccination.  Specific  VZV  IgM  was  not  detected 
in  any  of  sera  obtained  from  recurrent  aphthous  stomatitis,  lichen  planus  or  healthy 
194 individuals  indicating  that  there  has  been  no  history  of  VZV  infection  in  the  previous  two 
or  three  years.  (Figure  5.5) 
In  studies  by  Pedersen  (1989b)  and  Pedersen  and  Hornsleth  (1993),  increased  antibody 
against  VZV,  especially  VZV  IgM  has  been  reported  in  patients  with  recurrent  aphthous 
stomatitis  in  contrast  to  controls.  In  data  presented  in  this  thesis,  no  significant  difference 
was  observed  in  specific  VZV  IgG  antibody  in  sera  from  recurrent  aphthous  stomatitis 
patients  compared  to  the  other  two  groups.  Two  to  three  days  after  a  varicella  infection, 
anti-VZV  of  the  IgG,  IgM  and  IgA  classes  are  detectable  in  serum  (Zoulek,  1985).  Anti- 
VZV  IgM  and  IgA  will  disappear  after  one  or  two  years,  while  anti-VZV  IgG  persists 
for  many  years  (Zoulek,  1985).  The  present  results  show  that  probably,  no  infection  or 
reactivation  of  the  virus  had  occurred  during  at  least  the  last  two  or  three  years,  while  all 
serum  samples  from  recurrent  aphthous  stomatitis  patients  were  collected  in  the  active 
stage  of  the  disease.  In  addition,  in  previous  studies  (Pedersen,  1989b;  Pedersen  and 
Hornsleth,  1993),  a  history  of  infection  or  reactivation  of  virus  had  not  been  considered. 
In  the  present  study,  almost  in  all  patients  and  controls  specific  HHV-6  IgG  antibody  was 
detectable  and  no  significant  difference  between  the  groups  was  observed.  In  contrast, 
the  number  of  sero-positive  samples  to  specific  HHV-6  IgM  antibody,  which  appear  in 
first  step  of  infection  and  reactivation  of  the  virus,  was  significantly  higher  in  recurrent 
aphthous  stomatitis  patients  compared  with  healthy  individuals  (p=0.0076)  (Figure  5.5). 
Specific  HHV-6  IgG  was  detected  in  34  per  cent  of  sera  from  healthy  donors,  while  none 
of  these  samples  were  positive  for  specific  HHV-6  IgM  (Cuende  et  al.  1994).  This  result 
indicates  a  previous  infection  by  HHV-6  but  not  recent  infection  or  reactivation  of  virus 
(Cuende  et  al.  1994).  In  addition,  67  per  cent  of  recurrent  aphthous  stomatitis  patients 
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_,  ,  ýý and  94  per  cent  of  controls  have  been  reported  to  be  IgG  antibody  sero-positive  against 
HHV-6  (Pedersen  and  Hornsleth,  1993).  There  has  been  no  other  investigation  to  show 
IgM  sero-positivity  against  HHV-6  in  recurrent  aphthous  stomatitis. 
In  the  immunoflourescence  assay,  non-specific  positive  reactions  can  occur  in  samples 
from  patients  with  auto-immune  disease  which  show  antinuclear  antibody  reactivity 
(Manufacturer's  instructions).  Hence  the  aetiology  of  recurrent  aphthous  stomatitis 
remains  unclear,  though  viral  or/and  auto-immunity  may  be  involved.  The  results 
obtained  from  the  specific  HHV-6  IgM  by  immunoflourescence  assay  support  the  above 
hypothesis.  Since  there  is  more  clinical  and  laboratory  evidence  to  support  viral 
involvement  (Section  4.1),  HHV-6  is  more  likely  to  be  considered  as  a  possible  cause  of 
the  disease.  These  results  were  supported  by  the  PCR  findings  in  the  previous  chapter. 
In  conclusion,  the  involvement  of  VZV  and  HCMV  was  not  supported  in  this  study 
while  the  antibodies  against  HHV-6  showed  that  this  virus  might  be  a  cause  of  recurrent 
aphthous  stomatitis  by  inducing  autoimmunity  or  causing  immunity  imbalance. 
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197  0 6.1.  Introduction 
There  is  an  enormous  variation  in  the  presenting  signs  and  symptoms  among  patients 
with  recurrent  aphthous  stomatitis.  Some  individuals  are  quite  incapacitated  by  painful, 
severe  oral  ulcers,  while  others  have  such  mild  involvement  that  they  fail  to  seek 
treatment  for  the  disorder.  A  number  of  general  considerations,  regarding  the  problems 
associated  with  investigating  patients  with  recurrent  aphthous  stomatitis  must  be  taken 
into  account.  These  will  be  discussed  in  the  first  instance. 
Despite  the  broad  spectrum  of  disease  severity  seen  among  patients  with  oral  ulceration, 
there  is  no  doubt  that  recurrent  aphthous  stomatitis  exists  as  a  distinct  clinical  entity. 
There  are  no  laboratory  methods  to  identify  the  disease  and  diagnosis  is  based  on  the 
clinical  features  and  exclusion  of  other  diseases  with  similar  oral  manifestations.  It  is 
therefore  difficult  to  determine  whether  the  syndrome  is  one  condition  which  is  clinically 
modified  by  a  variety  of  influences  or  a  group  of  clinically  similar  conditions  with  distinct 
aetiologies.  Certainly  the  clinical  syndrome  of  recurrent  aphthous  stomatitis  maybe 
divided  into  the  major  and  minor  forms  and  herpetiform  ulceration.  Attempts  to  further 
classify  subgroups  of  patients  with  nutritional  deficiencies  as  having  clinically 
distinguishable  "pseudo-aphthae"  (Challacombe  et  al.  1977a)  have  not  gained  support. 
The  relationship  of  recurrent  aphthous  stomatitis  to  Behcet's  syndrome  is  unclear, 
although  an  aetiological  link  has  again  been  hypothesised. 
The  recent  investigations,  on  cross-reactivity  between  human  and  microbial  heat  shock 
proteins  show  that  recurrent  aphthous  stomatitis  and  Behcet's  syndrome  have  different 
patterns  in  cross-reactivity  to  heat  shock  proteins.  For  instance,  in  Behcet's  syndrome, 
198 this  cross-reactivity  is  more  significant  between  four  peptides  of  65  KD  human  heat 
shock  proteins,  whereas  in  recurrent  aphthous  stomatitis  only  peptide  91-105  derived 
from  65  KD  mycobacterial  heat  shock  protein  which  has  not  any  significant  cross- 
reactivity  in  Behcet's  syndrome,  caused  a  significant  lymphoproliferative  response  as  the 
result  of  homology  with  60  KD  mitochondrial  116-130  peptide.  (Hasan  et  al.  1995) 
The  ulceration  seen  in  recurrent  aphthous  stomatitis  is  recognised  as  a  distinct  clinical 
entity  on  the  basis  of  the  shared  end-organ  effect  of  the  disease,  which  is  recurrent, 
idiopathic  and  mucosal  ulceration.  There  is  a  diversity  of  host  or  environmental  factors 
which  may  initiate  the  mucosal  destruction  and  cause  the  disease.  The  point  at  which 
these  should  be  regarded  as  distinct  or  one  disease  process,  however  is  not  sufficiently 
understood.  In  this  thesis,  therefore,  minor  ulcers  have  been  studied  as  in  in  vitro 
experiments.  The  association  of  recurrent  aphthous  stomatitis  with  Behcet's  syndrome  is 
unclear  and  patients  with  the  latter  condition  of  Behcet's  syndrome  were  excluded  from 
experiments. 
The  observation  that  some  women  have  recurrent  aphthae  which  are  related  to 
menstruation,  but  that  the  disease  can  progress  independently  of  such  host  factors  in  the 
male  population,  lends  credence  to  the  idea  that  hormonal  and  other  host  factors  such  as 
haematological  deficiencies  or  psychological  factors  may  not  be  of  central  importance  to 
the  pathogenesis.  However  environmental  factors  may  have  a  uniform  effect  if  host 
susceptibility  could  be  controlled.  As  cited  in  the  introduction  to  this  thesis,  replacement 
of  haematological  deficiencies  is  therapeutic  although  a  universal  effect  can  not  be 
demonstrated. 
199 Furthermore,  recurrent  aphthous  stomatitis  is  almost  unique  in  that  the  disease  is 
characterised  by  rapid  spontaneous  regression  and  healing  of  oral  lesions  indicating  a 
transient  defect  of  host  resistance  to  mucosal  ulceration.  In  addition,  this  makes 
assessment  of  response  to  any  treatment  difficult. 
The  stage  of  the  disease  at  which  the  patient  is  studied  is  also  important.  A  reproducible 
pattern  of  recurrence  is  not  evident  among  the  patients.  Indeed,  the  majority  of 
individuals  can  experience  developing  and  healing  lesions  simultaneously. 
Although,  the  cause  of  recurrent  aphthous  stomatitis  is  not  demonstrable  yet,  generalised 
abnormalities  have  been  shown.  Circulating  levels  of  immunoglobulins  or  immune 
complexes  may  be  altered,  but  this  may  be  an  epiphenomenon  giving  little  information  on 
the  aetiology  of  the  ulceration.  Other  factors,  however,  such  as  cell  surface  antigens  are 
not  tissue-specific  and  may  reveal  a  genetic  susceptibility  to  the  disease  regardless  of  the 
organ  of  origin.  Assessment  of  the  haematological  status  of  an  individual  is  carried  out 
by  examination  of  the  peripheral  blood,  the  assumption  that  circulating  levels  of  these 
elements  reflect  tissue  concentrations  being  well  accepted. 
As  reviewed  in  chapter  one,  there  is  a  wealth  of  evidence  to  suggest  that  immunological 
alterations  are  present  in  patients  with  recurrent  aphthous  stomatitis.  Therefore,  it  seems 
likely  that  activation  or  alteration  of  the  effector  limb  of  the  immune  system  is  important 
in  the  end  stages  of  the  pathogenesis  of  recurrent  aphthous  stomatitis. 
In  addition  to  the  problems  of  selecting  patients  for  study,  there  is  also  the  difficulty  that 
the  patient  population  is  probably  pre-selected  on  the  basis  of  their  attitudes  to  medical 
200 care.  This  can  affect  the  results  obtained  from  prevalence  of  different  sex  and  ages  in 
patient  population. 
This  thesis  has  been  an  attempt  to  explore  the  relevance  of  several  host  and 
environmental  factors  in  the  pathogenesis  of  recurrent  aphthous  stomatitis  with  particular 
emphasis  on  the  viral  aetiology.  Also,  an  attempt  has  been  made  to  find  a  clinically  safe 
and  effective  medication  to  relieve  the  symptoms  of  the  disease.  A  number  of  both 
clinical  and  laboratory  studies  were  conducted  on  over  465  patients  with  the  history  of 
recurrent  aphthous  stomatitis.  This  chapter  was  aimed  at  further  discussion  of  those 
findings  which  were  presented  and  discussed  in  chapters  two  to  five. 
6.2.  Clinical  and  Epidemiological  Findings 
Epidemiological  data  amassed  from  patients  reveal  similarities  in  the  clinical  presentation 
between  the  two  groups  of  252  and  213  patients  with  recurrent  aphthous  stomatitis.  The 
prevalence  of  the  disease  in  the  present  study  (Chapter  2)  was  increased  in  the  third  and 
fourth  decades  of  life  (Figure  2.3).  However  in  the  review  of  the  literature  (chapter  one) 
this  prevalence  has  been  reported  to  increase  in  the  second  and  third  decade  of  life.  Such 
dissimilarities  may  be  due  to  differences  in  patient  populations,  or  due  to  diverse  host  or 
environmental  factors.  Despite  many  reports  indicating  an  increased  susceptibility  of 
females  to  recurrent  aphthous  stomatitis  compared  to  males  (Sircus  et  al.  1957;  Farmer, 
1958;  Brody  and  Silverman,  1969;  Donatsky,  1973),  such  a  difference  was  not  observed 
in  the  present  study.  The  number  of  female  patients  in  general  who  attended  the  Oral 
Medicine  Clinic  for  any  treatment  is  higher  than  males.  As  a  result  the  sex  difference 
between  male  and  female  patients  with  recurrent  aphthous  stomatitis  might  be  a 
reflection  of  this  general  trend  rather  than  a  female  preponderance  in  aphthae  sufferers. 
201 The  prevalence  of  the  subgroup  of  minor  recurrent  aphthous  stomatitis  was  higher  than 
other  reports  which  reviewed  in  chapter  one. 
Almost  all  recurrent  aphthous  stomatitis  patients  were  non-smokers  and  not  smokeless 
tobacco  users.  This  result  shows  that  nicotine  and  cigarettes  may  have  some  preventative 
or  therapeutic  effect  in  recurrent  aphthous  stomatitis.  A  preliminary  trial  on  recurrent 
aphthous  stomatitis  patients  with  nicorette  chewing  tablets  has  supported  this  hypothesis 
(Bittoun,  1991).  Nicotine  might  have  an  anti-oestrogen  effect  (Baron,  1996).  Also 
cigarette  smoking  has  been  reported  to  affect  several  elements  of  immune  function, 
including  those  of  T-cell  function  and  antibody  responses  (Baron,  1996).  Despite  all  the 
investigations  on  the  effect  of  smoking  on  the  immune  system,  little  has  been  discovered 
about  the  preventative  or  therapeutic  effects  of  smoking  in  diseases  like  recurrent 
aphthous  stomatitis. 
Haematological  screening  was  carried  out  on  the  first  group  of  252  patients  and  the 
second  group  of  213  patients.  In  the  first  group  33.33  per  cent  and  in  the  second  group 
31.91  per  cent  of  the  patients  had  some  haematological  deficiencies  (Table  2.6).  This 
prevalence  of  haematological  deficiencies  has  increased  in  the  Glasgow  population  since 
1975  (Wray  et  al.  1975;  Miller  et  al.  1994).  This  increase  may  be  due  to  the  change  of 
diet  or  the  higher  number  of  females  in  the  study  populations.  Also,  different  criteria 
applied  in  the  study  may  have  caused  these  changes.  It  should  also  be  considered  that 
folic  acid  deficiency  has  almost  disappeared  in  recurrent  aphthous  stomatitis  patients  in 
recent  investigations  (Miller  et  al.  1994).  Indeed,  many  of  the  deficiencies  were 
themselves  latent,  that  is,  they  had  produced  no  recognisable  abnormalities  in  the 
peripheral  blood  screening  alone.  Therefore,  a  full  blood  count  would  be  insufficient  to 
202 detect  an  underlying  abnormality  in  these  patients.  In  the  first  group  of  252  patients,  69 
had  a  low  level  of  ferritin  (Table  2.6).  Overt  deficiency  with  a  low  level  of  haemoglobin, 
MCV  or  both  of  them  was  observed  in  26  patients.  The  remaining  43  patients  had  latent 
iron  deficiency.  Deficiency  of  vitamin  B12  has  not  been  generally  recognised  as  a  cause  of 
recurrent  aphthae,  though  isolated  cases  have  been  reported  (Hjorting-Hansen  and 
Bertram,  1968;  Walker,  1973;  Porter  et  al.  1988;  Palopoli  and  Waxman,  1990).  In  the 
first  group  of  252  patients,  vitamin  B12  deficiency  was  diagnosed  in  15  subjects.  Three  of 
these  patients  had  at  least  one  of  the  anti-parietal  cell  or  anti-intrinsic  factor  antibodies 
present  in  their  serum  (Table  2.7).  Patients  with  vitamin  B12  deficiency  with  no  obvious 
clinical  explanation  were  referred  to  a  haematologist  for  more  investigations  and  further 
management.  In  these  15  patients  with  vitamin  B12  deficiency,  13  had  latent  vitamin  B12 
deficiency  which  by  full  blood  count  alone  would  not  be  identified.  Folic  acid  deficiency 
as  a  cause  of  recurrent  aphthous  stomatitis  is  also  not  generally  accepted,  though  several 
cases  of  folic  acid  deficiency  with  oral  ulceration  have  been  reported  (Hutcheon  et  al. 
1978;  Tyldesley,  1981).  No  patient  with  folic  acid  deficiency  was  diagnosed  in  this 
group.  These  results  supported  the  notion  that  with  the  change  of  diet  to  consuming 
more  green  vegetable,  folic  acid  deficiency  would  almost  disappear  in  the  population 
(Miller  et  al.  1994).  To  investigate  the  effect  of  these  changes  on  prevalence  of  coeliac 
disease  in  patients  with  aphthae,  venous  blood  of  66  patients  in  the  first  group  were 
tested  to  detect  IgA  anti-gliadin  antibodies  in  recurrent  aphthous  stomatitis  patients.  In 
seven  patients,  IgA  anti-gliadin  antibody  was  present,  but  anti-endomysial  antibody, 
which  is  a  diagnostic  test  for  coeliac  disease,  was  negative  in  all  cases.  The  presence  of 
anti-gliadin  antibody  in  the  sera  from  some  of  the  recurrent  aphthous  stomatitis  patients 
203 with  a  normal  diet  could  be  explained  as  latent  coeliac  disease  (O'mahony  et  al.  1990). 
Also  significant  raised  levels  of  IgG  antibody  to  gliadin  in  the  sera  from  patients  with 
ulcerative  colitis  and  Crohn's  disease  has  been  reported  (Williams  et  al.  1996). 
In  the  second  group  with  213  patients  with  a  history  of  recurrent  aphthous  stomatitis 
who  attended  the  Oral  Medicine  Clinic  in  the  period  of  April  1993  to  April  1994, 
haematological  deficiencies  had  almost  the  same  pattern  as  first  group  (Table  2.5).  In 
addition,  90  patients  with  normal  oral  mucosa  were  also  investigated  as  a  control  group. 
Folic  acid,  vitamin  B12  and  ferritin  deficiencies  were  diagnosed  in  68  (32  per  cent)  of 
recurrent  aphthous  stomatitis  patients  and  40  (44  per  cent)  of  controls.  The  increased 
prevalence  of  haematological  deficiencies  in  the  control  group  compared  to  the  recurrent 
aphthous  stomatitis  group  was  perhaps  due  to  the  high  number  of  females  (83  per  cent): 
female  patients  in  the  recurrent  aphthous  stomatitis  group  represented  68  per  cent. 
However,  there  was  no  significant  difference  between  recurrent  aphthous  stomatitis  and 
control  subjects  in  the  prevalence  of  haematological  deficiencies.  These  data  show  that 
haematological  deficiencies  is  not  a  prevalent  factor  in  causing  recurrent  aphthae.  After 
the  haematological  deficiencies  were  diagnosed,  patients  underwent  replacement  therapy. 
During  the  follow-up  period,  41  per  cent  of  the  patients  had  some  improvement  in  their 
ulceration. 
The  precise  role  of  iron,  vitamin  B12  or  folic  acid  deficiencies  in  the  pathogenesis  of 
recurrent  aphthous  stomatitis  remained  speculative,  although  malnutrition  can  interfere 
with  any  of  the  mechanisms  that  act  as  barriers  to  the  progress  of  micro-organisms 
throughout  the  body.  If  viruses  were  a  cause  of  recurrent  aphthous  stomatitis,  nutritional 
deficiencies  could  depress  the  cell  mediated  immune  response  and  thus  cause  an  increase 
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For  instance,  conjunctivitis  can  progress  to  cause  severe  eye  damage  and  blindness, 
especially  if  there  is  associated  vitamin  A  deficiency  (Mims  and  White,  1984).  The  small 
ulcers  of  the  mouth  that  constitute  Koplik's  spots  in  normally  nourished  children,  can 
enlarge  to  form  massive  ulcers  or  necrosis  of  the  mouth  (cancrum  oris)  (Mims  and 
White,  1984). 
There  have  been  a  few  experimental  investigations  of  the  impact  of  malnutrition  on  viral 
infections.  In  one  experiment  on  mice  which  from  the  age  of  three  weeks  had  received 
only  one-quarter  of  the  food  intake  necessary  for  normal  growth,  they  developed  marked 
atrophy  of  the  lymphoid  tissues  and  were  then  much  more  susceptible  than  normal  mice 
to  coxackievirus  B3  infection.  These  observations  showed  that  an  inadequate  host 
immune  response  to  infection  was  caused  by  malnutrition  (Mims  and  White,  1984).  Also, 
defects  of  cell  mediated  immunity  have  been  reported  in  iron  deficient  patients  (Joynson 
et  al.  1972).  The  oral  ulceration  which  occurs  with  folic  acid  antagonist  drugs  such  as 
methotrexate  is  also  well  recognised  and  responds  to  topical  folinic  acid.  Dreizen  et  al 
(1970)  induced  oral  ulceration  in  marmosets  by  feeding  them  a  diet  free  of  folic  acid. 
However,  in  the  present  study,  replacement  of  iron,  folic  acid  or  vitamin  B12  did  not 
completely  resolve  the  ulceration  in  most  of  the  patients. 
In  the  present  study,  the  prevalence  of  allergic  reactions  to  food  additives  were  not 
different  between  recurrent  aphthous  stomatitis  and  control  subjects.  Thus  allergy  seems 
to  play  a  minor  role  in  those  recurrent  aphthous  stomatitis  patients  with  a  positive 
allergic  reaction.  In  a  study  by  Wray  et  al  (1982),  60  recurrent  aphthous  stomatitis 
patients  were  screened  clinically  for  a  history  of  allergies  and  their  leucocytes  tested  in 
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had  a  history  of  clinical  allergy  to  environmental  antigens  and  this  was  confirmed  by  a 
histamine  release  assay.  In  18  patients,  an  ability  of  foods  to  induce  ulceration  was  found. 
However  in  eight  of  the  patients  this  was  correlated  with  the  histamine  release  assay 
(Wray  et  al.  1982).  Also  dietary  manipulation  could  not  eliminate  the  ulceration  in  any  of 
the  patients  (Wray  et  al.  1982).  As  a  result,  it  was  concluded  that,  although  foods  can 
cause  oral  lesions,  probably  through  an  IgE-mediated  mechanism,  there  may  be  other 
contributing  factors  and  patients  with  in  vitro  reactivity  to  foods  who  did  not  develop 
oral  lesions,  may  lack  other  factors  or  may  have  protective  mechanisms  such  as  blocking 
antibodies  (Wray  et  al.  1982). 
Despite  reports  supporting  a  possible  relationship  between  food  sensitivity  and  recurrent 
aphthous  stomatitis  (Wright  et  at.  1986;  Nolan  et  al.  1991a),  in  the  present  study,  such 
relationship  seems  only  a  minor  factor  in  causing  aphthous  lesions. 
The  oral  mucosa  is  influenced  directly  by  oestrogen  in  a  fashion  similar  to  vaginal 
epithelium  (Ferguson,  1975).  Oestrogen  and  progesterone  also  affect  vascular 
permeability  and  the  inflammatory  response  (Lindhe  et  al.  1968;  Lindhe  and  Branemark, 
1968).  Sex  hormones  can  influence  the  immune  system  and  cause  a  higher  frequency  of 
autoimmunity  in  females  (MacPhail  et  al.  1993).  Oestrogen  can  increase  antibody 
production  by  inhibiting  T-suppresser  (CD8+  cells)  activity,  while  progesterone  increases 
T-suppresser  function  (MacPhail  et  al.  1993).  T-suppresser  cells  play  an  important  role 
in  the  regulation  of  the  immune  response  to  antigens,  by  turning  off  the  positive  effector 
T  cells  after  they  have  completed  their  function  and  are  no  longer  needed  (Mims  and 
White,  1984).  In  some  viral  infections,  T-suppresser  cells  increase  due  to  the  infection 
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oestrogen  and  a  viral  infection,  may  lead  to  damage  of  the  host  cells  and  induce  an 
autoimmune-like  disease.  However,  if  the  virus  is  present  in  the  oral  cavity,  according  to 
this  hypothesis,  it  might  induce  oral  epithelial  damage  and  cause  diseases  such  as 
recurrent  aphthous  stomatitis.  Cyclical  changes  of  the  sex  hormones  and  latency  of  some 
viruses  in  the  oral  cavity  such  as  herpesvirus  may  explain  the  recurrent  nature  of  the 
disease.  Since,  recurrent  aphthous  stomatitis  is  not  related  to  the  menstrual  cycle  in  all 
female  patients  and  the  sex  difference  is  not  significant  in  recurrent  aphthous  stomatitis 
patients,  this  hypothesis  cannot  be  accepted  in  all  cases. 
The  results  presented  in  this  thesis  have  a  bearing  on  the  management  of  patients  with 
recurrent  aphthous  stomatitis.  Thus  41  per  cent  of  patients  with  haematological 
deficiencies  responded  to  replacement  therapy.  This  therapeutic  effect  indicates  the 
relevance  of  these  blood  disorders  regardless  of  their  aetiology.  As  discussed  previously, 
it  was  not  possible  to  distinguish  those  individuals  with  deficiencies  without  resort  to 
haematological  investigation. 
The  majority  of  patients  will  not  adequately  benefit  from  preventive  measures  such  as 
replacement  of  iron,  vitamin  B12  or  folic  acid.  These  patients  must  unfortunately  rely  on 
local  symptomatic  therapy.  In  the  observations  described  in  this  thesis,  patients  were 
maintained  on  topical  corticosteroids  (paste,  mouthwash  or  spray)  and  this  regime  was 
supplemented  with  local  anaesthetics  and  antiseptic  mouthwashes  (Table  2.9).  Only  a 
minority  of  patients  were  ultimately  given  intermittent  systemic  corticosteroids  because 
of  the  severity  of  the  disease.  As  no  patients  are  cured  by  symptomatic  therapy,  this 
group  continues  to  illustrate  the  symptoms  of  the  disease  until  spontaneous  remission  or 
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are  presumably  still  predisposed  to  oral  ulceration  which  could  recur  under  appropriate 
environmental  or  endogenous  conditions.  This  is  consistent  with  the  findings  previously 
discussed,  that  the  incidence  of  recurrent  aphthous  stomatitis  was  increased  in  individuals 
with  positive  family  history  (Miller  et  al.  1980).  In  addition  there  are  several  reports 
indicating  an  association  of  recurrent  aphthous  stomatitis  with  the  HLA  type  A2,  B12  and 
DR7  (Challacombe  et  al.  1977b;  Lehner  et  al.  1979a;  Gallina  et  al.  1985).  This  could  not 
be  confirmed  by  another  study  (Dolby  et  al.  1977).  The  HLA  histocompatibility  locus 
can  be  associated  with  different  diseases  such  as  autoimmune  diseases  or  disease  with 
unknown  aetiology.  However  until  now,  no  certain  role  of  HLA  has  been  identified  in 
the  development  of  autoimmunity  and  related  diseases  (Ollier  and  Symmons,  1992).  One 
of  the  hypotheses  for  HLA  disease  associations  is  that  the  cell  surface  HLA  molecule 
could  act  as  a  receptor  for  a  specific  virus  and  provide  a  way  for  it  to  infect  the  cell.  It 
makes  individuals  carrying  one  particular  gene  susceptible  to  disease.  Since  the 
association  of  the  HLA  histocompatibility  locus  with  viral  disease  has  been  reported 
(Russell  and  Schlaut,  1977),  diseases  with  autoimmune  or  unknown  aetiology  origin  such 
as  recurrent  aphthous  stomatitis  which  are  related  to  HLA  antigens  may  have  a  viral 
cause.  Thus,  although  a  role  for  genetically  determined  cell-surface  antigens  in  the 
immunopathogenesis  of  recurrent  aphthous  stomatitis  has  been  ,  suggested,  the 
mechanisms  involved  still  remain  undefined. 
6.3.  Effect  of  5  Amino-Salicylate 
A  randomised  double-blind  cross-over  study  was  conducted  into  the  effect  of  5  amino- 
salicylate  as  part  of  the  investigation  of  patients  seen  in  the  Oral  Medicine  Clinic. 
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selected  patients  with  recurrent  aphthous  stomatitis  (Collier  et  al.  1992)  and  one  patient 
with  Behcet's  syndrome  (Ranzi  et  al.  1986).  However  this  effect  was  not  shown  by 
another  study  (Bagg,  1985).  In  the  present  study  no  significant  effect  was  seen  by 
analysing  the  data  obtained  from  patients'  diary  cards  (Figure  3.3).  However  a  general 
improvement  was  noticed  during  the  course  of  the  treatment  regardless  of  the  effect  of 
the  active  or  placebo  cream.  As  a  result,  the  data  was  studied  by  dividing  the  patients  in 
two  groups.  This  time,  the  study  was  analysed  as  a  double-blind  trial.  Although,  there 
was  no  significant  different  between  the  two  groups  with  respect  to  the  patients'  diary 
card,  the  effect  of  5  amino-salicylate  cream  was  seen  in  the  patients'  self  reports  (Figure 
3.4).  This  time  a  higher  number  of  patients  preferred  the  active  cream  to  placebo, 
because  of  the  positive  effect  of  the  5  amino-salicylate  in  decreasing  the  pain  compared 
with  placebo.  Regardless  the  results  show  that  5  amino-salicylate  has  little  effect  on  relief 
of  the  symptoms  in  recurrent  aphthous  stomatitis.  They  may  prove  however  that  a 
double-blind  trial  with  cross-over  may  not  be  the  appropriate  way  to  investigate  the 
effect  of  drugs  in  recurrent  aphthous  stomatitis.  The  reason  is  that  the  process  of  the 
disease  is  not  predictable  in  different  individuals  and  in  the  second  period  of  the  trial  the 
severity  of  the  condition  may  be  totally  different  for  reasons  other  than  the  effects  of  the 
medication.  This  trial  also  highlights,  the  problems  encountered  in  trying  to  objectively 
assess  patient  responses.  These  results  indicate  that,  although  patient  and  investigator 
assessment  of  the  number  and  size  of  ulcers  correlates  well  (Graykowski  and  Kingman, 
1978),  it  may  be  necessary  to  assess  patients  subjectively  for  these  parameters  during  the 
trial.  Such  a  protocol  would  eliminate  patient  subjectively  and  allow  easier  collection  of 
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the  patients  noticed  subjective  pain  reduction  on  any  medication  emphasises  the  limits  of 
this  parameter  in  open  trials. 
6.3.  In  Vitro  Investigations 
Since  it  has  been  accepted  that  viral  or  microbial  involvement  as  a  first  event  may  cause 
autoimmune-like  disease,  the  hypothesis  of  involvement  of  autoimmunity  in  several 
diseases  can  be  no  longer  accepted  (Oilier  and  Symmons,  1992).  As  viruses  are  the 
strongest  candidates  for  inducing  autoimmune  diseases  (Oilier  and  Symmons,  1992),  the 
immune  changes  in  recurrent  aphthous  stomatitis  patients  reviewed  previously,  could  be 
a  secondary  phenomenon  to  a  viral  involvement  in  recurrent  aphthous  stomatitis. 
Autoimmune  diseases  are  more  prevalent  in  females  and  increase  with  advancing  age 
(Oilier  and  Symmons,  1992;  Pedersen,  1993),  whereas  the  prevalence  of  recurrent 
aphthous  stomatitis  is  increased  in  the  third  decade  of  life  and  the  first  appearance  of 
recurrent  aphthous  stomatitis  is  mainly  in  the  first  and  second  decade  of  life  (Farmer, 
1958;  Brody  and  Silverman,  1969;  Donatsky,  1973).  Observations  in  this  thesis  also 
show  that  the  disease  is  more  predominant  in  the  fourth  decade  of  life  And  there  is  no 
significant  difference  between  male  and  female  in  involvement  of  the  disease.  The  clinical 
features  of  recurrent  aphthous  stomatitis  also,  are  very  similar  to  those  seen  in  latent  viral 
infections  such  as  herpes  simplex  virus  and  for  both  diseases,  recurrent  herpes  labialis 
and  recurrent  aphthous  stomatitis,  an  HLA  background  has  been  postulated 
(Challacombe  et  al.  1977b;  Russell  and  Schlaut,  1977;  Lehner  et  al.  1979a). 
210 
-4  .--  "I--  I-  llý  --,,  I By  immunofluorescent  and  immunohistochemistry  methods,  as  has  been  reviewed  before, 
the  level  of  serum  IgG  and  IgM  was  significantly  increased  in  recurrent  aphthous 
stomatitis  patients  compared  with  controls  (Sun  et  al.  1986).  The  level  of  IgG  subclasses 
has  been  reported  to  be  normal  in  most  patients.  However  8.4  per  cent  of  recurrent 
aphthous  stomatitis  patients  had  marginally  raised  IgG1  levels  and  1.4  per  cent  a 
significantly  low  level  of  IgG3  (Porter  et  al.  1992).  Most  of  the  antiviral  IgG  is  of  the 
IgG3  subclass,  while  IgGi  responses  are  also  particularly  raised  in  herpesvirus  infections 
(Scully  and  Samaranayake,  1992).  Marginal  raised  IgGI  levels  in  recurrent  aphthous 
stomatitis  patients  also  might  be  due  to  a  herpesvirus  infection. 
It  has  been  reported  that  in  recurrent  aphthous  stomatitis  lesions,  the  percentage  of  T 
cells  with  CD8+  receptors  (T  suppressor)  was  increased  and  as  a  result  the  CD4+/CD8+ 
cell  ratio  is  decreased  (Kayavis  et  al.  1987;  Savage  et  al.  1988;  Pedersen  et  al.  1989). 
Also,  in  the  peripheral  blood  of  recurrent  aphthous  stomatitis  patients,  the  number  of  T- 
helper/inducer  cells  (Cdw29)  was  increased  and  the  number  of  T-suppressor/inducer  cells 
(CD45R)  decreased  during  both  remission  and  the  early  stage  of  ulceration  (Savage  et  at. 
1988;  Landesberg  et  at.  1990).  The  CD4/CD8+  ratio  usually  increases  in  autoimmune 
diseases  such  as  multiple  sclerosis,  autoimmune  hemolytic  anaemia  and  erythema 
nodosum  (Bach  and  Bach,  1981).  This  increase  seems  to  be  the  effect  of  decrease  in 
CD8+  T-lymphocytes  (Raeman  et  at.  1981).  T-lymphocyte  counts  in  patients  with  an 
early  stage  of  HIV  infection  showed  a  strong  relationship  between  an  increased  number 
of  CD8+  cells  and  development  of  intra-oral  lesions  (Melnic  et  at.  1991).  Changes  in 
CD4+  cells  were  not  found  to  be  related  to  the  presence  of  oral  lesions  (Melnic  et  at. 
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decreased  due  to  a  marked  increase  in  the  CD8+  T-cell  subset  (Roizman  et  al.  1993). 
The  comparison  between  the  CD4+/CD8+  cells  ratio  and  changes  in  T-lymphocyte 
subclasses  explained  above,  show  that  changes  in  T-cell  subclasses  in  recurrent  aphthous 
stomatitis  are  more  similar  to  those  in  viral  diseases  than  autoimmune  diseases. 
The  virus-carrier  lymphocyte  was  identified  in  the  sera  from  patients  using  an 
immunofluorescent-antibody  test  (Nasz  et  al.  1971).  In  this  study  antigens  of  adenovirus 
type  I  and  herpesvirus  caused  blastogenic  transformation  in  a  significant  proportion  of 
lymphocytes  from  the  blood  of  aphthous  patients  (Nasz  et  al.  1971). 
Antibody  levels  against  herpes  simplex  virus  are  not  raised  in  sera  from  recurrent 
aphthous  stomatitis  patients,  also  such  patients  do  not  have  positive  skin  tests  to  herpes 
virus  (Stark  et  al.  1954;  Sircus  et  al.  1957;  Sallay  et  al.  1973).  Herpes  simplex  virus  has 
not  been  isolated  from  any  lesion  of  recurrent  aphthous  stomatitis  (Sallay  et  al.  1973).  In 
more  recent  studies,  part  of  the  genum  of  herpes  simplex  virus  was  identified  in 
peripheral  blood  mononuclear  cells  of  recurrent  aphthous  stomatitis  patients  by  applying 
PCR  and  in  situ  hybridisation  (Eglin  et  al.  1982;  Studd  et  al.  1991).  These  data  did  not 
encourage  another  investigation  to  find  involvement  of  herpes  simplex  virus  in  recurrent 
aphthous  stomatitis. 
In  the  present  study,  there  were  no  significant  differences  in  levels  of  IgG  antibodies 
against  HCMV,  VZV  and  HHV-6.  The  specific  VZV  IgG  antibody  was  positive  in  all 
patients  and  controls.  Also  specific  HHV-6  IgG  was  positive  in  almost  all  patients  and 
controls.  IgG  against  HCMV  was  also  positive  in  36  per  cent  of  recurrent  aphthous 
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specific  IgM  antibody  was  negative  against  VZV,  IgM  antibody  against  HCMV  was  not 
significantly  different  between  patients  and  controls.  But,  on  the  other  hand,  the 
prevalence  of  positivity  of  IgM  antibody  against  HHV-6  was  significantly  different 
between  sera  from  recurrent  aphthous  stomatitis  patients  and  control  subjects  without  a 
history  of  recurrent  aphthous  stomatitis.  These  findings  were  similar  to  those  from  the 
PCR  investigations.  Biopsy  samples  used  in  the  PCR  tests  were  obtained  from  54 
patients  whose  blood  was  removed  for  serological  investigations.  Biopsy  and  blood 
samples  were  obtained  at  the  same  visit  from  patients  and  controls. 
In  the  PCR  investigations  VZV  DNA  was  not  detected  in  any  of  the  biopsy  samples. 
HCMV  DNA  was  identified  only  in  two  biopsy  samples  (10  per  cent)  of  oral  lichen 
planus  patients  and  in  none  of  the  recurrent  aphthous  stomatitis  or  control  subjects. 
However,  HHV-6  DNA  was  found  in  four  biopsies  (20  per  cent)  of  oral  lichen  planus 
and  six  samples  (29  per  cent)  of  recurrent  aphthous  stomatitis  patients.  In  none  of  the 
controls  was  HHV-6  DNA  detected.  Although  the  difference  in  detection  of  HHV-6 
DNA  between  recurrent  aphthous  stomatitis  and  non-aphthous  control  subjects  was  not 
statistically  different  (p=0.08).  This  difference  could  show  possible  involvement  of  HHV- 
6  in  recurrent  aphthous  stomatitis.  This  hypothesis  was  supported  by  data  obtained  from 
the  immunofluorescent  assay,  showing  a  significant  difference  in  IgM  antibody  against 
HHV-6  between  recurrent  aphthous  stomatitis  and  control  subjects  (p=0.0076). 
However  it  should  be  considered  that  the  number  of  control  subjects  in  the  serological 
study  was  higher  than  in  the  PCR  investigation.  The  difference  in  the  PCR  result  might 
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aphthous  control  subjects. 
Increased  specific  HCMV  IgG  was  identified  in  recurrent  aphthous  stomatitis  patients 
compared  with  controls  especially  in  the  remission  period  of  the  disease  (Pedersen  and 
Hornsleth,  1993;  Sun  et  at.  1996).  Also  by  applying  the  PCR  method,  HCMV  DNA  was 
recovered  in  oral  lesion  specimens  of  two  out  of  four  patients  with  Behcet's  syndrome 
and  three  out  of  nine  patients  with  recurrent  aphthous  stomatitis  (Sun  et  al.  1996).  Using 
in  situ  hybridisation,  HCMV  DNA  was  found  in  three  of  29  oral  mucosal  ulcers  but  not 
in  any  recurrent  aphthous  stomatitis  biopsies  (Sun  et  al.  1996).  Our  study  did  not  find 
any  significant  difference  in  positivity  to  antibodies  against  HCMV.  Also  no  HCMV 
DNA  was  identified  in  recurrent  aphthous  stomatitis  samples.  However  in  two  of  the  20 
biopsies  from  oral  lichen  planus  subjects,  HCMV  was  identified.  This  supports  the 
previous  findings  by  in  situ  hybridisation  (Leimol-Virtanen  et  al.  1995). 
The  increased  antibody  levels  against  VZV,  especially  IgM  has  also  been  reported  in 
recurrent  aphthous  stomatitis  patients  compared  with  control  subjects  (Pedersen,  1989b; 
Pedersen  and  Hornsleth,  1993).  In  addition,  VZV  DNA  has  been  detected  in  all  biopsies 
from  22  recurrent  aphthous  stomatitis  patients  (Pedersen  et  al.  1993),  but  an  unusual 
finding  of  this  study  was  that  VZV  DNA  was  only  amplifiable  using  one  set  of  primers 
tested,  which  targeted  the  protein  kinase  66  (PK66).  Two  other  primer  sets,  one 
targeting  another  region  of  the  VZV  PK66  gene  and  the  other  targeting  the  VZV 
thymidine  kinase  gene,  gave  negative  PCR  results.  Whilst  the  authors  offered  no 
explanation  for  this  discrepancy,  their  results  are  not  supported  with  the  findings  of  the 
present  study,  in  which  using  two  rounds  of  PCR  with  nested  primers  it  was  not  possible 
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11-1-1-  -  I-  --  .  .1--  .1---,  '  III  it, to  identify  VZV  DNA  in  any  of  the  samples  which  were  examined.  These  findings  by 
PCR  support  the  presented  serological  features  where  no  specific  IgM  antibody  against 
VZV  was  found  in  any  of  the  serum  samples.  The  serological  findings  indicate  that  there 
has  been  no  infection  or  reactivation  of  the  VZV  in  any  of  the  subjects  whose  blood  was 
tested. 
In  the  literature  pertaining  to  recurrent  aphthous  stomatitis,  there  is  only  one 
investigation  on  antibodies  against  HHV-6  (Pedersen  and  Hornsleth,  1993).  In  this  study 
IgG  antibody  was  tested  and  there  was  no  significant  difference  in  antibody  levels  in 
recurrent  aphthous  stomatitis  patients  compared  with  controls  (Pedersen  and  Hornsleth, 
1993).  In  the  present  study,  in  96.7  per  cent  of  all  serum  samples,  specific  HHV-6  IgG 
antibody  was  detected.  There  was  no  significant  difference  between  recurrent  aphthous 
stomatitis  patients  and  controls.  These  findings  support  previous  results  on  the  high 
prevalence  of  specific  antibodies  against  HHV-6  in  different  populations  (Knowles  and 
Gardner,  1988;  Briggs  et  al.  1988;  Levy  et  al.  1990;  Pedersen  and  Hornsleth,  1993).  In 
this  thesis,  PCR  detected  HHV-6  DNA  in  six  of  21  (29  per  cent)  recurrent  aphthous 
stomatitis  biopsies.  Also  specific  HHV-6  IgM  was  found  in  21  of  22  (95.5  per  cent)  sera 
from  recurrent  aphthous  stomatitis  patients.  This  finding  was  significantly  different  from 
control  subjects.  This  is  the  first  study  to  investigate  the  possible  involvement  of  HHV-6 
in  recurrent  aphthous  stomatitis  by  applying  PCR  to  aphthous  lesions  and  sera  from 
recurrent  aphthous  stomatitis  patients  to  detect  HHV-6  DNA  and  specific  HHV-6  IgM. 
All  patients  in  whom  HHV-6  DNA  was  present  in  their  aphthous  lesions,  specific  HHV-6 
IgM  was  also  detected  in  their  sera.  However  in  the  other  15  patients  with  positive  IgM 
antibody,  PCR  did  not  detect  any  HHV-6  DNA  in  their  aphthous  ulcers.  The  presence  of 
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L HHV-6  DNA  has  been  identified  in  peripheral  blood  monocytes  and  saliva  samples  of 
healthy  individuals  (Jarrett  et  al.  1990;  Kido  et  al.  1990;  Cone  et  al.  1993;  Cuende  et  al. 
1994),  although  IgM  antibody  against  HHV-6  was  not  present  in  any  of  the  subjects 
(Cuende  et  al.  1994).  In  this  study,  HHV-6  DNA  was  detected  in  peripheral  monocytes 
of  eight  of  20  individuals  when  one  microgram  of  DNA  was  amplified,  but  when  the 
amount  of  DNA  was  increased  to  five  micro-gram,  in  18  of  20  individuals  HHV-6  DNA 
was  present  (Cuende  et  al.  1994).  The  authors  suggested  that  HHV-6  is  present  in  a  high 
proportion  of  the  healthy  population  but  in  minimal  amounts  (Cuende  et  al.  1994). 
Detectable  HHV-6  DNA  in  some  individuals  seronegative  to  the  virus  also  has  been 
reported  (Cone  et  al.  1993). 
In  the  present  study,  saliva  samples  and  peripheral  blood  cells  were  not  tested  to  find  the 
presence  of  the  virus  in  recurrent  aphthous  stomatitis  and  control  subjects.  It  is  possible 
that  the  higher  number  of  recurrent  aphthous  stomatitis  patients  with  positive  IgM 
against  HHV-6  is  either  due  to  the  presence  of  the  viral  DNA  in  saliva  or  peripheral 
blood  monocytes  in  larger  amount  than  healthy  individuals  as  the  result  of  reactivation  of 
the  virus  or  alternatively  PCR  could  not  detect  viral  DNA  in  some  of  the  biopsy  samples 
because  of  the  small  amount  of  DNA  extracted  from  biopsies.  The  biopsy  samples  from 
recurrent  aphthous  stomatitis  patients  were  generally  smaller  than  those  from  lichen 
planus  and  normal  individuals.  In  one  study,  HHV-6  was  found  in  63  per  cent  of  salivary 
gland  biopsies,  three  per  cent  of  saliva  samples  from  healthy  individuals  and  in  17  per 
cent  of  saliva  samples  from  patients  with  a  history  of  recurrent  aphthous  stomatitis  (Di 
Luca  et  al.  1995).  In  this  study  PCR  did  not  detect  significant  differences  in  the  presence 
of  HHV-6  and  its  viral  load  between  saliva  from  recurrent  aphthous  stomatitis  patients 
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L and  from  healthy  subjects.  However,  it  is  not  clear  that  saliva  samples  were  collected 
during  the  active  ulceration  or  the  remission  period.  If  the  samples  were  collected  during 
the  remission  period  of  the  disease,  then  it  cannot  be  concluded  that  reactivation  of  the 
virus  does  not  play  a  role  in  the  aetiology  of  recurrent  aphthous  stomatitis. 
The  question  of  contamination  of  samples  during  biopsy  causing  false  positive  results  in 
the  PCR  findings  has  been  discussed  in  section  4.5.  In  addition,  the  significant  difference 
in  IgM  antibody  against  HHV-6  between  recurrent  aphthous  stomatitis  and  normal 
subjects  support  the  PCR  results. 
The  reported  benefit  of  antiviral  drugs  in  recurrent  aphthous  stomatitis  could  also 
support  the  involvement  of  viruses  in  aetiology  of  this  disease.  Although  the  effect  of 
oral  aciclovir  has  been  denied  in  one  report  (Wormser  et  al.  1988),  a  high  dose  of  oral 
aciclovir  was  found  to  be  effective  in  other  clinical  trials  (Pedersen,  1992;  Ozturkcan  et 
al.  1996).  Although  in  these  reports  (Pedersen,  1992;  Ozturkcan  et  al.  1996),  the  effect 
of  high  dose  aciclovir  was  assumed  to  support  the  recent  findings  of  involvement  of 
VZV  in  recurrent  aphthous  stomatitis  (Pedersen,  1989b;  Pedersen  et  al.  1993;  Pedersen 
and  Hornsleth,  1993),  the  data  presented  in  this  thesis  are  not  in  agreement  with  those 
studies.  The  homology  between  HHV-6  and  HCMV  (Wahren  and  Linde,  1991;  Chou 
and  Marousek,  1992)  suggests  that  this  virus  is  likely  to  be  inhibited  by  ganciclovir  and 
foscarnet  (Bums  and  Sandford,  1990;  MacPhail  et  al.  1993).  But  the  high  dose  of  25  to 
50  pM  aciclocir  (in  vitro)  was  found  to  cause  four  and  eight  fold  reductions  in  DNA 
synthesis  respectively  (Bums  and  Sandford,  1990).  Given  this,  the  effect  of  high  dose 
aciclovir  in  improving  the  symptoms  of  recurrent  aphthous  stomatitis  may  indicate  the 
217 involvement  of  a  virus  less  sensitive  to  aciclocir  such  as  HHV-6  in  recurrent  aphthous 
stomatitis. 
The  isolation  of  HHV-6  has  been  successful  from  CD4+  CD8-  and  CD3+  CD4+  cells 
which  suggests  that  cells  with  the  CD4+  surface  marker  are  involved  in  the  primary 
infection  (Wahren  and  Linde,  1991).  Most  cells  infected  in  vitro  carry  the  CD4  cell 
surface  antigens,  which  have  been  suggested  as  receptors  not  only  for  HIV  but  also  for 
HHV-6  (Wahren  and  Linde,  1991).  The  highest  HHV-6  antibody  titres  have  been  found 
in  patients  with  Epstein  Barr  virus  (EBV)  and  HCMV  infections  (Wahren  and  Linde, 
1991).  It  is  likely  that  a  previous  HHV-6  infection  becomes  reactivated  when  a  primary 
infection  with  another  herpesvirus  takes  place  (Wahren  and  Linde,  1991).  It  is  also 
possible  that  HHV-6  causes  reactivation  of  other  herpesviruses  such  as  HCMV  and  EBV 
which  also  reside  in  blood  cells  (Wahren  and  Linde,  1991).  Therefore,  the  high  titre  of 
specific  HHV-6  antibodies  in  other  diseases  with  a  different  pathogenesis  than  HHV-6, 
make  it  difficult  to  evaluate  the  involvement  of  HHV-6  by  detecting  its  specific 
antibodies  titres.  Although  our  findings  in  the  serological  investigations  of  HHV-6  are 
supported  by  the  PCR  results,  the  possible  involvement  of  other  herpesviruses  which 
were  not  investigated  is  not  excluded. 
In  conclusion,  the  results  of  laboratory  investigation  presented  in  this  thesis,  suggest  that 
HCMV  and  VZV  are  not  aetiological  agents  of  recurrent  aphthous  stomatitis.  Although 
there  is  no  established  clinical  manifestation  for  HHV-6  in  the  oral  cavity,  recurrent 
aphthous  stomatitis  may  be  one  of  the  features  of  HHV-6  reactivation. 
The  possible  involvement  of  bacteria  in  the  aetiology  of  recurrent  aphthous  stomatitis  for 
a  long  time  has  been  an  important  issue.  In  most  of  the  bacteriological  studies  an  L-form 
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Neisseria  and  staphylococci  were  obtained  from  major  and 
minor  recurrent  aphthous  stomatitis  (Bartle  et  al.  1963;  Graykowski  et  al.  1964;  Stanley 
et  al.  1964),  and  cross-reactivity  between  Streptococcus  sanguis  and  human  oral  mucosa 
has  been  discussed  as  a  pathologic  factor  in  recurrent  aphthous  stomatitis  (Donatsky, 
1975).  There  have  been  no  reports  to  show  the  presence  of  Mycobacterium 
paratuberculosis.  In  the  present  study,  PCR  detected  Mycobacterium  paratuberculosis 
DNA  in  four  recurrent  aphthous  stomatitis  tissues  (19  per  cent)  but  in  none  of  the  other 
samples.  Recently,  Hassan  et  al  (1995)  reported  73  per  cent  homology  between 
mycobacterial  peptide  91-105  and  human  mitochondrial  116-130  peptide.  Heat  shock 
proteins  are  very  conserved  and  may  cause  cross-reactivity  between  microbial  and 
cellular  host  materials  (Hasan  et  at.  1995).  The  involvement  of  oral  mucosa  in  this  cross- 
reactivity  procedure,  might  be  because  of  the  high  load  of  micro-organisms  in  the  oral 
cavity  (Hasan  et  al.  1995). 
Indeed  a  rabbit  antiserum  against  a  65  KD  heat  shock  protein  of  Mycobacterium 
tuberculosis  reveals  a  corresponding  65  KD  band  with  all  six  Streptococcus  sanguis 
strains  examined  and  Streptococcus  pyogenes  but  not  with  Streptococcus  salivarius 
(Lehner  et  al.  1991).  Significant  anti-65  KD  heat  shock  protein  and  anti-Streptococcus 
sanguis  ST3  antibodies  were  found  in  the  sera  from  patients  with  rheumatoid  arthritis 
and  recurrent  aphthous  stomatitis  but  the  anti-Streptococcus  sanguis  KTH-1,  KTH-2  and 
KTH-3  antibodies  were  found  only  in  Behcet's  syndrome.  Since  the  mycobacterias 
recognise  only  30  per  cent  of  the  entire  length  of  the  65  KD  heat  shock  protein,  the 
streptococcal  antigens  may  share  some  of  the  remaining  70  per  cent  of  the  65  KD  protein 
and  other  heat  shock  proteins.  (Lehner  et  al.  1991)  These  findings  raised  the  possibility 
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I of  cross-reactivity  between  mycobacterial  and  streptococcal  antigens  and  also  the 
possible  cross-reactivity  between  these  speices  with  oral  mucosa,  causing  diseases  like 
recurrent  aphthous  stomatitis. 
Although  in  the  present  results,  there  was  no  significant  differences  between  recurrent 
aphthous  stomatitis  patients  and  controls  with  respect  to  the  presence  of  Mycobacterium 
paratuberculosis  the  presence  of  this  micro-organism  only  in  recurrent  aphthous 
stomatitis  samples,  could  raise  the  possibility  of  involvement  of  this  bacterium  in  the 
aetiology  of  recurrent  aphthous  stomatitis.  More  investigation  is  necessary  to  explain  the 
recurrent  mode  of  the  disease  and  possible  involvement  of  microbial  heat  shock  proteins 
in  recurrent  aphthous  stomatitis. 
6.4.  Conclusion 
Review  of  the  above  discussion  could  be  concluded  as  follow: 
All  patients  should  be  screened  haematologically  for  haematological  deficiencies.  Blood 
tests  should  include  individual  assays  for  iron,  whole  blood  folate  and  vitamin  B12,  in 
addition  to  standard  haematological  examination  of  the  peripheral  blood.  Dietary 
manipulation  should  be  considered  in  those  patients  with  suspected  allergic  reactions  to 
foods.  Patch  testing  is  the  test  of  choice  to  identify  allergic  patients. 
The  symptoms  of  recurrent  aphthous  stomatitis  in  the  majority  of  patients  could  be 
improved  by  local  symptomatic  therapy  in  the  form  of  antiseptics,  local  anaesthetics  and 
topical  corticosteroids.  A  small  number  of  patients  require  on  intermittent  systemic 
corticosteroids. 
220 A  symptomatic  effect  of  5  amino-salicylate  on  decreasing  the  pain  was  observed  in  some 
patients,  but  this  effect  was  not  very  obvious  compared  to  placebo.  Also,  this  study 
showed  that  a  cross-over  trial  is  not  the  study  of  choice  for  investigating  the  effect  of 
drugs  in  recurrent  aphthous  stomatitis. 
In  the  review  of  the  literature,  it  seems  that  the  central  defect,  present  in  patients  with 
aphthae,  is  immunological.  But  the  main  cause  of  these  immunological  changes  is  not  yet 
clear.  A  viral  cause  is  the  most  plausible  factor  in  causing  all  immunological  imbalance  in 
recurrent  aphthous  stomatitis.  However  a  virus  has  not  been  identified. 
From  the  herpesvirus  group,  HHV-6  is  most  likely  to  be  a  cause  of  ulceration  in  this 
disease.  This  involvement  has  been  supported  by  the  findings  of  PCR  and  the  serological 
studies  on  specific  IgG  and  IgM  antibodies  against  this  virus.  A  difference  of  p=0.08  was 
observed  in  the  positivity  of  HHV-6  by  PCR  in  aphthous  lesions  compared  with  normal 
samples.  This  difference  was  increased  to  p=0.0079  by  IFA  in  specific  HHV-6  IgM 
antibodies  when  patients'  sera  were  tested  compared  with  the  control  group.  Such 
differences  were  not  detected  with  HCMV  and  VZV. 
Although  DNA  of  Mycobacterium  paratuberculosis  was  detected  in  four  of  15  samples 
of  aphthous  lesions  and  none  was  found  in  controls,  an  involvement  of  this  bacteria  could 
not  be  supported  only  by  these  findings  and  further  investigation,  especially  in  relation  to 
human  heat  shock  proteins  is  recommended. 
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t Appendix  1.  The  computer  software  provided  for  Oral  Medicine  Audit  system,  specific  to 
oral  ulceration. 
First  Contact  Screen-  First  of  Two 
The  Save  Button  will 
save  the  details  entered 
into  the  screen  to  the 
Database. 
NOT  save  the  data  entered 
Next  Screen  displays 
the  second  of  two 
screens  for  inputting 
data  relating  to  the 
First  Visit. 
lead  to  a  series  of  screens  allowing 
entry  of  data  with  respect  to  these  areas 
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Therapy  and  Investigation  Buttons First  Contact-  Second  of  Two. 
The  Butto 
screen  do  not  change  between  the  First 
and  Second  of  the  First  Contact 
screen.  The  functionality  of  these 
buttons  is  exactly  the  same  as  on  the 
first  screen  described  in  page  3-9 
Flips  back  to  the  first  of  the  screens  of  data. 
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Detail  of  screen  different  to  First  screen. Appendix  II.  Materials  used  in  PCR  and  their  sources. 
DNA 
Oligonucleotide  primers  for  human  herpes  virus  6,  human  cytomegalovirus,  human 
varicella  zoster  virus,  Mycobacterium  paratuberculosis  and  human  ß  haemoglobin 
primers:  Cruaclen  Ltd,  Glasgow,  United  Kingdom. 
DNA  from  HHV-6,  HCMV  and  VZV  (as  positive  control):  Gift  from  Mr.  Duncan  Clark, 
Royal  Free  Hospital,  School  of  Medicine,  London. 
IS900  DNA  from  Mycobacterium  paratuberculosis  (as  positive  control):  Gift  from 
Professor  John  Hermon-Taylor,  St.  George's  Hospital,  Medical  School,  London. 
Enzyme 
Dynazyme  I:  Flowgen  Instruments  Ltd,  Lichfield,  England. 
Chemicals 
PCR  buffer  (Dynazyme  TM):  Flowgen  Instruments  Ltd,  Lichfield,  UK. 
Trise  base,  ethidium  bromide,  EDTA,  sodium  chloride:  SIGMA,  Dourest,  UK. 
Guanidine  isothiocyanate  solution,  agarose:  GIBCO-BRL,  life  technologies  LTD, 
Paisley,  UK. 
Dynawax:  Flowgen  Instruments  Ltd,  Kent,  UK. 
dNTP: 
sd  H2O: 
Miscellaneous  Items 
Polaroid  film  type  667:  SIGMA,  Dorset,  UK. 
Omni  Gene  Thermal  Cycler:  Hybaid  Ltd,  Teddington,  UK. 
DNA  Purification  System 
Wizard  DNA  Clean  up  kit: 
ý. 
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